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Thesis Abstract 
Access to health care is a very important concept which has equally important implications to 
the health status of individuals. However, there have been a lot of debates among researchers 
and policy makers on what constitutes access, and how it can be made less conceptual and 
more operational. The concept of access has continued to receive increased attention because 
of a growing realisation of its importance in health policy. Furthermore, provision of services 
alone without understanding barriers individuals face in accessing services could result in less 
optimal outcomes. It is therefore necessary to have an understanding of what ‘access’  entails 
and factors that influence it if we are to have a real chance of improving access to health 
services and therefore enhance health. 
In this thesis access is viewed as consisting of three (3) interrelated and measurable
dimensions (availability, affordability and acceptability). These access dimensions are related
to both the system and user characteristics. Access is therefore said to have been achieved
when all the three dimensions have been satisfied. Using the above definition of access, the
main focus of this thesis is on access barriers (in relation to the three access dimensions) to
both Tuberculosis (TB) and Antiretroviral Treatment (ART) services in Mitchell’s Plain,
Cape Town South Africa. Secondary cross-sectional data was used for this purpose. Access
to TB and HIV treatment has been given priority because the two diseases have had a 
massive and negative impact on public health in the country. In addition, patients using these
services may face similar barriers to care. 
Findings of this thesis are expected to provide insights into the barriers TB and HIV patients 
face in seeking care vis-à-vis availability, affordability and acceptability of services. Findings
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Part A: Study Protocol 
Assessing access barriers to Tuberculosis (TB) and Antiretroviral 
(ARV) treatment in Mitchell’s Plain, Cape Town 
Synopsis  
 
Purpose of the study 
The purpose of this study is to explore the access barriers to Tuberculosis (TB) and 
Antiretroviral treatment (ART) services encountered by individuals in Mitchell’s Plain (MP), 
one of Cape Town’s sub-districts in the Western Cape, South Africa. The study will also 
assess the extent to which access to these services differs between individuals of different 
socio-demographic groups. 
 
Measurement of Access 
Access in this study context is viewed as the ‘degree of fit’ between providers and users of 
health care, and this access can be explained by the interaction of three distinct dimensions, 
namely availability, affordability and acceptability. This definition of access is adopted from 
McIntyre (2009) and also builds upon Penchansky’s (1983) work. 
 
Study Site 
The site for this study is Mitchell’s Plain (MP), a sub-district of Cape Town. This area is one 
of the most populated and busy places in the city. The site is important for the study purposes 
because it faces public health challenges related to Human Immunodeficiency Virus (HIV) 
and Tuberculosis (TB). 
 
Findings from this study will give health policy makers and facility managers in this area 
insight on what is required to improve people’s access to TB and ART services. It is also 
anticipated that improved access will improve health outcomes and set the country on a path 
to reversing the incidence of these diseases. This will be a positive step to achieving the 
Millennium Development Goals (MDGs)
2
 targets 6.A and 6.C of halting and/or reversing the 
spread of these diseases. 
                                                          
2
 2 The United Nations Millennium Development Goals (MDGs) are eight goals that all 191 UN member states 
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Design of Study 
This study uses secondary data collected in the REACH project, (Researching Equity in 
Access to Health Care), which examines access to health care services by focusing on the 
tracer services of TB, ART and obstetric care in South Africa. The secondary data used in 
this study was collected through a survey conducted within health facilities in Mitchell’s 
Plain, which is one of the four REACH study sites in South Africa. A total of 657 
respondents above 18 years were interviewed using questionnaires administered by trained 
interviewers.  
 
Study Ethics  
Ethics approval for this study will be sought from the University of Cape Town Ethics 
Committee and the study will conform to the requirements in as far as using secondary data is 
concerned. It is important to note that the parent study (REACH), has already received ethical 




Benefits of this study are not only restricted to  aiding MP health managers to improving 
access to TB and ART services, but also include the fact that the improved access to these 
services will benefit the community and future users of these services. The study results will 
further contribute to the existing knowledge on access to TB and ART using methods that 
have not been widely explored. The study will serve as a reference point and will provide 
valuable information to future researchers on related topics in health systems research. 
 
Study Harms 
The study does not anticipate any harm to the participants, but will nevertheless ensure that 
ethical requirements are met with regards to handling of data, i.e. confidentiality and privacy. 
Additionally, since the data do not include any identifying information such as names, 

















P a g e  | 10 
 
Background 
The United Nations 2015 Millennium Development Goals  (MDGs) numbers 6.A and 6.C 
suggest a respective halt and reversal of the spread of HIV/AIDS and other major diseases 
including TB by the year 2015 (UNAIDS 2010a). Despite this, HIV/AIDS and TB have 
continued to cause massive global morbidity and mortality, and there are suggestions that the 
MDGs will not be met. The World Health Organisation (WHO) and the Joint United Nations 
Programme on HIV/AIDS (UNAIDS) statistics on HIV showed that in 2008, there were 
about 2.7 million reported new cases of HIV in the world, and about 70% of these cases 
occurred in Sub-Saharan Africa (WHO 2010, UNAIDS 2008) making Sub-Saharan Africa 
the region with the most HIV/AIDS cases and HIV-related deaths in the world (UNAIDS 
2008).  It is further reported that, in 2009, about 1.3 million people died from AIDS in sub-
Saharan Africa while 1.8 million became infected with HIV (Avert website 2011a). Within 
Sub-Saharan Africa, Southern Africa and in particular South Africa co tinues to be most 
heavily affected by the HIV/AIDS pandemic (UNAIDS website 2009 AIDS Epidemic 
Updates). 
 
Similarly, TB continues to be a public health challenge. The WHO Global Tuberculosis 
Control Report estimated 9.4 million new cases of TB in 2009, most of which (35%) 
occurred in Asia, followed by Africa (30%). These new TB cases brought the total number of 
people living with TB in 2009 to 14 million globally, an increase from an estimated 11.1 
million in 2008 (WHO website 2011a). While TB incidence, prevalence and mortality rates 
have been declining in most regions of the world, Africa is still experiencing massive 
numbers of TB related deaths causing doubts as to whether Africa will be able to meet the 
50% mortality and prevalence reduction targets proposed by the MDGs (WHO website. 
2011b). More specifically, TB remains the leading cause of death in people living with HIV 
in South Africa (Statistics South Africa website 2008). 
 
Not only are TB and HIV/AIDS causing significant morbidity and mortality, these two 
diseases have an intimate relationship in which they reinforce each other to the extent that 
they are commonly referred to as co-infections or co-epidemics (Chamie 2010, UNAIDS 
2010b). As a result, regions that have high HIV prevalence rates tend to also have high TB 
incidence rates (Corbett 2003) resulting from reduced immunity among HIV patients. For 
instance Darley and others (Daley 1992) argue that HIV infection increases the risk of being 
infected with TB, while others have further stated that the risk of getting TB when HIV 
positive continues even for persons on antiretroviral therapy (Chamie  2010), and even after 
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treatment of HIV/AIDS very difficult. Tuberculosis has been noted for increasing HIV 
related deaths on one hand while on the other hand TB in HIV-infected persons is curtailing 
global efforts to control TB, therefore increasing the incidence of TB (Chamie 2010, Wells 
2007). To illustrate this, the WHO (2009) report estimated that of the 1.7 million TB patients 
that died in 2009, 24% of them were HIV positive (WHO 2011c). This co-infection also 
explains why South Africa, the country with the most HIV patients, has one of the highest 
TB-HIV co-infection rates (Avert website 2011b). 
 
As a result of TB/HIV co-infection, it is expected that many of the patients on TB treatment 
are also on ART. The concern therefore is that access barriers to treatment for such patients 
will be higher if they have to receive TB and ART services from different facilities.  There 
have been arguments as a result that, the most effective way to deal with these diseases is to 
address them together (Avert website 2011b), because if they are considered separately, we 
may miss opportunities for the prevention, identification and treatment of TB and HIV/AIDS 
(Coetzee 2004, Wood 2007). The WHO further stresses the importance of having a “one-stop 
shop” in dealing with these diseases (WHO 2005:3). It follows from this that we may get 
better results from studying and analysing these diseases together. It is against this 
background that this study examines access barriers to treatment of both diseases together, 
acknowledging that access barriers affecting one service are likely to affect access barriers of 




Mitchell’s Plain is situated 20 km from the city of Cape Town and is home to approximately 
500,000 people (Cleary et al. 2011), most of whom are ‘coloureds’ (i.e. mixed race) 




MP is the 
third-busiest nodal interchange in the City of Cape Town. Access to public amenities in MP 
is very challenging and as a result most residents have not completed high school and 
therefore mostly engage in informal businesses (Department of Provincial and Local 
Government; Mitchell’s Plain Nodal Economic Development Profile: No date). In terms of 
health services, MP is served by ten clinics, three Community Health Centres and one 
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Problem Statement and Study Justification 
 
Overview: South Africa 
South Africa continues to be the country with the largest number of people living with HIV in 
the world. It was estimated in 2009 that the country had a total number of 5.7 million people 
living with HIV (UNAIDS/WHO/UNICEF 2009). In relation to TB, South Africa had the 
third highest TB incidence rate in the world following India and China, in 2009 (WHO 2009). 
And even after substantial resources were dedicated towards the fight against TB and HIV in 
2008, South Africa could still not reach the National Strategic Plan target of screening HIV 
positive people for TB in this year. It is reported that only about 3% of HIV patients received 
TB prophylactic preventive treatment against a national target of 60% – all    this against a 
disease that is a leading cause of mortality among people living with HIV in the country 
(Republic of South Africa 2010). 
 
Western Cape and Cape Town 
Tuberculosis (TB) and HIV are among the four leading causes of mortality in the Cape Town 
Metro district (WHO website 2011d). Although the Western Cape has the lowest HIV 
prevalence in South Africa (Republic of South Africa 2010), prevalence is highly 
heterogeneous, with some sub-districts like Khayelitsha having very high prevalence (Shaikh 
2008). It has also been reported that the TB incidence in the Western Cape is amongst the 
highest in the world (City of Cape Town. 2003) and it may get worse considering the 
numbers of new cases of Multi-Drug-Resistant TB (MDR TB) that are being diagnosed every 
year in the province (Cape Gateway website 2011). The high urbanization and migration 
experienced in the area may be a contributing factor to increasing cases of TB and HIV. 
 
Mitchell’s Plain 
Mitchell’s Plain, like any other sub-district of Cape Town, faces health challenges mostly 
from HIV/AIDS and TB. For instance, statistics on TB reveal that, in 2006, MP had the 
fourth highest incidence of TB in the Cape Metropole (Capegateway website 2011). In 2010, 
HIV/AIDS and TB were respectively ranked as second and third highest causes of mortality 
in Mitchell’s Plain, behind homicide (Groenewald et al. 2010). It is important to note though 
that HIV services in this area are still not readily available which may not be a positive sign 
for the fight against HIV/AIDS. At the moment for instance, ART services in MP are only 
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ensuring easy access to those in need of this service, and also to reducing the opportunity cost 
associated with seeking care such as reduced time taken to see a health worker (Capegateway 
website 2011). 
 
It has also been shown that MP and Khayelitsha’s economies are dependent on each other 
(Department of Provincial and Local Government, Mitchell’s Plain Nodal Economic 
Development Profile), meaning that individuals move between these two areas for business 
purposes, school etc. The problem is that interdependence and proximity to Khayelitsha, a 
sub-district with some of the highest prevalences of TB and HIV/AIDS in South Africa 
(Western Cape Province Department of Health 2009), may potentially affect MP’s TB and 
HIV/AIDS incidence in the long run. 
 
Justification 
The previous section of this chapter has highlighted problems caused by TB and HIV/AIDS 
in South Africa and more specifically Western Cape and Mitchell’s Plain. This means that 
attempts should be made to come up with ways and means of countering the burden caused 
by these diseases if MDG 6A and 6C are to be realised. There have been efforts to this effect 
in South Africa. For instance, the government has committed itself to ensuring universal 
access to ART and has embarked on the largest antiretroviral treatment programme in the 
world (UNAIDS/WHO/UNICEF 2009). However, it can be argued that making medicines 
available alone is not sufficient, unless these medicines are made accessible to those that need 
them (Obrist 2007). It follows from this that it is relevant to examine barriers that people face 
in accessing TB treatment and ART. The hope is that findings from this study will be a 
pointer to health policy makers at various levels of care in improving access to treatment, so 
as to lessen the TB and HIV/AIDS stranglehold and hopefully improve health outcomes for 
patients. 
 
Further, it has also been shown that the most disadvantaged segments of the population face 
disproportionate ill-health, and are also more likely to face higher access barriers to health 
care than their wealthier counterparts (Whitehead 1992, Gilson 2007). With this in mind, the 
study will attempt to assess whether access to TB and ART in MP is equitable by assessing 
access differentials by socioeconomic status and gender. Findings on this should give insights 
about how services can be better realigned to improve access to health care by the more 
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The importance of this study derives also from a realisation that, apart from the REACH 
project, there has not been a study that has attempted to measure access to TB and ART 
services in Cape Town, let alone South Africa, using a comprehensive approach to the 
conceptualization and measurement of access along the three key dimensions of availability, 
affordability and acceptability. This means that there is a gap in the literature, thereby making 
this study important. Findings of this study will offer valuable inputs to researchers and 
relevant stakeholders on the structuring and organising of TB and ART services in South 
Africa, in an attempt to get the most out of TB and HIV/AIDS interventions. Also, the 
methods of measuring access used in this study could be applicable to research in other low 
and middle-income countries. Other beneficiaries of this study include the Western Cape 
department of Health and health system managers in Mitchell’s Plain. 
 
Lastly, as long as TB and HIV/AIDS are not under control, there is a need to continue 
looking for new approaches to tackling the burden caused by these diseases besides ensuring 
availability of medicines. It may entail improving access to medicines for those in need 
regardless of their socio-economic background. Such improvements are expected to improve 
patient in-take, patient compliance and possibly efficacy of medicines, and also future 
effectiveness of TB and HIV/AIDS interventions. The next section discusses the concept of 
access and the definition that has been adopted for this study. 
 
Literature Review 
What is Access to health Care? A Conceptual Framework 
Various attempts have been made to derive an operational definition of access and this is 
because access is at the “core of health systems” (Gulzar 1999: 14); if services were designed 
in such a way as to alleviate access barriers, this might lead to a more appropriate use of these 
services by those in need (Aday 1975a). In this study, access is defined as “the empowerment 
of an individual to use health care and as a multidimensional concept based on the interaction 
(or degree of fit) between health care systems and individuals, households, and 
communities”(McIntyre 2009: 179). Empowerment of individuals and interactive 
communication between providers and users are viewed here as key components that 
determine the level of access to be realised. 
 
To make the notion of access more comprehensible, the study will use three distinct 
dimensions related to both the health system factors and users’ characteristics, these being the 
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dimension is about “whether the appropriate health care providers or services are supplied in 
the right place and at the right time to meet the prevailing needs of the population” (McIntyre 
2009: 184). It can also be viewed as the extent to which provided services meet the needs of 
clients (Obrist 2007). The availability dimension can further be broken down, based on the 
McIntyre (2009) framework, into four elements: 1). how the location of services relates to the 
location of clients, 2). the “ability and willingness” of providers to offer services desired by 
the people, 3). the ‘degree of fit’ between the services’ operation hours and the time clients 
need services, and 4). the “relationship between the type, range, quantity and quality of health 
care services” in relation to the health needs of the users (McIntyre 2009: 184). 
 
The affordability dimension is an association between the total costs of health care – direct 
and indirect – and the users’ ability to pay these costs (Penchansky 1981, Obrist 2007, 
McIntyre 2009). Direct costs include all the health care costs directly related to health care at 
the point of use i.e. consultation fees, fees for any tests and costs of medicines  (McIntyre 
2009). Indirect costs on the other hand are costs incurred but not directly related to medical 
costs e.g. transport costs, money for food, lost income due to seeking care and lost 
productivity resulting from sickness (Obrist 2007, McIntyre 2009). Considering that being 
able to pay health care costs is dependent on the users’ ability to pay, factors such as income, 
medical insurance cover and household assets play a vital role in this dimension. 
 
The acceptability dimension is defined as the fit between providers and clients’ expectations, 
characteristics, practices, beliefs etc. towards each other (McIntyre 2009, Obrist 2007, 
Penchansky 1981). The importance of the acceptability dimension has been highlighted by 
some authors because of its relation to trust and equity (Gilson 2007). It has been argued that 
once providers’ expectations, characteristics, practices, beliefs and other related factors fit 
with those of their clients, trust between the two sides is enhanced. This trust will prompt the 
disadvantaged, who suffer more from acceptability and trust barriers, to access services more 
and hence promote equity (Gilson 2007). 
 
The figure below (Figure 1) represents a simplified illustration of how the system factors and 
individual factors interact amidst the availability, affordability and acceptability dimensions 
to achieve access. The figure shows that access is dependent on the interaction between the 
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Figure 1: The Access framework – Adopted from Thiede 2007 
 
In summary, access is defined as the empowerment of individuals to use services, where 
access is a multidimensional concept (availability, affordability and acceptability) whose 
achievement is based on the interaction between system and individual, household and 
community factors (McIntyre 2009).  
 
Empirical Review 
Objectives of the Review 
The objective of this review is to explore evidence from studies that have been conducted 
examining access to ART and TB treatment. The review will compare findings from various 
locations focusing on methods used to measure access to treatment and also identify gaps in 
this literature. This empirical review is a summary of the review that will be done in the next 
chapter (Part 2: structured literature review). 
 
Access to ART  
A study conducted in Zambia utilising ethnographic case study methods attempted to 
examine how TB patients co-infected with HIV accessed Antiretroviral (ARV) services 
(Chileshe 2010) . The study findings showed that access to treatment was affected by 
economic factors such as costs associated with accessing care i.e. transport costs, and also 
ownership of assets and income. Other factors identified included location of facilities 
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as congestion, faulty equipment etcetera. Access was also affected by social factors which 
were causing some patients to reject diagnosis. Cultural or traditional issues have also been 
shown elsewhere (Kwalombota et al. 2004) to be important determinants of access to ART 
services among African women.  
 
Other important determinants of access to ART services identified by some of these studies 
were financial factors or costs associated with treatment, both direct and indirect 
(Khonyongwa 2004, Kwalombota et al. 2004, Adeneye 2006, Mauch 2011, Mshana 2006, 
Posse 2008), as well as distance or location of facilities relative to clients (Dimbungu et al. 
2004, Khonyongwa 2004) and availability of facilities and needed services (Dimbungu et al. 
2004, Khonyongwa 2004, Kwalombota et al. 2004). 
  
Other factors influential in accessing ART services include the opportunity costs associated 
with seeking care, such as loss of income and impact of treatment on households (Mshana 
2006, Sanou 2004), stigmatisation of people living with HIV  (Dimbungu et al. 2004, Mshana 
2006) and lack of information or knowledge by clients about services (Dimbungu et al. 2004, 
Kwalombota 2004). Staff attitudes such as impoliteness, long waiting times (Mshana 2006), 
and inability to adequately sensitize the community and involve them in the planning of ART 
services (Dimbungu et al. 2004) were also mentioned as important in access to ART.  
 
Access to TB treatment 
Findings from reviewed studies on access to TB treatment were very similar to those from 
access to ART services. All the reviewed studies on access to TB treatment identified 
financial factors as key access barriers to seeking treatment (Eastwood 2004, Fong 2004, 
Sanou 2004, Xu 2004, Aye 2010, Mauch 2011). Other barriers to access included geographic 
factors such as distances to facilities and time taken to reach them (Fong 2004, Sanou 2004, 
Aye 2010), lack of knowledge by patients about TB services and symptoms (Eastwood 2004, 
Fong 2004, Sanou 2004), the opportunity cost associated with seeking care (Eastwood 2004, 
Sanou 2004), cultural factors such as the tendency for patients to seek care from traditional 
healers and self-treat (Sanou 2004) and for women to be culturally expected not to seek care 
without their partner’s consent (Eastwood,  2004).  
 
Some studies also showed that stigmatization of TB patients can affect their access to 
treatment (Aye  2010, Eastwood 2004), while two studies conducted in China showed that the 
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(Fong 2004, Xu 2004). Lack of privacy in the facilities was shown to be important to 
women’s access to treatment (Eastwood 2004), and also health care staff’s attitudes to 
patients such as the willingness to provide services (Fong 2004) and the distance they kept 
from clients (Sanou 2004). Other factors cited as affecting access to TB treatment include sex 
of patient (Eastwood  2004, Fong 2004), age and ownership of insurance (Xu  2004) and also 
side effects of the treatment (Aye  2010). 
 
It can be seen from the empirical review that determinants of access to both ART and TB are 
very similar between the two treatments. Relating the findings to the definition of access used 
in this study, the various findings have focused on the affordability and availability 
dimensions by respectively examining direct and indirect costs of treatment, and location of 
facilities and services offered. The reviews also show that not so much emphasis has been put 
on the acceptability dimension. In addition, the reviewed studies have tended to analyse 
access from one perspective i.e. the users’ without considering the ‘degree of fit’ between 
providers and seekers of treatment which is the definition of access used in this study. This 
shows the gap in the definition of access where only two dimensions receive attention while 
neglecting one, and this gap effectively makes this study relevant as it attempts to examine 
access in an integrated way using all three dimensions.  
 
Research Question 
What are the access barriers to using ART and TB treatment? The case of Mitchell’s Plain in 
the Western Cape, South Africa. 
 
Objectives of the Study 
The study will explore the access barriers to the use of TB and ART services in Mitchell’s 
Plain with a view to identifying policy-relevant solutions to these barriers. A further objective 
will be to explore whether these barriers differ between socio-demographic groups. Access 
will also be examined according to self reported adherence after which policy 
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Specific Objectives 
The study has three (3) specific objectives and these are to: 
1. Explore access barriers to TB and ART services in Mitchell’s Plain using the 
availability, affordability and acceptability dimensions, and provide solutions to 
improving access. 
2. Explore the socio-demographic differences in access to TB and ART services. 
3. Examine access barriers according to self reported adherence 
4. Present study findings and policy recommendations to various stake holders. 
Methods and Analysis 
As mentioned earlier, this study is part of a larger project, REACH (Researching Equitable 
Access to Health Care) and will therefore utilise secondary data from the survey conducted 
by the REACH project in Mitchell’s Plain. REACH is a five year project examining health 
systems access and equity in four sites across South Africa (REACH 2009) with Mitchell’s 
Plain being the site selected in the Western Cape. Given that these data have already been 
collected, the methods section will concentrate on methods of data analysis. 
 
Analysis 
Firstly, data will be explored so as to inform the type of analysis to be done. For non-
normally distributed variables, data transformation will be done, for example logarithmic 
transformation for variables which are right skewed and x
2
 transformation for those left 
skewed or non-parametric tests will be used. The importance of ensuring that variables are 
normally distributed is because statistical methods used in analysis assume normal 
distribution of data (Park 2008). In the event that variables are not normally distributed, an 
appropriate transformation, as described above, can be conducted. However, it is still possible 
to proceed with variables that are not normally distributed by using non-parametric tests, as 
these do not make any assumptions about normality of data (Fletcher 2009). 
 
Analysis will be done using Univariate, Bivariate and Multivariate methods. Univariate 
analysis will be used to describe the basic characteristics of the data e.g. sex, marital status, 
and age of respondents etc. Univariate analysis will inform on the type of analysis to be used 
(Park 2008). For example, it will show how the variables are distributed, thereby making it 
possible to decide between parametric/non-parametric methods, or whether or not to 
transform the data. Bivariate analysis, as the name implies, will be done to examine any 
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Bivariate analysis will be further used to determine if there are any potential confounding 
variables. For instance, it will be used to determine whether marital status is associated with 
borrowing money to pay for health care. Correlation coefficients will be computed to explore 
associations between numerical dependent and independent variables such as age and money 
spent on health care (both numeric variables). Parametric or non-parametric tests will be used 
to test associations between numerical and categorical dependent and independent variables, 
e.g. marital status (categorical independent) and money spent on health care (numerical
dependent). Chi-squared tests will be used to test associations between categorical dependent 
and independent variables such as marital status and having a treatment buddy (both 
categorical).  
Multivariate analysis will be used for analysing the final model because it will comprise of
more than two variables (Abdi 2003). The final model will be run using a logistic regression
for binary dependent variables while a linear regression will be run for quantitative dependent
variables. The final model will be the one with the lowest Akaike Information Criterion
(AIC)
3
and largest log likelihood
4
. Data analysis will be done using STATA version 11 for
Windows. (StataCorp. 2009. Stata Statistical Software: Release 11. College Station, TX: 
StataCorp LP).
Measurement and variables 
As discussed in the literature review, access in this study is defined using three dimensions 
(availability, affordability and acceptability) and as such variables in the questionnaire for the
study were designed to capture the notion of access as a multi-dimensional concept with these
three distinct and measurable dimensions. The table below shows dependent variables
measuring these dimensions and respective independent variables that will be run in the 
logistic models built for binary dependent variables, and in the linear regression models for
quantitative dependent variables. Note that the same independent variables will be regressed
with various dependent variables across the three dimensions, from both the ART and TB
tracers.
3
AIC is an estimator  that shows the amount of information lost when one model is used to represent another (Posada, 
2004)
4
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Table 1: Variables used in the analysis 
1. Social Economic Status and Demographic Variables 
- Categorized asset index 
- Employment of the respondent 
- Marital status of the respondent 
- Sex of respondent 
- Number of years of education 
- Age 
- Receiving a disability grant 
- Monthly household expenditure 
2. Availability variables 
- Time taken to travel to facility and home again 
- Time taken to fetch medicines during last visit 
- Time taken to see doctor or nurse during last clinical visit  
- Able to travel by foot to facility 
3. Affordability Variables 
- Money spent on other providers during past month (GPs, traditional healers etc.) 
- Money spent on self-care during past month (over the counter medicines, special foods, 
traditional medicines)   
- Money spent on most recent facility converted into monthly amount (transport, phone, food, 
etc.)  
- Total monthly expenditure on health care (Cost on Other Prov+ on Self-care + on most recent 
facility visited) 
- Needing to borrow money to pay for health care  
- Expenditure on health care >10% household expenditure 
4. Acceptability Variables 
- The health worker is too busy to answer my questions  
- Respondent agrees that queues are too long  
- Respondent agrees that some staff do not treat patients with sufficient respect    
- Respondent agrees that the health care facility is dirty 
- Respondent feels that people in the community judge him/her negatively for attending the TB 
or ART facility 
5. Adherence Variables 
- Ever missed taking your ARV or TB medicines 
- Ever missed a visit to the ART or TB facility 
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Ethics 
As mentioned in the first part of the protocol, this study is using secondary data from the 
REACH project which has already received ethical approval from the University of Cape 
Town Research Ethics committee. This study will therefore abide by the ethical regulations in 
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Part B: Literature Review 
Conceptual Review of Access to Health Care 
 
A number of definitions of access have been proposed in the literature. Some have defined 
access as the utilisation or use of health care services (Shortell 1973, Donabedian 1972, Fox 
1972, Aday 1974, Salkever 1975), arguing that proof of access should be evident in the use of 
services (Donabedian 1972, Aday 1974). Some proponents of this definition further claim 
that examining utilisation rates can inform on whether or not those in need of services have 
access to them (Shortell 1973). Similarly, Salkever (1975) claims that, “access is described 
by the empirical relationship between need and the probability of entering the health care 
system for treatment” (p. 373). For all of the above authors, when clients utilise health care 
systems, then access has been achieved. 
 
Other authors, though, have different views of access and define it in terms of adequate 
availability or supply of health care services in meeting people’s health needs (Fein 1972, 
Freeborn 1973, Mooney 1983, Rogers 1999, Goddard 2001, Gulliford 2002). It is argued 
from this perspective that having the right services available to the people, i.e. a multi-skilled 
workforce, facilities, and availability of other necessary services convenient to the people at 
an appropriate time, is indicative of access (Freeborn 1973, Rogers 1999, Goddard 2001). 
The implication of this is that the further away individuals are located relative to location of 
services, the lesser access to health care they have, as argued by Mooney (Mooney 1983). 
While acknowledging that acc ss is also determined by factors such as costs of health care, 
cultural factors and other factors, Gulliford (2002) maintains that “having access to health 
care requires that there is an adequate supply of health services available” (p. 186). For this 
group of authors, availability of facilities and services is viewed as the most important in 
achieving access. 
 
Contrary to those that define access as adequate supply of needed services, others have 
defined it as a demand side concept and consider users’ ability to pay for health care, or being 
in possession of assets to help them do so, as reflecting access (Simpson et al. 1997, Weinick, 
Weigers & Cohen 1998, White 2002, Falkingham 2004). The proponents of this definition 
consider having health insurance cover, sufficient financial resources to afford health care 
costs, and also other forms of ability to pay as key to accessing health care services (Simpson 
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side factors that have been cited to affect access include users’ “knowledge about health and 
health services, perceptions and preferences” (Thiede 2005).  
 
There are, however, authors who feel that the above access definitions have flaws, and argue 
that access should not be defined solely in terms of system utilisation, availability and supply 
of services, nor as a demand side concept. These authors (Donabedian 1973, Aday 1975, 
Andersen 1983, Khan 1994), realised that the co-existence of both health system factors and 
users’ characteristics are important determinants of access. They argue that the coexistence of 
certain system factors such as how the health system is organised, availability of services and 
appropriately trained health workers and user factors such as the cultural background of 
users, attitudes towards treatment, education level, gender sex and age etcetera, will 
determine whether or not individuals seek health care (Khan 1994, Gulzar 1999). For Thiede 
(2005), even after arguing for the importance of demand side factors to access, as discussed 
above, the author also acknowledges the importance of supply factors in achieving access. 
Achieving access, to these authors, is only possible if both supply and demand side factors 
are considered together. 
 
After reviewing these various definitions, this study acknowledges the importance of both 
system and user factors when defining access. However, it is felt that not enough was done by 
proponents of this definition, such as showing under which conditions access is achieved, or 
how system and user factors combine to achieve access. This study therefore goes beyond 
just acknowledging the co-existence of system and use factors to achieve access, and defines 
it (access) as the ‘degree of fit’ or compatibility between the health system and individuals in 
need of health care services. This definition has been used by others {{68 Penchansky,R. 
1981; 40 McIntyre,D. 2009}}. The ‘degree of fit’ which facilitates access should represent an 
interactive communication between service providers and health seekers such that it 
empowers individuals to use services {{40 McIntyre. 2009}}. Empowerment of users and 
interaction between providers and users are cornerstones of access in this study. 
 
With regards to those who have defined access as utilisation of services, the argument from 
this study perspective, and of proponents from whom this study definition is adopted {{90 
Thiede,M. 2008; 40 McIntyre,D. 2009}} is that making services available only offers  
individuals the opportunity to use services, but is not on its own enough to guarantee  access. 













P a g e  | 31 
 
necessarily result in use if an individual chooses not to use these services. Another author 
considers access as a “precondition to health services utilisation” {{90 Thiede,M. 2008}}. 
 
The argument levelled against defining access as a supply side concept on the other hand, is 
on the premise that availability and adequacy of health care services alone, are not enough to 
empower users and therefore guarantee access. Admittedly, adequate supply of services 
reduces the physical distance, and therefore transportation costs for users, but is not sufficient 
to give users the “freedom to use services” {{188 Thiede,M. 2005; 40 McIntyre,D. 2009}} as 
is the case with access. Thiede (2005) further adds that ensuring service availability alone, 
without “interchange of information” between providers and users, is not enough to achieve 
access (p. 1453). Others for example have stated that having services alone cannot represent 
access if users are unable to afford payment for the services provided {{44 Gulzar,L. 1999}}. 
The weakness of viewing access as a supply side phenomenon is clear – it fails to account for 
important user characteristics and backgrounds that may make individuals decide to use or 
not to use services, even when facilities are available e.g. socio-cultural issues such as 
religion and cultural orientation (Puentes-Markides, C. 1992) {{188 Thiede,M. 2005}}. 
 
Similarly, viewing access as a demand side concept, as argued by some authors, has not been 
considered an appropriate definition from this study perspective. This is because factors such 
as ability to pay for health care - the main driver of the demand side argument - fail to explain 
system deficiencies that can affect access. Two studies on access to Antiretroviral treatment 
(ART) showed that even when users demand services, access may not be realised if needed 
services are not available (Dimbungu et al. 2004, Chileshe 2010). It follows from this that the 
demand for health care services is also not so important if health workers are unwilling to 
attend to patients. As mentioned above, access is more likely to be achieved if there is 
interplay between system and user factors such that it results in desired services being 
provided, and also empowers individuals to use these services {{188 Thiede,M. 2005; 90 
Thiede,M. 2008; 40 McIntyre,D. 2009}}.  
 
In summary, access to health care in this study is defined as the communicative interaction 
between health providers and users of services (degree of fit), giving users the power to give 
their input on how services are to be made available, and also to have the freedom to decide 
when to use these services {{68 Penchansky,R. 1981; 90 Thiede,M. 2008; 40 McIntyre. 
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some authors, and also an in-depth discussion of the dimensions that have been considered to 
be appropriate for this study, and why these have been chosen. 
 
Access dimensions and barriers 
Given the complexity of the access concept, some authors (Penchansky, 1981; Obrist. 2007; 
McIntyre. 2009), have attempted to define a number of dimensions of access. It is argued that 
this conceptualization will assist in the empirical measurement of access barriers. These 
authors argue that if the developed access dimensions are considered independent of each 
other, access cannot be achieved. Rather, there is need for interaction between the 
dimensions, as it is from this interaction that we can explain why individuals may or may not 
use health services. Unpacking access in terms of these dimensions, rather than a single 
concept, may put to rest the debates on the meaning of access to health care (Gulliford 2002), 
and this will hopefully result in the appropriate use of access (Gulzar 1999).  
 
Penchansky (1981) has argued that access could be conceptualized as consisting of five 
dimensions, namely: availability, accessibility, accommodation, affordability and 
acceptability. The author defined availability as the relationship between the “volume and 
type” of services offered by the health care system, to those that are needed by clients. The 
accessibility dimension is viewed as the relationship between the location of health care 
services to the location of clients served, while the accommodation dimension is defined as 
the relationship between the way in which the health care system is organised and the clients’ 
response to this organisation. Affordability is viewed as the relationship between the costs of 
health care and payment mechanisms to the clients’ “ability to pay”. Lastly, Penchansky 
defines the acceptability dimension as “the relationship of clients' attitudes about personal 
and practice characteristics of providers to the actual characteristics of existing providers as 
well as to provider attitudes about acceptable personal characteristics of clients” (Penchansky 
1981) 
 
Following up on Penchansky’s work, Obrist (2007) also came up with five dimensions which 
are very much identical to the former’s work, with the only difference being that Obrist 
replaced the ‘accommodation’ dimension with the ‘adequacy’ dimension. However, 
reviewing both the accommodation and adequacy dimensions reveals that these two 
dimensions are very similar because they are both concerned with issues of health care 
system organisation and how these fit into clients’ expectations. This means that the 
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Unlike the two authors discussed above, McIntyre (2009) only developed three dimensions 
namely availability, affordability and acceptability. The major departure point between the 
McIntyre dimensions and those of the other two authors is that McIntyre collapses some of 
the previous authors’ dimensions together to come up with only three dimensions. For 
instance, McIntyre combined three of Penchansky’s dimensions (accommodation, 
accessibility, and availability) into what the author (McIntyre) called “a comprehensive 
definition of availability” (McIntyre 2009). McIntyre argues that all the aspects of 
Penchansky’s accommodation, accessibility and availability dimensions are captured under 
the author’s availability dimension, when it is defined as the “right health services being 
available in the right place and at the right time” (McIntyre 2009). Given that Obrist’s 
adequacy dimension is not differentiated from Penchansky’s accommodation dimension, it 
implies therefore that even the adequacy dimension is captured in McIntyre’s availability 
dimension. 
 
Further review of other dimensions common among these authors reveals that the McIntyre 
affordability dimension includes all the direct and indirect costs associated with health care. 
This means that the McIntyre affordability dimension encompasses that of Penchansky who 
defines his almost exclusively in terms of direct health care costs; and also Obrist’s, who 
defines it both as direct and indirect health care costs (Penchansky 1981, Obrist 2007). In 
addition, McIntyre’s affordability dimension goes further to include the “potential impact on 
household well-being of using household resources to cover the full cost of health care” 
(McIntyre 2009). The impact of health care costs on households has also been shown by other 
authors to be an important element in individuals’ decision on whether to use or not to use 
health care services (McIntyre 2006, Wagstaff 2003, Xu 2003). 
 
Looking at the acceptability dimension, both Penchansky (1981) and Obrist (2007) define it 
in terms of the relationship between what the clients expect from their providers and what 
they really get, and vice versa. Obrist though goes somewhat further to acknowledge the 
importance of information sharing between both sides, to enhance acceptability: such as 
whether clients feel cared for, clients trust their providers and also whether treatment takes 
into account “local illness concepts and social values”(Obrist 2007). Similarly, others 
(Hausmann-Muela et al 2003 as cited in (Gilson, McIntyre & Mooney 2007)) have defined 
acceptability as “the social and cultural distance between health care systems and their users” 
(p. 125). McIntyre, on the other hand defines the acceptability dimension as the fit between 
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also expectations of each other (McIntyre 2009). In addition, McIntyre identifies problems 
related to the acceptability dimension as resulting from the normative organisation of the 
health system where users are expected to take services as presented to them without any say 
(McIntyre 2009). It is argued rather that, to enhance access, the focus of a health care system 
should be on “conditions required to empower individuals to use services” (McIntyre 2009).  
Though the acceptability dimension of access has been less explored than the other two
(Gilson, McIntyre & Mooney 2007, Peters 2008), some consider it to be the most important
aspect of access, because it draws attention to the potential for positive interpersonal 
communication and trust to enhance access (Gilson, McIntyre & Mooney 2007). To highlight 
the importance of the acceptability dimension in access, Gilson (2007) categorises it into 3 
elements; 1) “fit between lay and professional health beliefs”, 2) “Nature of patient-provider
engagement and dialogue”, and 3) “Organisational arrangement of health care”(p. 126). The
first element has to do with how health care beliefs of users and their communities are
aligned with the views of health care by providers, and how this can enhance or impede the
use of services. The example of this was demonstrated in a study which explored barriers to
health care in which users rejected a medical diagnosis, and where this refusal was attributed
to the social and cultural gap between providers and users of services (Goudge et al. 2009). 
Following such incidences, some authors have advocated for increased communication
between providers and users regarding health beliefs so as to improve relationships between 
the two sides, and therefore increase acceptability of services (Gulliford et al. 2001). 
The second element focuses on communication between patients and providers, and how this 
is important in ensuring that providers gain trust of their patients and become empowered to
make use of services. Communication and its importance in acceptability of care and in
access has also been mentioned by others (McIntyre 2009, Thiede 2008). 
The third element is concerned with how services are tailored with regards to the needs of the 
people, and how this determines whether or not individuals use services or not. The 
organisational arrangements mentioned here may include provider characteristics or attributes 
such as type of provider, age, gender, race or ethnicity and religious affiliation of both 
providers and users. This means Gilson’s third acceptability element is closely related to 
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An important point worthwhile noting as we endeavour to bring the access concept to life, is 
that it is not enough to only understand factors that facilitates the realisation of access, but 
need also to examine factors that may hinder access so as to have an idea of how to overcome 
them (Aday 1975, McIntyre 2009). In the literature, barriers in access to health care have 
generally been associated with health system factors and user characteristics (Donabedian 
1973, Aday 1975, Andersen 1983, Khan 1994). Barriers relating to the health system have 
mostly been about issues of availability, which include supply, location and organisation of 
services (Donabedian 1972, Fox 1972, Obrist 2007).  
 
The issues of acceptability under the health system factors have only been mentioned when 
the organisation of services affect the social and cultural interactions between providers and 
users, i.e. how system treatment practices are organised to take into account users’ cultural 
orientation (Obrist. 2007). User barriers have mostly been associated with being able to pay 
for health services while availability and acceptability have received less attention. Ability to 
pay for health services includes users’ income, medical insurance cover and 
individual/household assets (Fox 1972, Andersen 1983, Obrist 2007). Availability barriers on 
users’ side include spatial factors or location of users relative to facilities, and how education, 
information, social and psychological factors influence users to avail themselves for care 
(Donabedian 1972, Stewart 1990). Acceptability barriers on the other hand may include 
users’ attitudes towards health care, their cultural backgrounds, and to some extent their 
social orientation, level of education and information factors (Donabedian 1972, Andersen 
1983, Khan 1994, Stewart 1990). Other access barriers that may fall in any of the three 
categories (availability, affordability and acceptability barriers) include sex, age, race, 
religion etc. 
 
This study will adopt the access dimensions developed by McIntyre and others (2009) – 
availability, affordability and acceptability. It is felt, from this study perspective, that the 
McIntyre dimensions are more comprehensive than those of the other two authors. For 
instance, it has been shown above that the McIntyre availability definition encompasses all 
aspects of Penchansky’s three dimensions; accommodation, accessibility, and availability 
(McIntyre. 2009), and one of Obrist’s dimensions (adequacy). It can be argued that the 
collapsed dimensions are not very different from each other, and therefore combining them is 
better than having to debate on for instance, how accessibility differs from availability. It can 
also be asserted that McIntyre’s other two dimensions –affordability and acceptability – have 
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how McIntyre’s affordability dimension takes into account both Penchansky and Obrist’s 
respective affordability dimensions. McIntyre goes even further to explore other issues under 
this dimension that are not alluded to by the other authors, such as the impact on households 
of seeking care. Though the acceptability dimension seems to be defined in a similar manner 
by all the authors, McIntyre’s dimension in addition discusses problems relating to 
acceptability, and proposes solutions.   
 
The other factor emphasised by the McIntyre framework and viewed as important to access in 
this study, but not tackled by the other two authors, is that of empowering health care users 
(McIntyre 2009).  The argument is that access does not only mean achievement of any one of 
the dimensions, but rather entails exchange of information and interaction between users and 
providers across the dimensions. This is aimed at sufficiently empowering individuals to use 
health care services and enable them to have command of health care resources (Gulliford et 
al. 2002). Information dissemination has been viewed by many as an essential pre-requisite to 
achieving access, and also critical in overcoming barriers to accessing health care (McIntyre 
2009, Thiede 2008, Nutbeam 2000).  It may be added here also that empowerment should not 
be one sided i.e. only to users, but should also extend to providers to enable them to improve 
their capacity and be able to provide that which is desired by users. As a result of the 
importance of empowerment in using health care services, this study therefore defines access 
to health care as the “empowerment of individuals to use health care services” (McIntyre 
2009). 
 
To make the discussion of access easy to follow and understand, Thiede (2007) and McIntyre 
(2009) developed two frameworks that summarise access: what it involves and how it is 
achieved. The two frameworks are: the Access framework (figure 1) and the Access 
evaluating framework (figure 2). The Access framework shows the three access dimensions 
and how they rely on each other in bringing about the degree of fit between the health system 
factors and the individual/household factors discussed above. It reinforces the assertion that 
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Figure 1: The Access framework – Adopted from Thiede M, 2007 
 
 
Figure 2: Access evaluating framework – Adopted from McIntyre 2009 
 
 
The Access evaluating framework above (figure 2) shows how the three dimensions relate 
and interract with each other, and also factors that define them in moving towards achieving 
access to health care. Borrowing from the McIntyre (2009) illustration for instance, we see 
that if the scope of staff training is in accordance with the needs of clients (root causes stage), 
then they will be better placed to meet the needs of the community with a range of services 
(factors) and effectively improve service availability (availability dimension). This 
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Importance of Access in Health care 
The importance of understanding access to health care is linked to the key role that it plays in 
health policy (Penchansky 1981, Eckert 2004). Others have pointed out that understanding 
what access is will enable policy makers to be able to identify factors that influence and/or 
constrain individuals to seek care from a health care system (Lewis 1977). Furthermore, 
having a comprehensive definition and understanding of access is a very important health 
policy tool to improving service provision and health status of the population (Gulliford 
2002, Aday 1975). It follows therefore that, without the knowledge of what access is, the 
work of health care professionals and policy makers would be hampered (Khan 1994). Obrist 
has argued for the importance of access to services by stating that the impact of medicines or 
treatment would not be realised if users have no access to them (Obrist 2007). For instance, a 
study in Zambia (Grant 2008) noted that making medicines available in facilities was not 
accompanied by improved access to services. This partly explains why the notion of access 
has been emphasised by policy makers when public health goals are dependent on patients 
being compliant to medicines, as is the case with TB and ART (McIntyre 2009). 
 
Similarly, Khan (1994) claims that knowledge of access by policy makers will help them to 
make the appropriate adjustment needed so as to ensure access at whatever level of care. 
Using another example from McIntyre (2009), if services are available and affordable but 
users are facing acceptability barriers, policy makers can then make necessary adjustments in 
this regard such as ensuring that providers take into account the cultural or religious beliefs of 
the community they serve by for example, changing the health staff training curriculum to 
include cultural issues of the communities they serve. In addition, it has been asserted that 
knowledge on what access is and its measurement will help policy makers to come up with 
outcome indicators to be able to know when and to what extent access has been achieved, 
allowing for informed decisions by policy makers on allocation of resource (Khan 1994). 
While it is true that access to health care is a very important aspect of health care and at the 
centre of health systems analysis (Gulzar 1999), its usefulness can only be fully realised if it 
is placed into “useful and relevant frameworks” (Stevens 1992 – as cited in Gulzar. 2004: 
14). This means that viewing access just as a concept is not very helpful and should therefore 
find use in a practical way to ensure health outcomes are enhanced.  
 
The WHO World Health Assembly of 1978 declared health a human right (WHO 1978), 
whose achievement is to a larger extent determined by the level of access to appropriate 
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access to health care not only in terms of its contribution to health status but also the role it 
plays in the development process (Obrist 2007). The most plausible explanation to Obrist’s 
assertion has to do with how improved access to health care affects health status of 
individuals positively, a notion which Khan (1994) termed as “realized access”, and the 
relationship between this improved health status and the amount of time available to an 
individual to spend on productive activities like earning money and producing commodities 
(Grossman 1972), which can be viewed as pre-requisites for any development process.  
 
In summary, it can be added that as long as the definition of access remains ambiguous it will 
remain difficult to grasp what access to health care means, or even how to know when access 
has been achieved. Further, without knowledge of access, it would be difficult to interpret 
and appreciate health policy goals relating to access, such as the meaning of “equal access” 
(Khan 1994). Therefore, using Andersen’s definition of access as “the means through which 
the patient gains entry to the medical care system and continues the treatment process” 
(Andersen 2005), it can be concluded that access does not only entail individuals using 
services, as is the case with utilisation of services. It rather means care which is sustainable, 
thereby granting users a choice of accessing it whenever they have the need. And considering 
that effective TB and HIV/AIDS intervention requires diagnosis and treatment at the right 
time, improved and sustained access will reduce diagnostic and treatment delays. Early 
diagnosis and treatment of TB and HIV/AIDS can help to avoid adverse outcomes and can 
reduce fatalities (Raviglione 2007, Chamie 2010). 
 
Equity in Health Care 
Braveman and Gruskin (Braveman 2003) view equity in health as the absence of systematic 
disparities in health between social groups that have different levels of underlying social 
advantage or disadvantage. Whitehead went on to define inequity as differences in health 
and/or (access to or use of) health care which are “unnecessary and avoidable”, and can be 
considered to be “unfair and unjust” (Whitehead 1991). The Author further came up with 
three important pre-requisites for inequity to be said to exist:  a) if differences in health or 
health care are systematic, (there is a pattern formed), b) if socially produced and c) unfair 
(Whitehead 2007). Building on Braveman (2003) and Whitehead (2007) definitions, inequity 
in health care can therefore be said to exist when there is a systematic difference in access 
patterns to health care between different socio-economic groups and this is evident when it 
becomes possible to predict the level of access to health care an individual will experience 
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It is important to note though that, since equity is based on fairness and justice (Braveman
2003, Whitehead 2007, Whitehead 1992) which are subjective concepts, and is also based on
the grounds that health is a human right (Whitehead 2007, Aday 1981), its definition and
meaning depends on the context and whatever else is happening in that society (Braveman
2003, Whitehead 1991). This is because, what is fair or just, and even what is considered 
right, vary considerably in different countries and places. However, in defining equity in
health care and to come close to a generic understanding of equity, it is important to always
take note of the three assumptions that define the objective of equity proposed by Aday
(Aday 1981). These assumptions are: 1) health care is a right, 2) resources for allocating 
health care are limited, and 3) based on the above two, policies in health should be designed 
in such a way as to ensure that these scarce resources are allocated in a “just” way (Aday
1981). Additionally, equity in health care has generally been categorised into two: horizontal
and vertical equity, and these are discussed below.
Horizontal versus Vertical Equity
It is important to note when pursuing and trying to understand equity in health care that 
equity can either be categorized as “Horizontal” or “Vertical” (Fein 1972, Macinko, Starfield
2002), with horizontal equity getting relatively more attention in the literature (Macinko, 
Starfield 2002). Fein defines horizontal equity as the provision of the same health services to 
individuals in the same state of need or illness (Fein 1972), and Macinko calls this “equal 
treatment for equal need” (Macinko, Starfield 2002). This implies for instance that
individuals diagnosed with TB are supposed to receive the same treatment regardless of their 
income, sex, race etc. without anyone getting preference based on such variables. It can be
noted that the definition of horizontal equity has been used synonymously with the general
definition of equity discussed above, and this has been acknowledged by Macinko as well
(Macinko, Starfield 2002).
As mentioned, vertical equity is the less explored form of equity (Macinko, Starfield 2002, 
Mooney 1997) and has been defined according to Fein (Fein 1972) as the fair distribution of 
services for people in different economic circumstances. It can also be defined simply as 
providing enhanced health care or giving preferential treatment to those in greater need of 
care (Macinko, Starfield 2002). Vertical equity, unlike horizontal equity, does not consider 
equal treatment of individuals, but rather acknowledges that individuals, even when faced 
with the same kind of need, have different starting points in life and therefore need to be 
treated unequally by giving preference to those that are considered to be worse off (Mooney 
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diagnosed with TB, vertical equity would imply giving preference to those generally 
considered as having a history of being disadvantaged, such as favouring blacks over whites 
in post-apartheid South Africa (McIntyre 2000). Vertical equity may therefore be viewed 
more as positive discrimination (do Rosario Giraldes 1988).  
 
When defining equity in access to health care therefore, it is important to take note of 
horizontal and vertical equity. And depending on what the equity goal is – vertical or 
horizontal –, it is important to note that equity in access to health care can only be said to 
exist when access to health care resources are based on a widely recognised definition of 
what is “fair and just”. It may be that either those with the same health needs receive equal 
access i.e., to achieve horizontal equity, or whether preference should be given to specific 
groups in as far as access to health care is concerned so as to achieve vertical equity 
(McIntyre 2000).  
 
Finally, based on the McIntyre framework (McIntyre 2009), defining access at an operational 
level should be viewed in terms of the fit between the health care system and users and how 
available, affordable and acceptable services are. Further, there is a need to evaluate the level 
of the discussed interaction and information sharing so as to determine whether individuals 
are sufficiently empowered to make use of services, which is the backbone of access adopted 
for this study. In addition, access should be evaluated on whether it is equitable or not, 
because as shown, equity concerns to a greater extent determine who gets which health care 
resources (Mooney 1997).  
 
It has been argued that the disadvantaged groups have less access to health care (Whitehead 
2007). As a result of this, other authors (Gilson, McIntyre & Mooney 2007) have argued for 
improved trust between providers and users, which is likely to enhance acceptability of 
services. The belief is that this will improve access to care for the disadvantaged as they are 
more likely to suffer trust and acceptability barriers (Gilson, McIntyre & Mooney 2007). In 
this study therefore, the concerned is about whether access barriers differ in the users 
sampled for the study. If the findings seem to suggest, for example, that affordability barriers 
differ by SES, this would not be a problem if the rich faced higher costs, because they would 
have a higher ability to pay. If on the other hand, the poor faced higher costs, then this would 
be evidence of inequitable access for the poor relative to the rich. So, inequity is said to arise 
if the “degree of fit” between users and the system is less favourable for the poor relative to 
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Empirical Review 
Objectives of the Review 
The objective of reviewing empirical research is to explore evidence from studies that have 
examined access to TB and ART in order to find out what factors influence access to 
treatment for these diseases. Reviewing empirical literature is also a way to identify gaps in 
the access literature, and therefore possible future research areas. 
  
The review includes studies from around the world that are considered to be relevant in 
relation to this study’s objectives. Therefore, studies utilising either qualitative or quantitative 
methods, and even mixed methods have been included in the review. The review starts by 
discussing the methods by which these studies were deemed fit for inclusion in the review 
after which the studies’ characteristics will be described (i.e. study setting, method etc.). This 
will be followed by findings of the review before discussing these findings.  
 
It should be noted that it was not possible to find studies that defined access as is proposed in 
this study i.e. three measurable dimensions: availability, affordability and acceptability. 
Except for a single study that used Obrist’s (2007) access dimensions, and which will be 
discussed later, the rest of the studies seemed to equate access to use of TB and ART 
services. This finding indicates how access is still being widely viewed simply as the use of 
services. Against the background that access is a multi-dimensional concept that goes beyond 
use of services, the finding above highlights the gap that exists in the access literature.  
 
Methods of selecting studies 
The selected studies were extracted from the following search engines and databases: Google 
as well as Google Scholar, PubMed and Medline. Searches were conducted using the 
following key words: Access, Barriers, Tuberculosis (TB), HIV/AIDS, Antiretroviral and 
Treatment. Inclusion of a study in the analysis was based on satisfying the following 
conditions: 
- The study had to be about TB and/or HIV/AIDS and focus on access to treatment for 
one or both of these diseases and also barriers associated with accessing treatment.  
- The study had to be in English.  
- The study had to have been conducted after the year 2000, so as to be up to date with 
the changing TB and HIV/AIDS scenario, such as the provision of free ART in most 
countries. 
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Reviewed studies 
A total of 26 studies were reviewed, of which 15 were on access to ART and the rest were on 
access to TB treatment. Of the reviewed studies, only one (Todrys 2011) examined access to 
both TB and HIV treatment, while the rest of the studies examined access to these services 
separately.  
 
Characteristics of studies on access to ART 
Out of the 15 studies that focused on access to ART, 12 were from Africa: four studies were 
from Zambia (Chileshe 2010, Grant 2008, Todrys 2011, Kwalombota, Shumba 2004) two 
from Malawi (Kwalombota, Shumba 2004, Makwiza 2009) while the rest of the studies were 
each from Botswana (Dimbungu et al. 2004), Congo (Van Rompaey et al. 2011), Ethiopia 
(Assefa et al. 2010), Mozambique (Posse, Baltussen 2009), Nigeria (Adeneye et al. 2006), 
Tanzania (Mshana et al. 2006) and Zimbabwe (Muchedzi et al. 2010). The remaining three 
studies were from Haiti (Mukherjee, World Health Organization 2003), Thailand (Kitajima et 
al. 2005)and Vietnam (Vu Song Ha, Hoang Tu Anh & Bao 2004). 
 
In terms of study design, six studies utilised quantitative methodology (Kwalombota, Shumba 
2004, Van Rompaey et al. 2011, Adeneye et al. 2006, Muchedzi et al. 2010, Kitajima et al. 
2005, Khonyongwa 2004), five were qualitative studies (Chileshe 2010, Grant 2008, 
Makwiza 2009, Mshana et al. 2006, Vu Song Ha, Hoang Tu Anh & Bao 2004), four studies 
used mixed methods (Dimbungu et al. 2004, Todrys 2011, Assefa et al. 2010, Posse, 
Baltussen 2009), while the remaining study used a case-study design (Mukherjee, World 
Health Organization 2003).  
 
All the quantitative studies used questionnaires except for the study in Congo (Van Rompaey 
et al. 2011), which used census data, hospital monthly reports and patient registers. 
Qualitative studies on the other hand used a variety of data collection tools. For example, of 
the two qualitative studies from Zambia, one used mainly ethnographic methods (Chileshe 
2010) while the other one (Grant 2008) used semi-structured interviews with participants and 
focus group discussions (FGDs). The study from Vietnam combined ethnography, FGDs and 
in-depth interviews (Vu Song Ha, Hoang Tu Anh & Bao 2004) while the one from Malawi 
analysed pre-existing data from literature and undertook key informant interviews, in-depth 
interviews, FGDs and also used some quotations from a qualitative project the same authors 
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FGDs and in-depth interviews. The table below (Table 1) summarises characteristics of the 
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Table 1: Studies on access to ART  
Author and Year Country Study Methodology Study Focus 
Adeneye, A. K & Others 
2006 
Nigeria Quantitative Limitations to Access and Use of Antiretroviral Therapy (ART) 
Among HIV Positive Persons in Lagos, Nigeria. 
Assefa, Y & Others. 2010 Ethiopia Mixed methods Toward Universal Access to HIV Counselling and Testing and 
Antiretroviral Treatment in Ethiopia: Looking Beyond HIV Testing 
and ART Initiation. 
Chileshe,M. 2010 Zambia Qualitative (Ethnography) Barriers and outcomes: TB patients co-infected with HIV accessing 
antiretroviral therapy in rural Zambia 
Dimbungu & Others. 2004 Botswana Mixed Methods Factors inhibiting access to ARVs treatment and PMTCT services: an 
analysis of the experience in North West Botswana. 
Grant, E & Others. 2008 Zambia Qualitative Factors facilitating and challenging access and adherence to 
antiretroviral therapy in a township in the Zambian Copperbelt. 
Vu Song Ha & Others. 
2004 
Vietnam Qualitative Access to care, support and treatment for PLHA in Vietnam: Users' 
perspective. 
Kitajima, T & Others. 2005 Thailand Quantitative Access to antiretroviral therapy among HIV/AIDS patients in Khon 
Kaen province, Thailand. 
Khonyongwa 2004 Malawi Quantitative HIV/AIDS Treatment access study a premise for policy and advocacy 
in Malawi. 
Kwalombota & Others. 
2004 
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Makwiza, I & Others. 2009 Malawi A Review of previous 
studies & Qualitative 
methods 
Who has access to counselling and testing and anti-retroviral therapy in 
Malawi – an equity analysis. 
Muchedzi, A & Others 
2010 
Zimbabwe Quantitative Factors associated with access to HIV care and treatment in a 
prevention of mother to child transmission programme in urban 
Zimbabwe. 
Mukherjee, J & Others. 
2003 
Haiti Case study Access to antiretroviral treatment and care: experience of the HIV 
Equity Initiative, Cange, Haiti: case study.
Mshana,G H & Others. 
2006 
Tanzania Qualitative Barriers to Accessing Antiretroviral Therapy in Kisesa, Tanzania: A 
Qualitative Study of Early Rural Referrals to the National Program
Posse,M. 2009 Mozambique Mixed methods Barriers to access to antiretroviral treatment in Mozambique, as 
perceived by patients and health workers in urban and rural settings. 
Todrys, K. W & Others. 
2011 
Zambia Mixed methods Imprisoned and imperilled: access to HIV and TB prevention and 
treatment, and denial of human rights, in Zambian prisons. 
Van Rompaey,S & Others. 
2011 
Congo Quantitative (Census data &
Patients’ record reviews)
Operational assessment of access to ART in rural Africa: the example 
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Characteristics of studies on access to TB treatment 
Eleven (11) studies were reviewed under access to TB treatment. Five of the studies were 
from China (Deng et al. 2006, Fong 2005, Wei et al. 2009, Xu et al. 2004, Xu, Diwan & 
Bogg 2007) while the other studies were each from Burkina Faso (Sanou et al. 2004), 
Ethiopia (Gele et al. 2010), Gambia (Eastwood, Hill 2004), Kenya (Mauch et al. 2011), 
Tajikistan (Aye et al. 2010) and Zambia (Todrys 2011). Important to note is that one of the 
reviewed studies (Fong 2005) was a Doctor of Philosophy (PhD) dissertation, submitted to 
The Johns Hopkins School of Public Health. 
 
With the exception of two quantitative studies (Deng et al. 2006, Xu, Diwan & Bogg 2007) 
and two mixed methods studies (Todrys 2011, Mauch et al. 2011), the rest of the TB studies 
used qualitative methods. Both of the quantitative studies used questionnaires while the 
mixed methods studies combined questionnaires with follow-up interviews of key informants 
(Mauch et al. 2011), and also used facility assessments, reviews f government legislation 
and policies, in combination with in-depth interviews of key informants (Todrys 2011). With 
regards to the qualitative studies, the most common tools used were FGDs (Xu et al. 2004, 
Sanou et al. 2004, Aye et al. 2010) and in-depth interviews (Fong 2005, Wei et al. 2009, 
Sanou et al. 2004). A couple of studies used semi-structured questionnaires (Fong 2005, 
Eastwood, Hill 2004) while one study conducted informal interviews (Gele et al. 2010). The 
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Table 2: Studies on access to TB treatment 
Author and Year Country Study Methodology Study Focus 
Aye,R. 2010 Tajikistan Qualitative Illness costs to households are a key barrier to access diagnostic and 
treatment services for tuberculosis in Tajikistan. 
Deng, H.J & Others. 2006 China Quantitative  Study on factors causing the delay of access to tuberculosis diagnosis and its 
influencing factors in migrating tuberculosis patients in Putuo district, 
Shanghai. 
Eastwood,S V. 2004 Gambia Qualitative A gender-focused qualitative study of barriers to accessing tuberculosis 
treatment in The Gambia, West Africa. 
Fong. 2005 China Qualitative 
( semi-structured in-
depth interviews) 
Gender and access to DOTS program (Directly Observed Treatment, Short 
Course) in a poor rural and minority area of Gansu province, China. 
Gele, A.A & Others. 2010 Ethiopia Qualitative Barriers to tuberculosis care: a qualitative study among Somali pastoralists in 
Ethiopia. 
Mauch,V & Others. 2011 Kenya Mixed methods Assessing access barriers to tuberculosis care with the Tool to Estimate 
Patients' Costs: pilot results from two districts in Kenya. 
Sanou,A & Others. 2004 Burkina 
Faso 
Qualitative Access and adhering to tuberculosis treatment: barriers faced by patients and 
communities in Burkina Faso. 
Todrys, K. W & Others. 
2011 
Zambia Mixed methods Imprisoned and imperilled: access to HIV and TB prevention and treatment, 
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Wei, X & Other. 2009 China Qualitative  Barriers to TB care for rural‐to‐urban migrant TB patients in Shanghai: a 
qualitative study. 
Xu,B & Others. 2004 China Qualitative Perceptions and experiences of health care seeking and access to TB care – a 
qualitative study in Rural Jiangsu Province, China. 
Xu, B & Others. 2007 China Quantitative Access to tuberculosis care: What did chronic cough patients experience in 
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Study Findings 
Access to ART  
Findings from the reviewed studies identified various barriers to accessing ART services in the 
various settings. Barriers cited by most authors were costs associated with accessing this service – 
both direct and indirect (Chileshe 2010, Grant 2008, Kwalombota, Shumba 2004, Makwiza 2009, 
Assefa et al. 2010, Posse, Baltussen 2009, Adeneye et al. 2006, Mshana et al. 2006, Muchedzi et al. 
2010, Kitajima et al. 2005, Vu Song Ha, Hoang Tu Anh & Bao 2004, Khonyongwa 2004). However, 
since ART services in all of the reviewed studies were offered free of charge at the point of delivery, 
transport costs were the major concern with regards to costs of accessing this service (Chileshe 2010, 
Assefa et al. 2010, Posse, Baltussen 2009, Muchedzi et al. 2010, Khonyongwa 2004). For instance, 
the study in Ethiopia (Assefa et al. 2010) revealed that transport barriers to access were 
acknowledged by both providers and users, and it was shown how they negatively affected retention 
of patients in the ART programme. Other cost related barriers identified were the costs of additional 
medicines that had to be taken with ARV drugs (Grant 2008, Makwiza et al. 2009), consultation fees 
(Makwiza et al. 2009) and the cost of the actual ARV drugs (Grant 2008). Note that the Zambian 
study (Grant 2008) that cited costs of ART drugs conducted a longitudinal study, and as such patients 
still had to pay for ART services during the first phase of the study. Muchedzi & colleagues (2010) 
highlighted the importance of opportunity cost as an access barrier i.e. looking after children, and 
caring for the sick etcetera. An important factor related to transportation costs, was the distance to 
ART services. Distance was also shown by some studies (Assefa et al. 2010, Posse, Baltussen 2009, 
Khonyongwa 2004) as a barrier to access ng ART. 
 
Other access barriers identified in some of the studies are related to the organisation of the health 
system. These barriers were concerned with the availability and adequacy of facilities and services 
(Dimbungu et al. 2004, Chileshe 2010, Grant 2008, Kwalombota, Shumba 2004, Posse, Baltussen 
2009, Muchedzi et al. 2010, Vu Song Ha, Hoang Tu Anh & Bao 2004, Khonyongwa 2004). Specific 
barriers cited include lack of facilities and health workers to attend to patients (Dimbungu et al. 2004, 
Chileshe 2010, Khonyongwa 2004). In the event that facilities were available, the barriers faced were 
unavailability of services, poor quality of services and drug unavailability (Kwalombota, Shumba 
2004, Posse, Baltussen 2009, Muchedzi et al. 2010, Vu Song Ha, Hoang Tu Anh & Bao 2004). Other 
system access barriers included long waiting times, queues and overcrowded systems (Chileshe 2010, 
Grant 2008, Mshana et al. 2006, Muchedzi et al. 2010). A case study conducted in Haiti revealed that 
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Knowledge of ART services was also cited as crucial in determining access (Dimbungu et al. 2004, 
Grant 2008, Kwalombota, Shumba 2004, Posse, Baltussen 2009, Muchedzi et al. 2010, Vu Song Ha, 
Hoang Tu Anh & Bao 2004). Specific knowledge factors deemed to be important to accessing 
services were complete and accurate information on HIV and information on drugs and treatment 
given to the community and patients (Grant 2008, Kwalombota, Shumba 2004, Posse, Baltussen 
2009, Vu Song Ha, Hoang Tu Anh & Bao 2004). There were suggestions therefore on the need for 
patient and community sensitisation (Dimbungu et al. 2004), and that the community and people 
living with HIV/AIDS should be involved in the planning of ART services (Dimbungu et al. 2004, 
Vu Song Ha, Hoang Tu Anh & Bao 2004). The involving of these individuals in planning is meant to 
enhance the “responsiveness and effectiveness” of ART services (Vu Song Ha, Hoang Tu Anh & 
Bao 2004). It can be concluded from the foregoing that lack of information on ART services is a very 
important access barrier to the use of ART. 
 
Furthermore, factors such as lack of support from family and friends were also identified as barriers 
to accessing ART (Grant 2008, Assefa et al. 2010, Posse, Baltussen 2009, Vu Song Ha, Hoang Tu 
Anh & Bao 2004). Also related to lack of support was the stigmatisation of patients, both at health 
centres and in the community, which further impeded access to ART services (Dimbungu et al. 2004, 
Chileshe 2010, Assefa et al. 2010, Adeneye et al. 2006, Mshana et al. 2006, Mukherjee, World 
Health Organization 2003, Vu Song Ha, Hoang Tu Anh & Bao 2004). 
 
Finally, other factors that were found to be barring individuals from accessing ART included patient 
beliefs and attitudes towards treatment (Grant 2008, Kwalombota, Shumba 2004, Posse, Baltussen 
2009), reliance on traditional medicines and self-treatment (Chileshe 2010, Assefa et al. 2010, Vu 
Song Ha, Hoang Tu Anh & Bao 2004), and the fear of side effects of ART drugs (Grant 2008, Assefa 
et al. 2010). Other barriers were location i.e. individuals in rural locations had less access compared 
to those in urban settings (Chileshe 2010, Van Rompaey et al. 2011, Makwiza et al. 2009), and sex of 
patients i.e. females were less likely to access treatment (Chileshe 2010, Kwalombota, Shumba 2004, 
Makwiza et al. 2009). 
 
Access to TB treatment 
Similar to the findings about ART access, reviewed studies on access to TB treatment also showed 
that the major barriers to accessing TB were costs associated with treatment (Todrys 2011, Wei et al. 
2009, Xu et al. 2004, Xu, Diwan & Bogg 2007, Sanou et al. 2004, Eastwood, Hill 2004, Mauch et al. 
2011, Aye et al. 2010). Most of these studies found indirect costs, specifically transport costs as very 
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Eastwood, Hill 2004). Distance was also identified as a barrier to accessing TB care by studies from 
Ethiopia (Gele et al. 2010) and Gambia (Sanou et al. 2004). As mentioned earlier, the importance of 
distance is the relationship it has with transport costs and also time costs i.e. the further users are 
located from services, the more transport and time costs they incur, and therefore experience 
relatively more barriers to services.  
 
A few studies (Wei et al. 2009, Xu et al. 2004) identified direct costs such as the cost of medicines 
and fee for service as important to achieving access. Accordingly, because of their relationship to 
‘ability to pay’ for health care services, income and ownership of health insurance were found to be 
important determinants of access to services (Deng et al. 2006, Xu, Diwan & Bogg 2007). The 
implication therefore is that lack of income and medical insurance is a barrier to accessing this 
service. The opportunity cost associated with seeking care was also identified as a key access barrier 
by some studies because it determines whether or not individuals will use services (Sanou et al. 2004, 
Gele et al. 2010, Eastwood, Hill 2004, Mauch et al. 2011, Aye et al. 2010). For example, seeking TB 
care was viewed as conflicting with employment (Eastwood, Hill 2004) and  leading to loss of 
income (Sanou et al. 2004, Aye et al. 2010), especially for those in agricultural activities (Sanou et al. 
2004).  
 
Similar to findings on access to ART, lack of knowledge about services was also identified by some 
of the studies as a barrier to accessing TB care (Fong 2005, Wei et al. 2009, Xu et al. 2004, Gele et 
al. 2010, Eastwood, Hill 2004). These studies showed that complete lack of knowledge (Fong 2005, 
Eastwood, Hill 2004) and limited knowledge about TB (Wei et al. 2009, Xu et al. 2004) were 
associated with individuals not accessing TB services. There were even individuals found who were 
not aware that TB was contagious (Gele et al. 2010). 
 
Another access barrier to TB treatment was the tendency by patients to treat themselves (Fong 2005, 
Wei et al. 2009, Xu et al. 2004, Sanou et al. 2004, Eastwood, Hill 2004, Aye et al. 2010). For 
instance, in their study in Burkina Faso, Sanou and others (2004) found that individuals would 
naturally tend to treat themselves i.e. buying over the counter medicines, and later decide to consult a 
traditional healer if self-treatment wasn’t successful. Tuberculosis treatment within the formal health 
sector was only sought when these avenues failed. Though not a significant finding from Tajikistan 
(Aye et al. 2010), it could be inferred that sometimes patients may resort to self-treatment if they are 
not sure about whether or not they have been cured. Lack of resources to meet health care costs can 
sometimes also lead patients to treat themselves, as was the case among the elderly in a study in 
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Gele et al. 2010, Eastwood, Hill 2004) found that patients who were visiting these healers and using 
their medicine had worse access to TB services compared to those who did not visit traditional 
healers.  
System related factors were also identified as critical in determining access to TB services (Todrys 
2011, Fong 2005, Xu et al. 2004, Sanou et al. 2004, Aye et al. 2010). Specific system factors cited 
were the ability of the health workers to detect and make a correct TB diagnosis (Fong 2005). Other 
studies found that health workers’ qualifications (Todrys 2011) and their attitudes to users (Sanou et 
al. 2004) determined whether or not individuals sought care. An additional system barrier to TB 
access in a Gambian study (Eastwood, Hill 2004), was the lack of privacy in the TB facilities, 
especially for women. 
Lastly, the sex of users was also identified as a factor in determining access to TB treatment (Deng et
al. 2006, Fong 2005, Xu et al. 2004, Sanou et al. 2004, Eastwood, Hill 2004). Just as was the case
with findings on access to ART services, all the studies that identified sex as an access factor found
that women had worse access to TB services compared to men. Two of these studies (Sanou et al.
2004, Eastwood, Hill 2004), attributed women’s worse access to TB services to their lower incomes, 
and therefore inability to manage health care costs. Fong (2004) on the other hand identified
traditional beliefs, such as roles that women are traditionally expected to perform, as worsening their
access to TB services. Other access barriers identified by individual studies included waiting time in
facilities (Sanou et al. 2004) and age i.e. the elderly tended to delay in seeking treatment (Xu et al.
2004). 
Discussion 
Findings on access to TB and ART services were very similar across the reviewed studies. It has
been revealed that the cost of seeking care was the most significant barrier to accessing both services. 
More specifically, transport costs posed the largest barrier for users of both TB and ART services.
Another barrier common between the two tracers (TB and ART), were the distances that the users
had to cover to reach needed services. It was noted that individuals with TB were more likely to 
experience direct costs of care such as drug costs and having to pay user fees, compared to those on
ART. This finding was expected as ART services, in all the reviewed studies, were offered free of
charge. The opportunity cost of seeking care was also identified as a critical barrier to accessing both 
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Other barriers common between the two services were the lack of knowledge about TB and ART 
services. The importance of knowledge about services cannot be ignored. For example, it was 
demonstrated by Ngamvithayapong and others (Ngamvithayapong, Winkvist & Diwan 2000) that 
inadequate knowledge of TB leads to delay in seeking treatment. Also, lack of proper information 
and understanding of TB and HIV by health workers and communities, another identified barrier, 
may to a large extent be responsible for the stigmatisation of patients. A study in the US showed that 
stigma was associated with misunderstanding the mechanism through which HIV is transmitted 
(Herek, Capitanio & Widaman 2002) – the same can be said of TB related stigma. Stigma is therefore 
a very important access barrier in TB and HIV programs (Herek, Capitanio & Widaman 2002, 
Hadley, Maher 2000). It has even been asserted, for example, that prevention and treatment of HIV 
can only succeed if stigma is eradicated (Nyblade 2006). Stigma and information barriers are related, 
in that one way to reduce stigma is by rigorous community sensitisation and education, and positive 
interaction between providers and users. Odhiambo and colleagues ((Odhiambo et al. 2008), for 
instance, pointed out that communication between providers and users can help reduce stigma 
barriers to care.  
 
The implication of the above argument, therefore, is that patients and the community should be 
involved in the planning process of these services. This might make communities, families and 
friends of patients more receptive to treatment, and possibly improve support for those on treatment. 
Hadley and Maher (2000) also suggest addressing community beliefs and attitudes through 
“awareness campaigns” (p. 402) as one way to eliminate stigma. Interactive communication not only 
takes care of stigma barriers, but also ensures that patients understand the dangers of actions such as 
delay in seeking care, self-treatment and use of traditional healers. 
 
Furthermore, system level barriers were also identified in both cases. However, the difference was 
that while ART system barriers were associated with lack of facilities, services and drugs, TB system 
barriers were related to improper TB detection and diagnosis in the facilities. It can be concluded 
from this finding that compared to TB, Antiretroviral treatment (ART) services are not as available, 
and this has been acknowledged elsewhere (Dong et al. 2007). In addition to this problem, the 
findings seem to suggest that even when ART services are available, they are notable for poor quality 
and sometimes unavailability of drugs. The findings suggest that there is a need to expand ART 
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Another access barrier identified for both TB and ART services was the tendency by individuals to 
self-treat before seeking care. This is a very important finding because, together with lack of 
knowledge about services, this may explain why most individuals delay seeking care, and only 
present themselves in facilities when complications arise, as was shown by a study on Malaria in 
Uganda (Nuwaha 2002). Antiretroviral services were also associated with drug side effects, which 
created another barrier for individuals in need of this service. On the contrary, fear of drug side 
effects was not mentioned in studies examining access to TB services. Additionally, studies on ART 
services reported more barriers related to lack of support from family and friends, and also related to 
facing stigma in facilities, as well as in the community. As mentioned earlier, access barriers such as 
the use of self-treatment and stigmatisation can be lessened by information dissemination and 
community awareness campaigns. It can even help promote family and community support for both 
TB and HIV patients. 
 
Additional suggestions can be put forward aimed at lessening identified access barriers to both TB 
and ART services. For example, where fear of side effects associated with ART drugs leads to lower 
adherence, the ART services may need to introduce a treatment similar to the Directly Observed 
Treatment (DOT) used in TB treatment (Posse 2008). Such a strategy was tried in a study examining 
the integration of the two services in South Africa (Gandhi 2009), and proved very effective. The 
downside of this strategy though is that it creates further barriers, since patients will have to visit the 
facility every day, and it requires additional res urces such as transport costs. A possible solution to 
help patients overcome transport costs would be to ensure that all the patients on treatment receive 
social grants to cover transportation and other similar costs. As has been shown by the review, TB 
patients identify drug costs as barriers and as such social grants can be valuable in this regard. 
Another option would be to have treatment supporters in the community charged with the 
responsibility of collecting drugs from facilities on behalf of patients.  
 
The conclusion we can draw from this review is that ART and TB treatment are often needed by the 
same individuals, and integration has therefore been proposed to minimize imposing additional 
barriers to access on these patients. Further, integration of these services is proposed because it has 
been said to improve access to TB and ART services (Harris et al. 2008). Integration is also a way of 
freeing resources, as it has been shown that TB and ART services are noted for overlap of services, 
and service duplication and under-utilization of health care staff (Dong et al. 2007, Coetzee 2004). 
The overlap and duplication of services mostly results from the fact that TB and HIV/AIDS 
infections mostly occur in the same individuals (Gasana 2008). It follows from this that when these 
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accessing these services will be enhanced. For example, individuals on both TB and ART will have 
to face the distance and opportunity cost barriers twice as they move between the two services.  
 
Integrating TB and ART treatment thus seems a very promising strategy to improve the effectiveness 
of TB/HIV interventions, and also to remove some of the treatment barriers that patients face. 
However, integration has drawbacks that need to be thought through carefully before proceeding. For 
instance, bringing TB patients together with immune deficient HIV patients in one facility can lead to 
the spread of TB, enhance HIV progression and worsen related morbidity and mortality (Dong et al. 
2007, Coetzee 2004). Furthermore, without additional facilities and appropriately trained staff, 
integration may result in overcrowding – a condition in which TB thrives (Coetzee 2004).  
 
Conclusion 
Generally, the review presented an access definition considered to be very comprehensive, unlike 
other discussed definitions proposed by some scholars. It has also been shown how the measurement 
of access is dependent on the interaction of three dimensions: availability, affordability and 
acceptability – amidst system and user factors. The key to access in this study is the empowerment of 
individuals to use health services. The importance of access in health care, especially in health policy 
and planning, has also been highlighted. In addition, the review has shown that equity is a very 
important issue in access to health care, since individuals have different underlying social advantages 
and disadvantages, which needs to be considered when implementing policies aimed at improving 
access to care.  
 
The review further explored empirical studies on access to both TB and ART services, which have 
been undertaken in various locations. Among the many barriers identified, the notable one is 
transportation costs, which closely relates to distance to services. Another important revelation from 
the empirical review is that, though TB and HIV/AIDS services overlap, their respective services are 
still offered as parallel programmes in all the reviewed studies, and this worsens access barriers to 
services even further. The review has also attempted to offer solutions to overcome most of the 
barriers, the main ones being integration of these services, and increased community sensitisation on 
TB and HIV to promote acceptance, improve patient support and reduce stigma.  
 
It is interesting to note that of all the reviewed studies, only one study from Tajikistan (Aye et al. 
2010), came close to the definition of access proposed in this study. The study used Obrist’s (Obrist 
2007) five dimensions of access to guide their analysis (availability, adequacy, acceptability, 













P a g e  | 57 
 
and acceptability), meaning that a lot of important information that defines access, from our study 
perspective, was left out. 
 
Another important finding from the review was that none of the studies meeting our criteria for 
inclusion in our review was from South Africa. It is a rather surprising finding considering that the 
country is facing arguably the worst TB and HIV/AIDS burden in the world. The finding only 
highlights the existing gap in the literature on access to TB and ART services in South Africa, 
therefore making this study even more relevant. 
 
Finally, it should be mentioned that though it has been considered by some authors, including this 
study, to be the most important access dimension, the acceptability dimension did not receive as 
much focus in the literature as the other two dimensions – affordability and availability of services. 
The importance of the acceptability dimension, as discussed earlier, cannot be ignored and until it is 
given equal priority in research, we may not be able to understand why patients still decide not to use 
services even when they are available free of charge.  
 
Lastly, there is a need for more research using the integrated method of measuring access as defined 
in this study, as it covers all relevant aspects of access. Also critical is the need for more research 
focused on the benefits and harms of integration from users’ perspectives. This is because most of the 




























P a g e  | 58 
 
References 
Aday, L.A. 1981, "Equity of access to medical care: a conceptual and empirical overview", Medical 
care, vol. 19, no. 12, pp. 4.  
Aday, L.A. & Andersen, R. 1975, Development of indices of access to medical care, Health 
Administration Press.  
 Aday, L.A. 1974, "A framework for the study of access to medical care", Health services research, 
vol. 9, no. 3, pp. 208.  
Adeneye, A., Adewole, T., Musa, A., Onwujekwe, D., Odunukwe, N., Araoyinbo, I., Gbajabiamila, 
T., Ezeobi, P. & Idigbe, E. 2006, "Limitations to access and use of antiretroviral therapy (ART) 
among HIV positive persons in Lagos, Nigeria", World health & population, vol. 8, no. 2, pp. 
46-56.  
Andersen, R.M. 1983, "Exploring dimensions of access to medical care.", Health services research, 
vol. 18, no. 1, pp. 49.  
Andersen, R. 2005, "Societal and individual determinants of medical care utilization in the United 
States", The Milbank quarterly, vol. 83, no. 4, pp. Online.  
Assefa, Y., Damme, W.V., Mariam, D.H. & Kloos, H. 2010, "Toward universal access to HIV 
counseling and testing and antiretroviral treatment in Ethiopia: looking beyond HIV testing and 
ART initiation", AIDS Patient Care and STDs, vol. 24, no. 8, pp. 521-525.  
Aye, R., Wyss, K., Abdualimova, H. & Saidaliev, S. 2010, "Illness costs to households are a key 
barrier to access diagnostic and treatment services for tuberculosis in Tajikistan", BMC Research 
Notes, vol. 3, no. 1, pp. 340.  
Braveman, P. 2003, "Defining equity in health", Journal of epidemiology and community health, vol. 
57, no. 4, pp. 254.  
Chamie, G. 2010, "Tuberculosis as part of the natural history of HIV infection in developing 
countries", Clinical infect ous diseases (Online.University of Chicago.Press), vol. 50, no. 
Supplement 3, pp. S245.  
Chileshe, M. 2010, "Barriers and outcomes: TB patients co-infected with HIV accessing 
antiretroviral therapy in rural Zambia", AIDS Care, vol. 22, pp. 51.  
Coetzee, D. 2004, "Integrating tuberculosis and HIV care in the primary care setting in South 
Africa", TM IH.Tropical medicine international health, vol. 9, no. 6, pp. A11.  
Deng, H.J., Zheng, Y.H., Zhang, Y.Y. & Xu, B. 2006, "Study on factors causing the delay of access 
to tuberculosis diagnosis and its influencing factors in migrating tuberculosis patients in Putuo 
district, Shanghai", Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi, vol. 27, 
no. 4, pp. 311-315.  
Dimbungu, R., Nduhura, D., Hadjipateras, A. & Bajenja, E. 2004, "Factors inhibiting access to ARVs 
treatment and PMTCT services: an analysis of the experience in North West Botswana.", 













P a g e  | 59 
do Rosario Giraldes, M. 1988, "The equity principle in the allocation of health care expenditure on 
primary health care services in Portugal: the human capital approach", The International journal 
of health planning and management, vol. 3, no. 3, pp. 167.  
Donabedian, A. 1973, Aspects of medical care administration: specifying requirements for health 
care, . 
Donabedian, A. 1972, "Models for organizing the delivery of personal health services and criteria for 
evaluating them", The Milbank Memorial Fund quarterly, vol. 50, no. 4, pp. 103. 
Dong, K., Thabethe, Z., Hurtado, R., Sibaya, T., Dlwati, H., Walker, B. & Wilson, D. 2007, 
"Challenges to the success of HIV and tuberculosis care and treatment in the public health sector 
in South Africa", Journal of Infectious Diseases, vol. 196, no. Supplement 3, pp. S491.  
Eastwood, S. & Hill, P. 2004, "A gender-focused qualitative study of barriers to accessing 
tuberculosis treatment in The Gambia, West Africa", The International Journal of Tuberculosis 
and Lung Disease, vol. 8, no. 1, pp. 70-75.  
Eckert, K.A. 2004, "Does health service utilisation vary by remoteness? South Australian population 
data and the Accessibility and Remoteness Index of Australia", Australian and New Zealand 
Journal of Public Health, vol. 28, no. 5, pp. 426. 
Falkingham, J. 2004, "Poverty, out-of-pocket payments and access to health care: evidence from 
Tajikistan", Social science medicine, vol. 58, no. 2, pp. 247. 
Fein, R. 1972, "On achieving access and equity in health care", The Milbank Memorial Fund 
quarterly, vol. 50, no. 4, pp. 157. 
Fong, C. 2005, "Gender and access to DOTS program (Directly Observed Treatment, Short-course)
in a poor, rural and minority area of Gansu Province, China", Gender and access to DOTS 
program (Directly Observed Treatment, Short-course) in a poor, rural and minority area of 
Gansu Province, China, . 
Fox, P.D. 1972, "Access to medical care for the poor: the federal perspective", Medical care, vol. 10, 
no. 3, pp. 272.  
Freeborn, D.K. 1973, "Evaluation of the performance of ambulatory care systems: research 
requirements and opportunities", Medical care, vol. 11, no. 2, pp. 68. 
Gandhi, N.R. 2009, "Successful integration of tuberculosis and HIV treatment in rural South Africa: 
the Sizonq'oba study", Journal of acquired immune deficiency syndromes, vol. 50, no. 1, pp. 37. 
Gasana, M. 2008, "Integrating tuberculosis and HIV care in rural Rwanda", The international journal 
of tuberculosis and lung disease, vol. 12, no. Supplement 1, pp. S39. 
Gele, A., Sagbakken, M., Abebe, F. & Bjune, G. 2010, "Barriers to tuberculosis care: a qualitative 
study among Somali pastoralists in Ethiopia", BMC Research Notes, vol. 3, no. 1, pp. 86.  
Gilson, L., McIntyre, D. & Mooney, G. 2007, "Acceptability, trust and equity", The economics of 
health equity, . 
Goddard, M. 2001, "Equity of access to health care services::: Theory and evidence from the UK", 













P a g e  | 60 
 
Goudge, J., Gilson, L., Russell, S., Gumede, T. & Mills, A. 2009, "Affordability, availability and 
acceptability barriers to health care for the chronically ill: longitudinal case studies from South 
Africa.", BMC health services research, vol. 9, pp. 75.  
Grant, E. 2008, "Factors facilitating and challenging access and adherence to antiretroviral therapy in 
a township in the Zambian Copperbelt: a qualitative study", AIDS Care, vol. 20, no. 10, pp. 
1155.  
Grossman, M. 1972, "On the concept of health capital and the demand for health", Journal of 
political economy, vol. 80, no. 2, pp. 223.  
Gulliford, M., Figueroa-Munoz, J., Morgan, M., Hughes, D., Gibson, B., Beech, R. & Hudson, M. 
2002, "What does' access to health care'mean?", Journal of health services research & policy, 
vol. 7, no. 3, pp. 186.  
Gulliford, M., Morgan, M., Hughes, D., Beech, R., Figeroa-Munoz, J., Gibson, B., Hudson, M., 
Arumugam, C., Connell, P. & Mohiddin, A. 2001, "Access to health care", Report of a Scoping 
Exercise for the National Coordinating Centre for NHS Service Delivery and Organisation 
R&D, London, .  
Gulliford, M. 2002, "What does' access to health care'mean?", Journal of Health Services Research 
Policy, vol. 7, no. 3, pp. 186.  
Gulzar, L. 1999, "Access to health care", Image: the journal of nursing scholarship, vol. 31, no. 1, 
pp. 13.  
Hadley, M. & Maher, D. 2000, "Community involvement in tuberculosis control: lessons from other 
health care programmes", The International Journal of Tuberculosis and Lung Disease, vol. 4, 
no. 5, pp. 401-408.  
Harris, J., Hatwiinda, S., Randels, K., Chi, B., Kancheya, N., Jham, M., Samungole, K., 
Tambatamba, B., Cantrell, R. & Levy, J. 2008, "Early lessons from the integration of 
tuberculosis and HIV services in primary care centers in Lusaka, Zambia", The International 
Journal of Tuberculosis and Lung Disease, vol. 12, no. 7, pp. 773-779.  
Herek, G.M., Capitanio, J.P. & Widaman, K.F. 2002, "HIV-related stigma and knowledge in the 
United States: Prevalence and trends, 1991-1999", American Journal of Public Health, vol. 92, 
no. 3, pp. 371.  
Khan, A.A. 1994, "Access to health care", Evaluation the health professions, vol. 17, no. 1, pp. 60.  
Khonyongwa, L. 2004, "HIV/AIDS Treatment access study a premise for policy and advocacy in 
Malawi.", International Conference On Aids, pp. abstract no. TuPeD5136.  
Kitajima, T., Kobayashi, Y., Chaipah, W., Sato, H., Toyokawa, S., Chadbunchachai, W. & 
Thuennadee, R. 2005, "Access to antiretroviral therapy among HIV/AIDS patients in Khon Kaen 
Province, Thailand", AIDS Care, vol. 17, no. 3, pp. 359-366.  
Kwalombota, K. & Shumba, C. 2004, "Influence of gender on access to antiretroviral therapy among 
African women.", International Conference On Aids, pp. abstract no. TuPeD5158.  
Lewis, C.E. 1977, "Improved access through regionalization", Regionalization and Health Policy, , 













P a g e  | 61 
 
Macinko, J. & Starfield, B. 2002, "Annotated Bibliography on Equity in Health, 1980-2001.", 
International journal for equity in health, vol. 1, no. 1, pp. 1.  
Makwiza, I., Nyirenda, L., Bongololo, G., Banda, T., Chimzizi, R. & Theobald, S. 2009, 
"International Journal for Equity in Health", International Journal for Equity in Health, vol. 8, 
pp. 13.  
Makwiza, I. 2009, "Who has access to counseling and testing and anti-retroviral therapy in 
MalawiÃ¢ÂÂ“an equity analysis", International journal for equity in health, vol. 8, no. 1, pp. 
13.  
Mauch, V., Woods, N., Kirubi, B., Kipruto, H., Sitienei, J. & Klinkenberg, E. 2011, "Assessing 
access barriers to tuberculosis care with the Tool to Estimate Patients' Costs: pilot results from 
two districts in Kenya", BMC public health, vol. 11, no. 1, pp. 43.  
McIntyre, D. 2000, "Redressing dis-advantage: promoting vertical equity within South Africa", 
Health care analysis, vol. 8, no. 3, pp. 235.  
McIntyre, D. 2009, "Access as a policy-relevant concept in low-and middle-income countries", 
Health economics, policy and law, vol. 4, no. 02, pp. 179.  
McIntyre, D. 2006, "What are the economic consequences for households of illness and of paying for 
health care in low-and middle-income country contexts?", Social science medicine, vol. 62, no. 
4, pp. 858.  
Mooney, G.H. 1983, "Equity in health care: confronting the confusion.", Effective health care, vol. 1, 
no. 4, pp. 179.  
Mooney, G. 1997, "Vertical equity: weighting outcomes? or establishing procedures?", Health policy, 
vol. 39, no. 1, pp. 79.  
Mshana, G.H., Wamoyi, J., Busza, J., Zaba, B., Changalucha, J., Kaluvya, S. & Urassa, M. 2006, 
"Barriers to accessing antiretroviral therapy in Kisesa, Tanzania: a qualitative study of early 
rural referrals to the national program", AIDS Patient Care & STDs, vol. 20, no. 9, pp. 649-657.  
Muchedzi, A., Chandisarewa, W., Keatinge, J., Stranix-Chibanda, L., Woelk, G., Mbizvo, E. & 
Shetty, A.K. 2010, "Factors associated with access to HIV care and treatment in a prevention of 
mother to child transmission programme in urban Zimbabwe", Journal of the International AIDS 
Society, vol. 13, no. 1, pp. 1-9.  
Mukherjee, J. & World Health Organization 2003, Access to antiretroviral treatment and care: the 
experience of the HIV Equity Initiative, Cange, Haiti: case study, World Health Organization 
Geneva.  
Ngamvithayapong, J., Winkvist, A. & Diwan, V. 2000, "High AIDS awareness may cause 
tuberculosis patient delay: results from an HIV epidemic area, Thailand", Aids, vol. 14, no. 10, 
pp. 1413.  
Nutbeam, D. 2000, "Health literacy as a public health goal: a challenge for contemporary health 
education and communication strategies into the 21st century", Health promotion international, 













P a g e  | 62 
 
Nuwaha, F. 2002, "People's perception of malaria in Mbarara, Uganda", Tropical Medicine & 
International Health, vol. 7, no. 5, pp. 462-470.  
Nyblade, L. 2006, "Measuring HIV stigma: existing knowledge and gaps", Psychology, Health and 
Medicine, vol. 11, no. 3, pp. 335-345.  
Obrist, B. 2007, "Access to health care in contexts of livelihood insecurity: a framework for analysis 
and action", PLoS Medicine, vol. 4, no. 10, pp. 1584.  
Odhiambo, J., Kizito, W., Njoroge, A., Wambua, N., Nganga, L., Mburu, M., Mansoer, J., Marum, 
L., Phillips, E. & Chakaya, J. 2008, "Provider-initiated HIV testing and counselling for TB 
patients and suspects in Nairobi, Kenya", The International Journal of Tuberculosis and Lung 
Disease, vol. 12, no. Supplement 1, pp. S63-S68.  
Penchansky, R. 1981, "The concept of access: definition and relationship to consumer satisfaction", 
Medical care, vol. 19, no. 2, pp. 127.  
Peters, D.H. 2008, "Poverty and access to health care in developing countries", Annals of the New 
York Academy of Sciences, vol. 1136, no. 1, pp. 161.  
Posse, M. & Baltussen, R. 2009, "Barriers to access to antiretroviral treatment in Mozambique, as 
perceived by patients and health workers in urban and rural settings", AIDS Patient Care and 
STDs, vol. 23, no. 10, pp. 867-875.  
Posse, M. 2008, "Barriers to access to antiretroviral treatment in developing countries: a review", TM 
IH.Tropical medicine international health, vol. 13, no. 7, pp. 904.  
Raviglione, M.C. 2007, "XDR tuberculosisÃ¢ÂÂ”implications for global public health", The New 
England journal of medicine, vol. 356, no. 7, pp. 656.  
Rogers, A. 1999, "Improving access needs a whole systems approach", BMJ.British medical journal, 
vol. 319, no. 7214, pp. 866.  
Salkever, D.S. 1975, "Economic class and differential access to care: comparisons among health care 
systems", International journal of health services, vol. 5, no. 3, pp. 373.  
Sanou, A., Dembele, M., Theobald, S. & Macq, J. 2004, "Access and adhering to tuberculosis 
treatment: barriers faced by patients and communities in Burkina Faso", The International 
Journal of Tuberculosis and Lung Disease, vol. 8, no. 12, pp. 1479-1483.  
Shortell, S. 1973, "Patterns of Medical Care: Issues of Access, Cost, and Continuity", Workshop, 
Center for Health Administration Studies, University of Chicago.  
Simpson, G., Bloom, B., Cohen, R.A. & Parsons, P.E. 1997, "Access to health care. Part 1: 
Children.", Vital and health statistics.Series 10.Data from the National Health Survey, , no. 196, 
pp. 1.  
Stewart, M.J. 1990, "Access to health care for economically disadvantaged Canadians: a model.", 
Canadian Journal of Public Health, vol. 81, no. 6, pp. 450.  
Thiede, M. 2005, "Information and access to health care: is there a role for trust?", Social science 













P a g e  | 63 
 
Thiede, M., Akweongo, P., McIntyre, D. & Mooney, G. 2007, "Exploring the dimensions of access.", 
The economics of health equity, , pp. 103-123.  
Thiede, M. 2008, "Information, communication and equitable access to health care: a conceptual 
note", Cadernos de saÃƒÂºde pÃƒÂºblica, vol. 24, pp. 1168.  
Todrys, K.W. 2011, "Imprisoned and imperiled: access to HIV and TB prevention and treatment, and 
denial of human rights, in Zambian prisons", Journal of the International AIDS Society, vol. 14, 
pp. 8.  
Van Rompaey, S., Kimfuta, J., Kimbondo, P., Monn, C. & Buvé, A. 2011, "Operational assessment 
of access to ART in rural Africa: the example of Kisantu in Democratic Republic of the Congo", 
AIDS Care, vol. 23, no. 6, pp. 686-693.  
Vu Song Ha, S., Hoang Tu Anh, T. & Bao, V. 2004, "Access to care, support and treatment for 
PLHA in Vietnam: Users' perspective.", International Conference On Aids, pp. abstract no. 
B11104.  
Wagstaff, A. 2003, "Catastrophe and impoverishment in paying for health care: with applications to 
Vietnam 1993Ã¢ÂÂ“1998", Health economics, vol. 12, no. 11, pp. 921.  
Wei, X., Chen, J., Chen, P., Newell, J.N., Li, H., Sun, C., Mei, J. & Walley, J.D. 2009, "Barriers to 
TB care for rural‐to‐urban migrant TB patients in Shanghai: a qualitative study", Tropical 
Medicine & International Health, vol. 14, no. 7, pp. 754-760.  
Weinick, R.M., Weigers, M.E. & Cohen, J.W. 1998, "Children's health insurance, access to care, and 
health status: new findings.", Health affairs, vol. 17, no. 2, pp. 127.  
White, P.H. 2002, "Access to health care: health insurance considerations for young adults with 
special health care needs/disabilities", Pediatrics, vol. 110, no. Supplement, pp. 1328.  
Whitehead, M. 1992, "The concepts and principles of equity and health", International journal of 
health services, vol. 22, no. 3, pp. 429.  
Whitehead, M. 1991, "The concepts and principles of equity and health", Health promotion 
international, vol. 6, no. 3, pp. 217.  
Whitehead, M. 2007, Concenpts and principles for tackling social inequities in health, WHO 
Regional Office for Europe, Copenhagen.  
World Health Organization (WHO). (1978). Primary health care. "Report of the International 
Conference on the Primary Health Care", Alma Ata, 6-12 September. Geneva, Switzerland. 
Xu, B., Diwan, V.K. & Bogg, L. 2007, "Access to tuberculosis care: What did chronic cough patients 
experience in the way of healthcare-seeking?", Scandinavian Journal of Public Health, vol. 35, 
no. 4, pp. 396.  
Xu, B., Fochsen, G., Xiu, Y., Thorson, A., Kemp, J. & Jiang, Q. 2004, "Perceptions and experiences 
of health care seeking and access to TB care--a qualitative study in rural Jiangsu Province, 
China", Health Policy, vol. 69, no. 2, pp. 139-149.  
Xu, K. 2003, "Household catastrophic health expenditure: a multicountry analysis", Lancet, vol. 362, 













P a g e  | 64 
 
 
Part C: Journal Manuscript 
 
Availability, affordability and acceptability barriers to accessing Tuberculosis and HIV 





University of Cape Town, Cape Town South Africa 
 

















P a g e  | 65 
Abstract 
Objectives: The disadvantaged segments of the population are not only at a higher risk of being 
infected by tuberculosis (TB) and HIV, but also face more access barriers to health care services 
compared to their richer counterparts. This study explores access barriers in the use of TB and 
Antiretroviral Treatment (ART) services in Mitchell’s Plain with a view to identifying policy-
relevant solutions to these barriers. The study will also assess how these barriers differ by socio-
demographic status, and by self reported adherence to treatment.  
Methodology: Access in this study is measured using a multi-dimensional approach, and is 
conceptualized as the interaction of three distinct and measurable dimensions namely availability, 
affordability and acceptability. The study utilised secondary cross-sectional data collected using
questionnaires administered by trained interviewers. A two-stage sampling approach was used by
first selecting a representative sample of health facilities before selecting a representative sample of 
users in the facilities. A total of 657 respondents above 18 years, and who have been on TB treatment 
for at least 8 weeks or on ART for 2 weeks were sampled for the study. Data analysis was done using
STATA version 11 for Windows.
Results: Availability of services: Compared to TB services, ART services are inadequate to meet the
needs of everyone in need i.e. there are fewer ART facilities compared to TB facilities. Further, 
women on both services take longer to see a health worker and to collect medicines.
Affordability of services: Despite their lower ability to pay for services, TB patients incur higher 
monthly health care costs compared to HIV patients. TB patients are more likely than HIV patients to 
incur catastrophic expenditure, defined as spending more than 10% of their household income on 
health care. Furthermore, female TB patients spend more money on a monthly basis on transport 
compared to males. On the other hand, younger patients on both services spend more money on self-
care than older respondents.
Acceptability of services: Comparison between the two services with regards to acceptability of 
services revealed that ART services were less acceptable. This was evident in more patients on ART, 
compared to TB patients, feeling that facilities were dirty, had long queues and therefore long waiting 
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Conclusion: Users of TB and ART services in MP face access barriers. The users of TB services are 
particularly faced by affordability barriers caused by higher transport costs resulting from relatively 
more frequent facility visits under the policy of facility-based daily observed treatment (DOTs). On 
the other hand, the users of ART services face availability and acceptability barriers. Overcoming 
access barriers can enhance entry to care and retention in care and can therefore improve health 
outcomes. 
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Background 
Low- and middle-income countries have a disproportionately high burden of Human 
Immunodeficiency Virus and Acquired Immune Deficiency Syndrome (HIV/AIDS) compared to 
developed countries [1]. Considering that HIV patients are at a relatively greater risk of being 
infected with TB due to the weakened immune system [2], and that TB is worsened by poverty [3], TB 
incidence is generally higher in countries with high HIV prevalence. The tragedy is that regions most 
affected by the two diseases have limited resources, and therefore find it challenging to manage 
interventions aimed at controlling the spread of TB and HIV/AIDS [1]. With regards to HIV 
treatment for instance, in 2009 low- and middle income countries provided Antiretroviral Treatment 
(ART) to about 42% of those that needed it [4], which can be considered to be insufficient [1]. 
 
Among the developing countries, sub-Saharan Africa is hardest hit by the HIV epidemic [5]. 
Similarly, the WHO TB statistics for 2008 revealed that sub-Saharan Africa had the highest incidence 
of TB [6]. Within sub-Saharan Africa, South Africa remains the country with the most HIV infected 
people and also has the second highest incidence of tuberculosis in the world [7]. As a result of this 
coexistence between TB and HIV, South Africa has one of the highest TB/HIV co-infection rates in 
the world [8] as evidenced by the 2009 WHO estimates which showed that 60% of TB patients in the 
country were co-infected with HIV [6].  
 
In an effort to curb the TB and HIV/AIDS epidemics, the South African government, with support 
from the US President’s Emergency Plan for AIDS Relief (PEPFAR) and the Global Fund [9], has 
embarked on a campaign to enrol as many people as possible onto ART and TB treatment. Such 
efforts have resulted in the country having more people on ART than any other country in the world [2]. 
Critics have however argued that South Africa has not made as much headway as would have been 
expected. For instance, by the end of June 2011, the country had only managed to enrol about 1.4 
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in need of treatment at 2.6 million [10]. The probable reason for the poor performance in HIV 
interventions for instance, could be a result of delayed initiation and rollout of the ART program in 
the country [2, 7], and also the more centralised organisation of ART services [7]. 
 
Further, the Antiretroviral Treatment (ART) program has been experiencing challenges such as 
insufficient resources to meet the needs of all those in need [9, 11]. It is also likely that the above 
challenges in HIV treatment have tended to worsen the TB scenario in the country due to the 
relationship described earlier. Considered separately, TB control has also been reported to be moving 
slowly in the country, and that the country has not been doing as well as other African countries on 
the DOTS (Daily Observed Treatment, Short-course) program [8]. Being on DOTs entails that 
patients should visit TB facilities on a daily basis to be observed taking their medication. The TB 
scenario is exacerbated by the emergence of Multi-Drug Resistant TB (MDR-TB), which results 
from among other things, poor adherence to TB treatment. The draft National Strategic Plan for HIV 
and AIDS, STIs
5
 and TB (2012-2016) places South Africa as having the fourth highest case-load of 
MDR-TB in the world, highlighting the impact TB has had on the country. 
 
It can be concluded therefore that after massive investments in both TB and HIV control in most 
countries, including South Africa, little has been achieved with regards to the fight against these 
diseases. HIV/AIDS continues to cause high levels of morbidity and mortality, while TB not only 
remains one of the ‘world's biggest infectious killers’ [12], but is still the main cause of death in 
people that are HIV–positive [13]. For South Africa and other low- and middle income countries to 
achieve the 2015 Millennium Development Goals (MDGs) 6A and 6C, which call for a halt and 
reversal of HIV/AIDS and TB respectively,  much more effort is needed in addressing the ‘needs of 
the poor and the vulnerable populations’ [6]. This is because, as highlighted earlier, the two diseases are 
more prevalent among the poor.  
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The disadvantaged segments of the population are not only more likely to be affected with TB and 
HIV/AIDS, but also have worse access to health care services [14]. The implication of the above is 
that addressing the ‘needs of the poor and the vulnerable populations’ as suggested by the WHO, 
should also involve the identification of factors that impede them from accessing needed health care.  
 
While there have been calls for improved access to TB and HIV/AIDS treatment if countries are to 
achieve the MDGs, the concept of access itself is not straightforward, and the meaning of access is 
disputed. In an attempt to evaluate access barriers, this study adopts a comprehensive framework of 
access [15].  
 
Based on this framework, access is defined as the ‘degree of fit’ between the health care system and 
health care users. Access is further viewed as a concept whose achievement is determined by the 
interaction of three distinct and measurable dimensions namely availability, affordability and 
acceptability. While access has been defined differently by various authors i.e. as the use of health care 
services [16-20], the adequate supply of needed services [21-26] and as  the ability to pay for services 
[27-30], the argument made by this study is that the above access definitions are insufficiently 
comprehensive, because they tend to focus on one of the three dimensions. Even when they define 
access using more than one dimension, these definitions do not acknowledge the inter-relationship 
and interaction of the three dimensions in determining access.  
 
Within this framework, access can only be achieved when system and user factors, related to the 
access dimensions (availability, affordability and acceptability), interact in such a way as to 
‘empower’ users or give them the ‘freedom’ to use services [15, 31]. The interaction referred to in 
this definition involves the active exchange of information on services between users and providers 
[31]. The definition of access used in this study is appealing not only because it enables the 
comprehensive measurement of access, unlike other definitions before it, but also because it is a new 
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The study utilises survey data collected by the REACH project (Researching Equity in Access to 
Health Care). REACH is a five year project whose main objective is to examine health systems 
access and equity in South Africa. The project has four sites in South Africa i.e. Bushbuckridge 
(Mpumalanga), Mitchell’s Plain (Western Cape), Soweto Region D in Johannesburg (Gauteng) and 
Hlabisa (KwaZulu-Natal). The REACH institutions include Centre for Health Policy (CHP), 
University of Witwatersrand, Health Economics Unit (HEU), University of Cape Town, McMaster 
Institute of Environment and Health (MIEM), Centre for Health Economics and Policy Analysis 
(CHEPA), McMaster University, Africa Centre for Health and Population Studies, University of 
KwaZulu-Natal, and the Rural AIDS and Development Action Research Programme, University of 
Witwatersrand. 
Objectives of the study 
The main objective of this study is to examine access barriers in the use of TB and Antiretroviral 
Treatment (ART) services in Mitchell’s Plain, one of Cape Town’s sub-districts, in the Western Cape 
Province of South Africa. The study will also examine access to services between socio-demographic 
groups and also access barriers according to self reported adherence. The study will furthermore 
endeavour to identify policy relevant solutions to access barriers. Note that access in this study is 
defined as the “degree of fit” between service users and the health system, and is conceptualised in 
terms of availability, affordability and acceptability of services. 
 
Methods 
Study Site and Service Organisation 
This study was conducted in Mitchell’s Plain (MP), a sub-district of Cape Town located about 20km 
from the city centre and home to about 500,000 people [32]. Like most sub-districts of Cape Town in 
the Western Cape, MP faces high TB and HIV burdens. While TB Services are available in most of 
the clinics in the sub-district, HIV treatment i.e. ART, was only offered in three facilities at the time 
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While tuberculosis (TB) services in Mitchell’s Plain include both clinic-based and community based 
DOTs (Directly Observed Treatment, Short-Course), patients for this study were on clinic based 
DOTs. Both TB and ART services in MP are organised in such a way that they involve treatment 
supporters and patient advocates, and also treatment buddies and support groups, respectively. This is 
meant to reinforce treatment adherence and continuity of care. 
Sampling and data collection
A two-stage sampling approach was used, first selecting a representative sample of health facilities, 
then within these facilities, a representative sample of users.  As most public health facilities provide
TB services, a minimum of five facilities were selected and probability proportional to size (PPS) 
methods were used to select facilities using routine data on the total number of users in each facility
at the time of the research. Within each chosen facility, a random sample of patients was interviewed 
until the proposed facility sample size was reached. For ART, all accredited facilities were included. 
Proportional sampling methods and routine facility data on the number of ART users per facility at 
the time of data collection were used to determine the number of interviewees per facility. In total, a
minimum of 300 patients were interviewed within each tracer; the planned sample size was therefore
600 respondents. Respondents were included provided that they were over 18 years of age and had 
been on TB treatment for at least 8 weeks or on ART for 2 weeks.
The questionnaire was administered by trained interviewers in the language of the respondent’s 
choice. Completed questionnaires were checked for accuracy by a data collection coordinator and 
double entered into a data entry platform specifically designed for this purpose in Epidata. 
Study Variables 
The study collected socio-economic (SES) and demographic data in addition to a number of variables 
that were designed to capture attributes related to the three dimensions of access (availability, 
affordability and acceptability). Other variables included levels of patient adherence to treatment. All 
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Table 1: Study variables 
1. Social Economic Status and Demographic Variables 2. Availability variables 
- Categorized asset index (Categorical: 0=Poorest, 1=Richest) 
- Employment status (Categorical: 0=Unemployed, 1=Employed) 
- Marital status (Categorical: 0=single, 1=married or living with 
partner) 
- Sex of respondent (Categorical: 0=female, 1=male) 
- Number of years of education (Continuous variable)  
- Age (Continuous variable; measured in years) 
- Receiving a disability grant (Categorical: 0=no, 1=yes) 
- Monthly household expenditure (Continuous variable: measured 
in Rand ) 
- Time taken to travel to facility and 
home again (Continuous variable:  time 
measured in minutes –median time used) 
- Time taken to fetch medicines during 
last visit (Continuous variable: measured in 
minutes – median time used) 
- Time taken to see doctor or nurse during 
last clinical visit (Continuous variable: time 
measured in minutes – median time used) 
- Able to travel by foot to facility 
(Categorical: 0=no, 1=yes) 
3. Affordability Variables 4. Acceptability Variables 
- Money spent on other providers during past month (GPs, 
traditional healers etc.) (Continuous variable: measured in Rand – 
Mean amounts used) 
- Money spent on self-care during past month (over the 
counter medicines, special foods, traditional medicines) 
(Continuous variable: measured in Rand – Mean amounts used)  
- Money spent on most recent facility visit converted into 
monthly amount (transport, phone, food, etc.) (Continuous 
variable: measured in Rand – Mean amounts used) 
- Total monthly expenditure on health care (Cost on: Other 
Providers+ Self-care + monthly facility visits) (Continuous 
variable: measured in Rand – Mean amounts used) 
- Needing to borrow money to pay for health care (Categorical: 
0=no, 1=yes) 
- Expenditure on health care >10% household expenditure 
(Categorical: 0=no, 1=yes) 
- The health worker is too busy to answer 
my questions (Categorical: 0=no, 1=yes) 
- Respondent agrees that queues are too 
long (Categorical: 0=no, 1=yes) 
- Respondent agrees that some staff do not 
treat patients with sufficient respect 
(Categorical: 0=no, 1=yes)   
- Respondent agrees that the health care 
facility is dirty (Categorical: 0=no, 1=yes) 
- Respondent feels that people in the 
community judge him/her negatively for 
attending the TB or ART facility 
(Categorical: 0=no, 1=yes) 
5. Adherence Variables  
- Ever missed taking your ARV or TB medicines (Categorical: 
0=no, 1=yes) 
- Ever missed a visit to the ART or TB facility (Categorical: 
0=no, 1=yes) 
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Data Analysis 
Data analysis was undertaken in STATA version 11 for Windows [33]. Univariate analysis was used 
to describe the basic characteristics of the respondents e.g. sex, marital status, and age etc. while 
bivariate analysis was used to examine associations between two variables, and  to assess potential 
confounding between variables before the analysis. The main analysis utilised multivariate analysis 
through logistic regression for binary dependent variables, and linear regression for quantitative 
dependent variables.  
 
Before the analysis, a variety of multivariate linear and logistic regression models were built. In each 
model, standard control variables of age, sex, and socioeconomic status (categorized as rich versus 
poor) were included. Access variables were used as outcome variables (including travel time to the 
facility, waiting time to fetch medicine and to see a health worker, ability to travel by foot to the 
facility, money spent on self-care and on other providers during past month, money spent on most 
recent facility visit converted into monthly amounts, total monthly expenditure on health, needing to 
borrow money to finance health care, expenditure on health care greater than 10% of household 
expenditure,  health workers too busy to answer patients’ questions, some staff not treating patients 
with sufficient respect, dirty facilities and patients being judged negatively in the community), while 
explanatory variables included a range of socio-demographic (employment, marital status, number of 
years of education, recipient of a disability grant and monthly household expenditure), treatment 
related (duration on treatment) and self-reported adherence variables (i.e. missing taking medicine 
and missing facility visits).  
 
Regression models were developed through the inclusion of conceptually relevant variables, and 
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Results  
A total of 657 respondents took part in the cross-sectional study to determine factors that affect 
access to ART and TB treatment in Mitchell’s Plain. The number of respondents was almost equally 
divided between those on TB treatment (50.84%) and those on Antiretroviral Treatment (ART) 
(49.16%). Table 2 shows other characteristics of the study population. 
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Receiving a Disability Grant 71 (21.3%) 100 (30.9%) 
 
AVAILABILITY OF TB AND ANTIRETROVIRAL TREATMENT (ART) SERVICES 
The availability of services is an important aspect of access and was estimated in four ways: 
i. Examining the time it took patients to travel to and from the facilities 
ii. The time it took patients to fetch medicines 
iii. The time it took patients to see a doctor or nurse during their last clinical visit, and 
iv. The mode of transport respondents used to get to the facilities (i.e. on foot or other modes of 
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Note that since time taken to travel to the facility and time taken to fetch medicine was not normally 
distributed for both TB and ART services, median times were used for analysis. The Wilcoxon Sum 
Rank Test, a non-parametric test, was used to test for significant difference between TB and ART 
services median times (i.e. travel time, waiting times for health workers and to fetch medicine). 
While time taken to see a doctor or nurse during the last visit was normally distributed for ART 
services, median time was still used for comparison because time taken to see a doctor or nurse under 
TB services was not normally distributed. Mode of transport used was a dummy variable (i.e. 
1=travel by foot; 0=other means of transport), and therefore proportions were used for comparisons 
between TB and ART services. 
 
Comparisons between TB and ART services revealed that TB services were generally more available 
than ART services. This conclusion was reached at after the Wilcoxon Sum Rank Test (non-
parametric test used to test whether two populations have equal medians) revealed significant 
differences in median times between the two services. Specifically respondents on TB treatment 
spent significantly less time fetching medicines (p<0.001) and less waiting time to see a doctor or 
nurse (p<0.001) compared to respondents receiving HIV treatment. Furthermore, it was found that 
compared to patients on HIV treatment, significantly more TB patients travelled on foot to the 
facilities (67.7% vs. 32.1% for ART) as opposed to using other modes of transport (p-value=0.001), 
and spent slightly less time to reach facilities (Wilcoxon Sum Rank Test p-value<0.001). This 
highlights the proximity of TB services. Note however that although results revealed similar median 
travel time between the services, a Wilcoxon Sum Rank Test showed a significant difference in travel 
time between services (p<0.001), with patients on ART taking significantly longer to get to facilities 
(Mean travel time = 23.5 minutes vs. 20.9 minutes for TB patients).  Table 3 and figures 1 and 2 
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Table 3: Availability of Services 
Availability Variables 
 
TB ART P-Value 
Time taken to travel to facility and vice versa 
(Median Time) 
20 min 20 min <0.001 
Time taken to fetch medicines during last visit  
(Median Time) 
15 min 180 min <0.001 
Time taken to see doctor or nurse during last 
clinical visit (Median Time) 
60 min 240 min <0.001 







*Wilcoxon Sum Rank Test, a non-parametric test, was used to test significance difference in median time (in minutes) 
between TB and ART service. 
 
Figure 1: Availability of Services (median time) 
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Factors Associated with Availability of Services 
Availability of TB Services 
Multivariate analysis revealed that the sex of the respondents was associated with waiting time to see 
a health worker. The results showed that male respondents were more likely to spend less time 
waiting to see a health worker compared to female respondents, with an average of 17.7 minutes less 
than females (p-value=0.015, CI: -31.9 – -3.5). Note however that when waiting time to see a health 
worker was examined by facility, sex was no longer a significant predictor for all 5 TB facilities.  
Further results on availability of TB services revealed that time spent on treatment was an important 
factor when it came to the time taken to see a doctor or nurse. More precisely, an additional month 
spent on treatment resulted on average in 4 additional minutes waiting time to see a doctor or nurse 
(p-value=0.002, CI: 1.5 – 6.6).  
Availability of HIV treatment Services
Similar to TB services, multivariate analysis on availability of ART services also found that patients 
that had been on treatment for longer spent more time waiting to see a health worker. Specifically, an 
additional month spent on ART was likely to increase the time taken by respondents to wait for the 
doctor or nurse by an average of 0.73 additional minutes (p-value=0.039, CI: 0.04 – 1.41). 
AFFORDABILITY OF TB AND HIV TREATMENT SERVICES 
To assess the affordability of services, various factors were considered which included individuals’ 
abilities to pay for health care services, and the actual expenditures they incurred in the process of 
seeking health care. Ability to pay was assessed by examining employment rates, whether or not 
respondents had to borrow money to pay for health care, whether or not respondents were recipients 
of the disability grant and also the number of respondents who had to incur health care costs of more 
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On the other hand, actual health care costs included total monthly expenditure on health care, money 
spent on self-care and on other providers in the past month and money spent on transport, phone, 
food costs etc., converted into monthly amounts These two components of affordability are discussed 
below. 
 
Ability to Pay for Services 
Employment rates were generally low for respondents on both TB and HIV treatment (21% and 31%, 
respectively) in MP. However bivariate analysis revealed that respondents attending TB services had 
lower employment rates than those on ART (p-value=0.0034, CI: -0.17 – -0.03). With regards to 
borrowing money to pay for health care, there were a number of patients who were borrowing money 
to pay for health care and other related costs (45 patients on TB and 36 patients on ART). The 
numbers of respondents borrowing money for health care was however similar between TB and ART 
services (p-value=0.37, CI: -0.03 – 0.073). 
 
With regards to the numbers of patients receiving the disability grant, it was found that only about 
21.3% and 31.9% of patients on TB and ART services, respectively were receiving the disability 
grant. While the numbers receiving the disability grant were low for both services, bivariate 
comparisons between the services revealed that significantly more people on ART were recipients of 
the disability grant compared to patients on TB treatment (p-value=0.0046, CI: -0.26 – -0.03).  
 
A very important factor with regards to affordability of services was to examine the number of 
patients between TB and ART services that had spent more than 10% of household expenditure on 
health care. It was found that significantly more patients on TB treatment compared to patients on 
ART (32.2% vs. 8.2%, p-value<0.001, CI: 0.2 – 0.3) incurred health care costs exceeding 10% of 
their household expenditure. This implies that TB services exposed patients to catastrophic health 
expenditure more than ART services. Table 4 and figure 3 below summarises findings on the ability 
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Table 4: Ability to Pay for Services 











0.0034 -0.17 – -0.03 





0.3722 -0.03 – 0.073 






0.0046 -0.26 – -0.03 
Expenditure on health care >10% 





<0.001 0.2 – 0.3 
 
Figure 3: Ability to Pay for Health Care (TB and ART) 
 
 
Factors Influencing Patients’ Ability to Pay for Services 
Ability to Pay for TB Services 
Multivariate analysis showed that spending more money on self-care and on other providers was an 
important indicator of whether an individual was going to borrow money for health care, and/or incur 
catastrophic health care expenditure. It was specifically found that spending an additional Rand on 
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of borrowing money to pay for health care (OR=1.37, p-value=0.006, CI: 1.1 – 1.7) and also of 
incurring catastrophic health care expenditure (OR=1.87, p-value=0.056, CI: 0.9 – 3.6). Similarly, 
spending an additional Rand on other providers also increased the chances of borrowing money to 
finance health care (OR=1.18, p-value=0.049, CI: 1.0 – 1.4), and also significantly higher odds of 
incurring catastrophic health care expenditure (OR=3.58, p-value<0.001, CI: 2.4 – 5.2). 
Comparisons between the richest and poorest TB respondents revealed that richer respondents had 
significantly lower chances of experiencing catastrophic health expenditure than their poorer 
counterparts (OR=0.11, p-value<0.001, CI: 0.03 – 0.39). For example, the majority (52%) of those 
that experienced catastrophic health expenditure fell into the poorest 50% of the sampled respondents 
(according to the asset index). Furthermore, married respondents (OR=0.25, p-value=0.056, CI: 0.06 
– 1.03) and also employed respondents (OR=0.3, p-value=0.084, CI: 0.08 – 1.17) had lower odds of 
spending more than 10% of their household expenditure on health care. Specifically, only about 29%
and 23% of respondents incurring catastrophic health expenditure were married and employed, 
respectively. Note that findings on ‘married and employed’ with regards to catastrophic health 
expenditure were only significant at 10% level of significance.
Just a note that the mode of transport used to get to the facilities, i.e. travelling on foot versus other
modes of transport such as travelling by taxi, bus and train etc., was an important determinant of 
whether or not a patient would borrow and/or incur catastrophic health expenditure. This highlights 
the importance of having facilities as close to the people as possible. 
Ability to Pay for ART Services 
Examining factors affecting ability to pay for patients on HIV treatment utilising multivariate 
analysis revealed that the likelihood of incurring catastrophic health expenditure increased with every 
additional Rand patients spent on self-care (OR=5.43, p-value=0.001, CI: 2.0 – 14.7) and seeking 
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13.1). Specifically, the odds of experiencing catastrophic expenditure increased by more than 5 times 
for every Rand spent on both self-care and on other providers.  
In addition, the results also showed that the odds of borrowing money to pay for health care were
higher for respondents who spent relatively more money on self-care and on other providers. More
precisely, an additional Rand spent on self-care resulted on average in 1.25 higher odds of borrowing 
money to pay for health care (OR=1.26, p-value=0.066, CI: 0.9 – 1.6) while an additional Rand spent 
on other providers resulted in an average of 1.21 higher odds of borrowing (OR=1.21, p-value=0.065, 
CI: 0.9 – 1.5). Note though that these results were only significant at 10% level of significance. The
results further revealed that the likelihood to borrow money for health care diminished with an 
additional month a patient spent on ART (OR= 0.95, p=0.026, CI: 0.89 – 0.99). 
Finally, the sex of patients was found to be an important factor with regards to ability to pay for ART
services, specifically in incurring catastrophic health care expenditure. Specific results further 
showed that the likelihood of incurring catastrophic health care expenditure was 7.6 times higher for
male respondents compared to their female counterparts (OR=7.6, p-value=0.027, CI: 1.3 – 45.8).
Health Care Related Costs
As mentioned earlier, health care related costs included the total monthly expenditure on health care. 
Total monthly cost was made up of money spent on self-care (over the counter medicines, special 
foods, traditional medicines) and money spent on other providers (GPs, traditional healers) in the past 
month, and also money spent on transport, phone, food and other related costs incurred by patients 
expressed in monthly amounts. Examining these various costs will give an idea about the cost of 
being on both TB and ART in MP.
Examining health care costs within each service showed that in TB services, the largest share of total 
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numerous monthly facility visits. The numerous TB visits resulted from the fact that most of these 
patients have to visit the facility every day to be observed taking their TB treatment. To put this into 
perspective, the majority of TB patients (92.8%) visited their respective facilities daily during the 
week i.e. 20 times in a month, while most of those on ART (78.2%) only made a single visit to the 
facility in a month. This explains why TB services are associated with high monthly transport costs 
compared to ART services. The second largest contributor to health care costs came from money 
spent on other providers and this was followed by money spent on self-care.  
 
On the other hand, the largest contributor to total health care costs in the ART services was money 
patients spent on other providers followed by money they spent on self-care. Unlike under TB 
services, and as a result of varying frequencies of facility visits between the two services as described 
above, expenditure on transport, phone calls and food in the ART service expressed in monthly 
amounts was lower than in TB services for obvious reasons.  
 
Bivariate analysis was used to compare costs across the two services,  and it was found that 
respondents receiving TB treatment spent an average of R108.72 (median cost=R0) in a month on 
health care while their colleagues on ART only spent an average monthly total cost of R44.92 
(Median Cost=R10) on health care.  
 
When the various components of total cost were examined separately, it was also found that while 
patients on TB treatment spent an average of R74.98 (Median amount=R0) on transport, phone calls 
and food costs in past month, those on ART only spent an average of R8.53 (Median amount=R8) in 
the same period. With regards to money spent on other providers and self-care in the past month, TB 
patients spent an average of R26.8 (Median=R0) and R6.84 (Median=R0) on other providers and 
self-care respectively, compared to R23.16 (Median=R0) and 12.95 (Median=R0) spent on other 
providers and on self-care, respectively by HIV patients. Table 5 and figure 4 present the 
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Total Monthly Expenditure on health care 108.72 44.92 
Money spent on other providers  26.8 23.16 
Money spent on self-care 6.84 12.95 
 
 




Factors Associated with Health Care Costs 
Health Care Costs on TB services 
Multivariate analysis on the factors that affect health care costs showed that age and sex of 
respondents were important variables with regards to health care spending. Specifically, with every 
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-0.003), while male respondents had significantly lower expenditure on transport, phoning and on
food expressed in monthly costs, compared to female respondents (p-value=0.004, CI: -0.5 – -0.1). 
Further, it was revealed that the longer the time respondents spent waiting to fetch medicines, the 
more likely they were to spend significantly more money on other providers such as private general 
practitioners (GP) and traditional healers (p-value<0.001, CI: 0.006 – 0.020). Relatively longer time 
to fetch medicines was also associated with patients resorting to spending more money on self-care, 
i.e. over the counter and traditional medicines (p-value=0.051, CI: -0.00002 – 0.00899).
In addition, respondents who felt disrespected by some health workers spent more money seeking
care from other providers compared to those that felt respected by health workers (p=0.035, CI: 0.04
– 1.18). Finally, it was revealed that the relatively richer respondents had lower expenditure on 
transport, phone and food when expressed in monthly costs compared to their poorer counterparts (p=
0.09, CI: -0.4 – 0.02). Note that though results between the richest and poorest respondents showed 
significance at 10% level, the confidence intervals revealed no significant differences between the
two groups. 
Health Care Costs on ART services
Further multivariate analysis on the factors that affect health care costs in the ART services revealed 
a number of factors ranging from demographic variables (e.g. sex), availability variables (e.g. time 
taken to fetch medicines and to see a doctor or nurse), acceptability variables (e.g. some health 
workers lacking respect towards patients, health workers too busy to answer questions, dirty facilities 
and long queues in facilities) and also time spent on HIV treatment.
Specific results showed that an additional month spent on treatment was associated with spending 
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travelling, making phone calls and on food expenses when expressed as monthly costs (p<0.001, CI: 
-0.02 – -0.01).  
 
With regards to waiting times to see a doctor or nurse and costs on health care, results showed that an 
additional minute spent waiting to see a doctor or nurse increased the likelihood of spending more 
money on other provider (p-value=0.032, CI: -0.0042 – -0.0002). A related finding was that an 
additional minute spent waiting to fetch medicines significantly increased the likelihood of patients 
spending more on self-care (p-value<0.001, CI: 0.002 – 0.005). 
 
As mentioned earlier, the acceptability of health care services proved to be important with regards to 
health care costs. Specifically, HIV patients who agreed that some health workers did not treat them 
with sufficient respect were more likely to spend significantly more money on self-care (p-
value=0.007, CI: 0.15 – 0.98). Similarly respondents who agreed to the statement that the ART 
facilities were dirty were more likely to spend significantly more money seeking care from other 
providers compared to patients who felt facilities were clean (p-value=0.028, CI: 0.06 – 1.08). At a 
lower significance level (10%), patients who answered in the affirmative that queues were too long in 
the facilities had a higher likelihood of spending more money seeking care from other providers 
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ACCEPTABILITY OF TB SERVICES 
To assess the acceptability of both TB and ART services in MP, patients were asked a range of 
questions about the health workers and organisation of health services in general. Specifically, 
respondents were asked about whether they agreed or disagreed with the following statements: 
1. The health worker is too busy to answer my questions 
2. Queues are too long in the facilities 
3. Some staff do not treat patients with sufficient respect 
4. The health care facility is dirty 
5. People in the community judge the respondent negatively for attending the TB or ART 
facility 
Generally, most of the respondents from both TB and ART services seemed to feel that the respective 
services they attended were acceptable. The only exception was regarding queues in ART facilities in 
which the majority (67.6%) of respondents agreed that queues were too long.  
 
Bivariate analysis between TB and ART services however revealed that TB services were relatively 
more acceptable from patients’ perspectives. This conclusion is based on the fact that significantly 
more respondents on HIV treatment were likely to agree that health workers were too busy to answer 
their questions (16.5% vs. 11%: p-value=0.045, CI: -0.107 – -0.001), that queues were too long in the 
facilities (67.6% vs. 43.5%, p-value<0.001, CI: -0.3 – -0.2) and that health care facilities were dirty 
(25.8% vs. 14.1%, p-value<0.001, CI: -0.18 – -0.06). It was only on the notion of being judged 
negatively in the community for attending TB or ART facilities that more respondents on TB 
treatment, as compared to those on ART, agreed to being judged negatively in the community for 
attending facilities (11% vs. 6%, p-value=0.027, CI: 0.006 – 0.091). Table 6 summarises comparative 
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Table 6: Acceptability of Services: TB vs. ART  
% of patients who agree to the following 
statements 
 
TB (%) ART (%) P-Value 95% 
CI 
Respondents agree that the health worker is too 
busy to answer my questions 
11.11% 16.51% 0.045 -0.107 – -0.001 
Respondents agree that queues are too long 43.54% 67.60% <0.001 -0.3 – -0.2 
Respondent agree that some staff do not treat 
patients with sufficient respect 
19.76% 16.61% 0.298 __ 
Respondent agrees that the health care facility is 
dirty 
14.11 25.86% <0.001 -0.18 – -0.06 
Respondents feel that people in the community 
judge him/her negatively for attending the TB or 
ART facility 
11.08% 6.21% 0.027 0.006 – 0.091 
 
Factors Affecting Patients’ Acceptability of Services 
Acceptability of TB Services 
In as far as acceptability of TB service  was concerned, multivariate analysis revealed that the 
likelihood of complaining about ‘too busy’ health workers was higher for the richest respondents 
than it was for the poorest ones (OR=2.6, p-value=0.018, CI: 1.2 – 5.8). The sex of respondents was 
also found to be very important in the acceptability of TB services as it was revealed that males were 
less likely to assert that facilities were dirty as compared to females (OR=0.29, p-value=0.002, CI: 
0.1 – 0.6). It was further found that the odds of complaining about busy health workers was lower for 
males than it was for females, at 10% significance level (OR=0.49, p-value=0.081, CI: 0.2 – 1.1). 
 
Time spent on treatment was also important in as far as agreeing to the statement that ‘health workers 
were too busy to answer patients questions’ was concerned. Though the finding was only significant 
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likelihood that a patient would allude to the issue of health workers being too busy to answer their 
questions (OR=1.11, p-value=0.084, CI: 0.9 – 1.3) 
 
Acceptability of HIV Treatment Services 
Regarding factors affecting acceptability of HIV treatment services, multivariate results revealed that 
time spent on HIV treatment was important in this regard. Similar to results on the TB services, it 
was found that an additional month on treatment increased the likelihood of respondents agreeing 
that health workers were too busy to answer their questions (OR=1.03, p-value=0.003, CI: 1.01 – 
1.05). As would be expected however, the likelihood of feeling judged negatively in the community 
for attending HIV treatment services reduced significantly with an additional year a respondent spent 
in school (OR=0.95, p-value=0.027, CI: 0.90 – 0.99).  
 
ADHERENCE TO TB AND HIV TREATMENT SERVICES 
Estimating the level of access to TB and ART services would not be complete without also 
considering the level of adherence to treatment. To assess adherence to both services, respondents 
were asked whether they had ever missed taking their medicines, and also whether they had ever 
missed a visit to the respective facilities they were attending.  
 
Comparison between the services using bivariate analysis revealed significant difference in 
adherence levels with ART services performing better.  As illustrated in the table below (Table 7), 
significantly more respondents on TB treatment reported ever missing taking their drugs compared to 
those reporting missing taking ARVs (p-value<0.001, CI: 0.08 – 0.20). There were also more missed 
visits for TB than there were for ART services (p-value<0.001, CI: 0.17 – 0.28). The table below shows 
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Table 7: Adherence to Services 
% of patients who agree to the following 
statements 
TB (%) ART (%) P-Value 95% 
CI 






<0.001 0.08 – 0.20 






<0.001 0.17 – 0.28 
 
Factors Affecting Adherence to Services 
Adherence to TB Services 
Multivariate analysis of the factors that affect adherence to TB services indicated that the age of 
respondents was important in this regard. Results showed that the likelihood of missing a visit to a 
TB facility decreased with age i.e., with every year increase in age, the likelihood of missing a TB 
visit also diminished (OR=0.97, p-value=0.049, CI: 0.95 – 0.99). In addition, examining the impact 
of respondents’ age against ever missing taking TB drugs also revealed that, at 10% significance 
level, the odds of missing taking drugs diminished with a year increase in age (OR=0.97, p-
value=0.061, CI: 0.9 – 1.0).  
 
The analysis further found that time spent on treatment was an important determinant of TB 
adherence. For instance, results showed that the odds of ever missing taking TB drugs increased for 
an additional month a patient spent on treatment (OR=1.25, p-value<0.001, CI: 1.1 – 1.4). Time spent 
on treatment was also a factor with regards to missing visits to TB facilities. Similarly, the likelihood 
of ever missing a visit to the TB facility significantly increased for every additional month a patient 
spent on treatment (OR=1.22, p-value<0.001, CI: 1.1 – 1.4). While it is expected that those who have 
been on treatment longer have a higher probability of having missed taking drugs and visiting a 
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decrease with additional months spent on treatment, which could be because patients start feeling 
much better and become complacent. 
Adherence to HIV treatment Services
Multivariate analysis on adherence to HIV treatment services revealed that the odds of ever missing 
taking ARVs was lower for patients receiving the disability grant, compared to the odds of missing
taking drugs for non-recipients of the disability grant (OR=0.45, p=0.074, CI: 0.2 – 1.1). Specifically,
only 19.5% of the disability grant recipients reported ever missing taking their HIV drugs compared 
to 80.5% of patients not receiving the disability grant. The age of respondents was also found to be 
important in as far as missing an ART visit was concerned. Specifically, every year increase in 
patients’ age reduced the likelihood of missing a visit to the ART facility (OR=0.94, p=0.065, CI: 
0.882 – 1.003). Note that the above results were significant at 10% level of significance.
Similar to findings on TB adherence, it was shown under ART that the odds of patients ever missing
taking their ARVs increased with every additional month spent on treatment (OR=1.05, p<0.001, CI:
1.03 – 1.07). The results also revealed that with every additional month spent on treatment, patients 
were more likely to miss a visit to the ART facility than they were previously (OR=1.07, p<0.001, 
CI: 1.04 – 1.09). As mentioned earlier, care needs to be taken when examining findings on adherence
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Discussion  
This analysis has revealed a number of barriers to accessing both TB and ART care in MP. Most of 
the identified barriers are common between both services, which may be a good thing as it may be 
possible to implement a one-strategy-suits-all solution. The discussion of the findings will be 
categorised into socio-economic barriers and health system barriers, borrowing from Kagee and 
Delport’s analysis on the barriers to adherence to antiretroviral treatment [34]. 
 
Socio-economic barriers to care 
Socio-economic barriers to accessing care in MP included health care costs incurred by patients in 
the process of seeking care, and also the tendency by patients to resort to spending more money on 
self-care and on other providers. Spending more money on self-care and on other providers were 
important barriers because they have a potential to cause patient migration from the formal health 
care services and also contribute to catastrophic health care expenditure. 
 
Health care costs are an important challenge with regards to accessing care and in ensuring long term 
adherence [35, 36]. In this study, tuberculosis service users experienced relatively higher costs to 
seeking care, most of which was on transport. These costs were worsened by the lower ability to pay 
of TB patients i.e. lower employm nt rates, lower likelihood of receiving a disability grant and the 
higher frequency of visits to the facilities for their daily Directly Observed Treatment, Short –Course 
(DOTs). The importance of ability to pay for services cannot be ignored as it has been shown to 
influence access to chronic care [37]. It can be further argued that the huge monthly amounts spent on 
transport for TB services, resulting from more facility visits, were responsible for most TB patients 
having to spend more than 10% of their household expenditure on health care. Note that female TB 
patients spent more on transport than male patients. The importance of transport costs as a key 
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Lessening health care costs of TB services may require improving patients’ ability to pay for health 
care related costs. This can be done by improving the targeting of the disability grant to cover as 
many TB patients as possible, especially women who incurred significantly higher costs on transport 
to TB facilities than males. In addition, the process of acquiring the disability grant for TB patients 
may need to be eased to make it compatible with the relatively shorter term TB treatment compared 
to HIV treatment. Alternatively, TB services can make use of the services of TB treatment supporters 
in the community to collect TB medicines from the facilities on behalf of patients. This can 
significantly reduce patients’ daily costs on transport, phone calls and food, and ultimately on 
monthly expenditure on health care. This can also reduce the number of TB patients incurring 
catastrophic health care expenditure, thereby improving their ability to absorb other health costs. 
Integration of services is another strategy that has been shown to reduce patients’ transport costs, 
especially in cases where TB patients also need HIV treatment [34]. 
 
On the other hand, the cost of seeking care from other providers was the largest cost incurred by HIV 
patients. Patients on HIV treatment therefore need to be sensitised to the dangers of seeking care 
from other providers on whom they spend a lot of money. Seeking care from other providers such as 
private GPs and/or traditional healers has been shown to delay seeking TB care in Zambia [42]. In 
addition, adding drugs from other providers to ARVs may result in drug toxicity and even affect the 
efficacy of the ARVs. Considering that the tendency of patients to resort to seeking care from other 
providers could be due to health system inefficiencies or perhaps acceptability barriers, there is a 
need for health system managers to ensure systems are responsive to patient needs to prevent patient 
migration. 
 
Health system barriers to care 
Other observed barriers to accessing services in MP were related to health system organisation. 
Specifically, ART services in MP were inadequate, and located further from patients as evidenced by 
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considering that while TB facilities were widely spread around MP at the time of the research, there 
were only three facilities offering ART services in the area. The problem of inadequate ART services 
compared to TB services seems to be a common challenge in South Africa because another study 
conducted in KwaZulu-Natal province of South Africa also found ART services to be significantly 
inadequate compared to TB services [43]. 
 
Related to the problem of inadequate ART services, queues were another health system barrier that 
was identified in MP. Long queues in the ART facilities may not only indicate that ART facilities are 
few, but may also mean that health workers in the facilities were insufficient in number to cope with 
patients’ demand. The problem of inadequate health workers in HIV treatment has been shown to 
constrain treatment access [44]. Inadequacy of health workers in ART facilities seems to be a key 
access challenge to HIV treatment in Southern Africa as was also revealed by other studies from 
Botswana, Zambia and Malawi [45-47].  
 
Furthermore, poor system organisation of both services was evidenced by poor attitudes of health 
workers. Disrespect from some health workers and unhygienic facilities may explain why some 
patients resorted to either buying over the counter medicines and/or paying for the services of other 
providers. In addition, the long waiting times in the facilities, especially ART facilities, may worsen 
the problem of patient retention because of the opportunity costs of waiting for medicines and for 
consultations. Appropriate health system organisation does not only improve access to care but has 
also been shown to improve patient retention and compliance to treatment. For instance having health 
care providers offering support and education to HIV patients has been shown to improve patient 
compliance to treatment [35]. 
 
Looking at the findings from an equity perspective, a number of issues have been identified that 
require attention if equitable access to TB and ART services in MP is to be enhanced. Firstly, the 
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the way the disability grant is targeted, then we would expect more TB patients to be on the grant 
because they have the worst ability to pay for services, and pay significantly more for health care on 
a monthly basis than their counterparts on HIV treatment. More TB patients on the disability grant 
will ensure better ability to pay and better ability to manage health care costs.  
 
Secondly, both TB and ART facilities in MP need to ensure gender-friendly services especially 
towards female patients because services in MP seem to be tailored to suit male patients as evidenced 
by shorter waiting times for males in collecting medicines and seeing a health worker. Further 
investigation may be required on sex and organisation of TB services to have a complete 
understanding of the above results. For instance, it could be that TB services in the old part of MP, 
which serves more ‘coloured’ (mixed race) and male patients, are better organised than the services 
in the informal settlements that serve largely the African and female TB patients (e.g. Crossroads II). 
Such differing service organisation described in TB provision may also explain why health workers 
seemed to have more time to answer questions from males than they did with females. Similar to 
findings in this study, other studies elsewhere have also found that female patients tend to have worse 
access to HIV treatment [47-49] and to TB treatment [38, 39, 50-52], compared to males. 
Furthermore, services in MP need to meet the needs of the less educated and younger respondents 
who also had longer waiting times and were less compliant to treatment, respectively.  The younger 
patients also spent more money on self-care indicating the unacceptability of the services. 
 
It is worrying that there are still patients in both services reporting missing visits and taking 
medication, with TB services having worse adherence. Poor adherence to treatment can cause 
undesirable health care outcomes such as drug resistance resulting from interruption of treatment [53, 
54]. Reinforcing adherence to treatment will also require additional engagements with patients that 
have shown higher likelihood of defaulting treatment such as the younger patients, unmarried 
patients and those that stay further from the facilities. Special attention should also be paid to patients 
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that adherence worsened with time spent on treatment. Adherence to treatment, both for TB and HIV, 
cannot be ignored due to its importance to successful treatment [55]. 
 
It may seem obvious that the solution to improving access to services and patient retention is to 
increase the number and quality of facilities. However, it has to be noted that making services 
available alone is not a guarantee of access without understanding the underlying cause of access 
challenges [15, 56], and without ensuring services are affordable and acceptable. Further, there 
should also be interactive communication and engagements between health workers and patients [37, 
56] to ensure that patients have sufficient knowledge about their conditions, and the dangers of self-
care and seeking care from other providers. It has been shown that without such knowledge, patients 
have tended to seek alternative care [37]. 
 
Based on the similarities of barriers between TB and ART services, and the revelation that TB and 
HIV/AIDS infections mostly occur in the same individuals [57], the one-strategy-fits-all solution 
would be to integrate the provision of these services in MP. As mentioned earlier, not only would 
integration ensure improved access to care [58], but would also ensure reduced patients’ costs to 
accessing treatment i.e. transport and opportunity costs by having services provided in the same 
location [34]. It can also be asserted that integration of these services is essential in reducing costs of 
providing these services by eliminating service overlaps and work duplication by health care staff 
which is common when services are offered separately [43, 59]. Further, integration can be an 
opportunity to make services more efficient. For instance, the TB service can learn the patient-
centred approach of the HIV treatment service to improve adherence [43]. 
 
The study findings are a revelation that access is a multi-dimensional concept that requires assessing 
all the three dimensions at the same time to be able to know if and to what extent access has been 
achieved. For instance, analysing access this way has enabled this study to show that availability of 
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rates even after having adequate facilities. Among other factors, poor access to TB services is mainly 
due to high transport costs (affordability dimension) and also the frequency of the visits that 
characterise the service. Poor access may also stem from the fact that TB seems to be a stigmatised 
disease in MP (acceptability). The analysis has also shown that access to ART services has not yet 
been achieved because even when this service is relatively affordable, it is marked by inadequate 
services (availability) and poor acceptability of services i.e. longer waiting times, dirty facilities and 
poor health worker attitudes. Viewing access as a multi-dimensional concept therefore enables 
analysis across a range of factors i.e. availability, affordability and acceptability of services, and 
therefore also offers a multi-dimensional approach to solving access problems. 
Limitations of the study
Note for future studies that the acceptability dimension can best be understood using qualitative 
interviews, making this one of the limitations of this study since it utilised quantitative data. In 
addition, since study respondents were those patients receiving treatment in various facilities, patients 
that were lost to follow-up were automatically excluded from the study. The implication of this is that 
we may not be able to understand access barriers that made these patients drop out of treatment. 
Similarly, since the study is limited to only those attending health facilities, it is not possible to 
understand access barriers faced by patients not using services at all.
Furthermore, since sampling of respondents is clustered by clinic attended, it is likely that some 
responses by participants attending the same clinic will be similar, e.g. the cleanliness of the clinic or 
waiting time. This implies a lack of independent observations and therefore a limitation. 
Finally, the data used for the analysis did not allow for analysis of TB/HIV co-infection and patient-
health worker ratios, and how this impact on access to TB and HIV services. Understanding the 
impact of TB/HIV co-infection and patient-health worker ratios on access would have provided 
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Conclusions  
The study presented findings on the barriers to accessing TB and ART services in MP using a multi-
dimensional approach. Using this approach has helped to show how intertwined the access 
dimensions are, and why it is important to examine them together. For instance, it has been shown in 
the case of TB services that availability of services does not result in better treatment adherence. This 
is because other factors come into play such as the affordability and the organisation of services to 
meet the expectations of patients. 
 
The study findings indicate that a number of access challenges still exit in MP, particularly high costs 
associated with TB treatment and patients’ lower ability to meet these costs, and also inadequacies of 
ART services and lower acceptability for the available ones. A number of solutions have been 
proposed, the key being the integration of both TB and ART services. It has to be noted though that 
integration on its own is not enough to eliminate access barriers in MP without solving other 
underlying access challenges. Other challenges that need attention include poor targeting of the 
disability grant, long waiting times in facilities especially for women, the tendency to resort to self-
care especially for younger patients and also the use of other providers by patients. 
  
With regards to the ART services, there is need to improve system factors vis-à-vis cleaner facilities 
and provider-patient engagement. In relation to engaging with patients, particular attention should be 
paid to the relatively younger patients who seem to spend more on self-care and are also more likely 
to default treatment. As shown earlier, female patients seemed to have longer waiting times in 
facilities to see a health worker and fetch medicines, and as such should be monitored as they may 
resort to either self-care or seek care from other providers.  
 
Finally, it is clear from the foregoing that a comprehensive understanding of access is the first and 
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therefore to examine the interrelated dimensions namely availability, affordability and acceptability 
of services together, without which access will be nothing more than a concept.  
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Part D: Policy Brief 
Assessing access barriers to Tuberculosis (TB) and Antiretroviral (ARV) treatment in 
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BACKGROUND 
South Africa carries the largest burden of people 
living with the Human Immunodeficiency Virus 
(HIV) globally (UNAIDS, 2010), and is also 
among the top three countries with the highest 
Tuberculosis (TB) incidence rates in the world 
(WHO. 2009).  
 
The South African government, with support 
from donors, has dedicated substantial resources 
towards the fight against TB and HIV. However, 
patients attending both services continue to face 
challenges in accessing treatment. For example, 
in 2009 only about 37% of HIV infected people 
were on Anti-Retroviral Therapy (ART) in 
accordance to the guidelines prescribed by the 
WHO (WHO/UNAIDS/UNICEF , 2010). Owing 
to the fact that South Africa has one of the 
highest TB-HIV co-infection rates in the world 
(Avert website. 2011), and that HIV infection 
increases the risk of being infected with TB 
{{102 Daley,C L. 1992}},  tuberculosis remains 
the main cause of mortality among people living 
with HIV in the country (Republic of South 
Africa. 2010).  
 
With the above background, this study aimed to 
examine access barriers to TB and ART services 
in Mitchell’s Plain (MP). The hope is that 
findings will inform policy makers about the 
barriers patients face in using these services and 
also ways to solve them. Both TB and 
HIV/AIDS are important causes of premature 
mortality. Between 2001-2006, Cape Town 
mortality data indicated that HIV/AIDS had 
replaced homicide as the leading cause of 
Box 1: Key Findings 
 Patients on TB treatment incur higher health 
care costs, mostly on transport because of 
relatively higher frequency of facility visits 
compared to HIV patients. Women spent more 
money on transport than men. 
 More TB patients compared to HIV patients 
spend greater than 10% of their household 
expenditure (HHEXP) on health care. 
 There are fewer ART service points in MP 
compared to TB services. 
 ART services perform relatively poorly 
with regards to meeting patient 
expectations e.g. longer waiting times and 
inability by health workers to answer 
patients’ questions. 
 Patients on TB treatment have worse 
adherence to treatment than patients on 
ART. 
 Despite their eligibility, fewer patients on 
TB treatment receive disability grants than 
those on ART. 
 Results suggest that female TB patients 
have longer waiting times to see a health 
worker compared to males. Further 
investigation is needed to determine 
whether this difference is due to different 
service organisation between the facilities 
attended more by women compared to 
those attended more by men. 
 Younger patients on both services are more 
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premature mortality (Groenewald et al. 2010). 
Tuberculosis was also among the four leading 
causes of mortality. Similarly, MP also faces 
HIV and TB related health challenges. The 2010 
figures, for instance, showed that HIV/AIDS and 
TB respectively ranked as second and third 
highest causes of mortality in Mitchell’s Plain, 
after homicide (Groenewald et al. 2010). 
Mortality might increase if nothing is done to 
improve access to TB and HIV treatment, and 
other related interventions in the area.  
 
It is against this background that this study was 
undertaken to identify specific factors affecting 
access to treatment of HIV and TB. The two 
services were assessed together because not only 
are 60% of TB cases co-infected with HIV, but 
TB is also the major cause of mortality in HIV 
patients (Gasana 2008; National Department of 
Health. 2011), and patients using these services 
are therefore likely to be faced with similar 
challenges to accessing care.  
 
METHODS  
The study used an approach that defines access 
to health care as comprising three distinct and 
measurable dimensions namely: availability, 
affordability and acceptability. It follows from 
this that to ensure a comprehensive evaluation 
and therefore understanding of access to health 
care, the three access dimensions need to be 
examined together because they are interrelated. 
This study used secondary survey data from the 
REACH project (Researching Equity in Access 
to Health Care project). REACH is a programme 
working to examine health system access and 
equity in South Africa focusing on the tracer 
services of TB, ART and obstetric care. The 
analysis presented in this policy brief included 
TB and ART patients aged above 18 years that 
were receiving care from health facilities in 
Mitchell’s Plain, Cape Town. 
 
STUDY FINDINGS 
 Availability of Services. 
The results reveal that ART services are 
inadequate to meet the needs of everyone in need 
of treatment.  This inadequacy of health facilities 
is evident from 
longer waiting 
times to collect 
medicines and 
to see a health 
worker, 
compared to TB services.  Specifically, at the 
time of the study, there were only three (3) ART 
facilities in Mitchell’s Plain. 
Further investigation on waiting time in the 
facilities showed that female patients on both TB 
treatment and ART spent more time waiting to 
collect medicines and to see a health worker, 
compared to male patients. As alluded to earlier, 
further investigation needs to be done to 
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 Affordability of Services
The results 
revealed that 
patients on TB 
treatment incur 
higher monthly 
health care expenditure than their counterparts
on HIV treatment. Most of this expenditure is
on transport resulting from higher frequency
of facility visits for the daily DOTs (Directly
Observed Treatment, Short-course). 
The higher health care costs together with
lower ability to pay for services (lower
employment rates, fewer patients on the
disability grant etc) result in many TB
patients spending more than 10% of their
household expenditure (HHEXP) on health
care. Spending so much money on health in
relation to their ability to pay is viewed to be
catastrophic as it may drive households into 
poverty.
Furthermore, female TB patients incurred
higher monthly transport costs compared to
their male counterparts, while relatively
younger respondents on both TB and HIV
treatment spent more money on self-care i.e.
buying over-the-counter drugs, buying 
traditional medicines etc.
 Acceptability of services
With regards to acceptability of services, it
was found that in addition to the majority of
patients who complained about long queues
and therefore long waiting times, more 
patients on ART, compared to those on TB 
treatment, felt that facilities were dirty, and 
that health workers did not have time to 
answer their questions.  
 Adherence to Treatment
Although neither of the services experienced
100% patient adherence to treatment, there
were more patients on TB treatment than on 
ART who reported ever missing a health 
facility visit and also missing treatment 
doses. This could be as a result of the higher 
costs associated with seeking TB care i.e.
transport costs plus the higher frequency of
visits to the facilities.
In addition, results revealed that younger 
patients on TB treatment were more likely to 
miss both a health facility visit and TB 
treatment dose, and that younger patients on 
HIV treatment were more likely to miss a 
health facility visit.  
CONCLUSION 
 Patients receiving both TB and HIV
treatment face barriers to accessing care
in MP. Barriers are either related to
patients’ socio-economic status i.e. costs
of seeking care, or to the organisation of
the health care system i.e. over-crowded
facilities.
 The disability grant should be better
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on TB treatment, to cover their relatively 
higher health care costs, and protect them 
from being driven into poverty by having 
to pay more than 10% of their HHEXP 
on health care.  
 Integrating TB and ART services should 
reduce the cost of seeking care for 
patients. Having a one-stop-shop for both 
services should help patients who need 
care from both services to cut down on 
transport costs and travelling time, 
thereby giving patients more resources 
and time for other economic activities.  
Integration will also improve system 
performance by lessening work over-lap 
of health workers and over-stretching 
health care resources by having separate 
services. 
 Availability, affordability and 
acceptability of services need to be 
examined together if access to health care 














 Promote the integration of TB and HIV 
services in Mitchell’s Plain 
 Increase HIV treatment services and 
make them as close to the people as 
possible 
 Improve targeting of the disability grant 
to include more TB patients 
 Improve organisation of health care 
systems by ensuring user-friendly 
services especially to women and 
younger respondents. Also ensure cleaner 
facilities to improve patient retention. 
 Train providers on the importance of 
patient engagement and education with 
regards to patient retention and treatment 
compliance. There is no doubt that 
patients’ participation in decisions about 
health care organisation is essential for 
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Box 2: Lessons from Mitchell’s Plain 
 Access can only be achieved by the 
interaction of three interrelated dimensions 
(availability, affordability and 
acceptability) 
 Catastrophic health care costs are very 
common in the TB service, potentially 
putting patients at risk of being driven 
further into poverty 
 Inadequacy of services can result in over-
crowding and long queues in facilities, 
leading to work overload for health 
workers and hence reduced time per 
patient.  
 Poor attitudes by health workers and dirty 
facilities result in poor acceptability of 
services and affect adherence to care. 
 Patients will resort to self-care and even 
seeking care from other providers if 
services are unavailable, costs are too high 
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Part E: Appendices  
Appendix 1: Data Collection Tools 
 
1. ART Tracer Questionnaire 
REACH  
 




CONSENT TO PARTICIPATE IN THE INTERVIEW  
 
 
Facility: [enter name of facility]_____________________________________ 
 
 
I HAVE BEEN INFORMED ABOUT THE PROJECT RESEARCHING EQUITY IN ACCESS TO HEALTH CARE, AND I 
UNDERSTAND THAT IT IS UP TO ME WHETHER OR NOT TO BE INTERVIEWED.   
 
I understand that there will be no consequences of any kind through my responding to this questionnaire; in particular, there will 
be no impact on the care that I receive in this hospital. 
 
I understand that I can ask the person interviewing me to stop the interview at any time.  
 
I understand that the information that I give will be treated in the strictest confidence and that my name will not be used when 
the interviews are analysed. 
 
 
Yes, I give my permission for the interview      
 
 
__________________________________  _________________ 
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___________________________________ 
Interviewer’s name (please print) 
___________________________________ ___________________ 
Interviewer’s signature     Date 
REACH 
PATIENT EXIT INTERVIEW QUESTIONNAIRE 
TRACER: ART 
0.1 
Date of interview 
































        hour                         min 
0.5 







Instructions for interviewers: 
 
 
This research is part of a multi-center study and the questionnaire has therefore been adapted to suit the different sites. In your 




Questions or parts of questions that do not always need to be read out and instructions are 
 in highlighted text. 
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Unless specifically asked to do so, options do not need to be read out. 
SECTION 1: SOCIOECONOMIC AND DEMOGRAPHIC BACKGROUND QUESTIONS ABOUT THE RESPONDENT, HIS/HER 
HOUSEHOLD AND HOUSEHOLD HEAD 
READ OUT  
I am going to start by asking you a few questions about you and your household. When I talk about your household, I am 
including all the people who live in your house and who share the same food with you. 
 













If other, specify 
1.3 
What was your age at your last birthday?  











Who is the head of your household? By this, I mean, who is the person 
who usually makes the important decisions in the household. Indicate 







Code sex of HHH. If not clear ask: What is the sex of your HHH? 
Male  1 
Female 2 
1.6 
Code position in HH of respondent. If unclear, ask:  
  
What is your position in the household, in relation to the 
household head such as …read out a few relevant options. 
Head/acting head 1 
Husband/wife/partner 2 
Son/daughter/stepchild/adopted child 3 
Brother/sister/step brother/step sister 4 
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Circle one only 
Grandparent/great grandparent 6 
Grandchild/great grandchild 7 
Other relative (e.g. in laws or aunt/uncle) 8 
Non-related persons (tenant, boarder, lodger) 9 
Don’t know 99 
Other 97 
If other, specify 
 
1.7 
What was the age of your HHH i.e. husband / father / 














What is your current marital status? 
Circle one only 
Married 1 
Living with partner 2 
Widow/widower 3 
Divorced or separated 4 
Never married (single) 5 
Other 97 
If other, specify 
1.10 
What is YOUR highest level of 
education? 
Circle one only 
 
If the person is NOT the HHH ask 
 
What is the highest level of education 
of your HHH i.e. husband / father / 
mother etc. 
Type of education You Your 
HHH 
No schooling  0 0 
Highest grade passed in school  (1-12)  
 
  
Completed diploma/certificate 13 13 
Completed degree 14 14 







Are you currently employed working or earning money? 
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If the person is NOT the HHH ask 
 
Is your HHH i.e. husband / father / mother etc. currently employed? 
Yes, full-time 1 1 
Yes, part-time 2 2 
No 3 3 
Don’t know 99 99 
1.12 
If respondent employed ask: 
Are you self-employed or do you work for someone else? 
 
If HHH employed, ask: 
Is your HHH i.e. husband / father / mother etc. self-employed or does 
HE/SHE work for someone else? 
Type of employment You Your 
HHH 
Self-employed 1 1 
Employee 2 2 
Don’t know 99 99 
1.13 
If respondent not employed ask: 
 
What are the reasons that you are not employed?  
 




Reason Yes No 
Studying 1 0 
Looking for work 1 0 
Retired or pensioner 1 0 
Sick or injured 1 0 
Pregnant or caring for own children 1 0 
Caring for other children 1 0 
Caring for sick/injured 1 0 
Retrenched 1 0 
Nothing 1 0 
Don’t know 99 
Other 97 
If other, specify 
1.14 
Including yourself, how many adults (18 years or older) live in your household? When I talk 
about your household, I am including all the people who live in your house and who share 




No. Adults 18 or older 
1.15 




No. Children under 18 
1.16 
Does anyone in your household 
receive a government grant OR 
income from the government such 
as…….read out each option and 
circle yes or no.   
 
IF YES ask:  
How many of each type of grant is 




Type of grant Yes No If yes, number 
received 
Unemployment insurance (UIF) 1 0  
Worker’s compensation 1 0  
State old age pension 1 0  
Disability grant 1 0  
Child support grant 1 0  
Care dependency grant 1 0  
Foster care grant 1 0  
Grant in aid 1 0  
Social relief 1 0  
Other 1 0  
Don’t know 99  
1.17 
If someone in the household receives a disability grant, ask:  
Is it you that receives the disability grant?  
Yes 1 
No 0 
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1.18 
If YES ask:  










If NO ask:  




Where were you born? READ OUT I know this is a sensitive question to 
ask at this stage, but we are asking because we want to see if health 
services treat South Africans differently to those who are not from South 
Africa.  
South Africa 1 
Other 97 






If respondent born in South Africa, ask: 
 
Which province were you born in? 
Use current province borders  
Western Cape 1 
Eastern Cape 2 
Northern Cape 3 
Free State 4 
KwaZulu-Natal 5 








If respondent not born in South Africa, ask:  








SECTION 2: UTILISATION OF HIV AND OTHER HEALTH SERVICES AND INDIRECT COSTS OF THE DISEASE  
READ OUT: In this section I am going to be asking you some questions about the health care that you have used for your HIV.  
2.1 
When did you find out you were HIV positive? 
 
___________________________________ 
                    MM                    YYYY 
2.2 
When did you FIRST begin receiving antiretroviral (ARV) treatment? 
 
___________________________________ 
                    MM                    YYYY 
2.3 









How often do you collect your ARV treatment here at the clinic? 
 
 
Monthly or less (weekly/bi-weekly) 1 
2-monthly 2 
More than 2 monthly 3 
2.5 
Who supports you in taking your ARV treatment each day? indicate 













































If NO ask: 






READ OUT: Some people find it quite hard to stick to the ARV treatment and might not always be able to make their 
appointments at the clinic. We are now going to ask you about whether you have had any of these sorts of problems and what 
the reasons might be. 
2.9 








Did you miss taking any ARV tablets 3 DAYS AGO? Specify the calendar day in relation to the day













How many visits did you miss? _______________ 
No. visits 
2.15 
What was the reason(s) for missing the 
visits? 
Do not read the list aloud; probe 
respondent to give you up to three 
reasons 
Circle up to three yes options and circle 
all others no 
Reason Yes No 
Lack of money 1 0 
Lack of time 1 0 
I felt better 1 0 
I could not take time off from work 1 0 
No transport 1 0 
Too ill to travel 1 0 
Other responsibilities 1 0 
The treatment is not effective / does not make me feel better 1 0 
The queues in the facility are too long 1 0 
The staff are rude or uncaring 1 0 
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Don’t know 99 
Other 97 
If other, specify (1) 
If other, specify (2) 
2.16 
Apart from visits to this clinic for 
your ARVs, have you used this 
clinic or any other health service 
in the last four weeks? 
Specify in relation to the 
calendar date 
Read out each option one at a 
time. IF YES ask: 
How many visits (or inpatient 
days) did you have? 
Then ask: 
How much did you have to pay 
the provider for each? 
Circle all that apply “Yes” and 
others “No” 






Chemist/pharmacy 1 0 
This clinic (not for ARVs) 1 0 
A different public clinic 1 0 
A private doctor 1 0 
A traditional healer 1 0 
A public hospital emergency/ outpatient 
department 
1 0 
Inpatient stay in a public hospital 1 0 
A private hospital emergency/ outpatient 
department
1 0 
Inpatient stay in a private hospital 1 0 
TB clinic 1 0 
Leave blank 
Antenatal clinic [women only] 1 0 
Other 1 0 
If other, specify 
2.17 
Have you spent any other money on health care in the past month
(e.g. traditional medicines, spaza shops, special food, etc). IF 
YES, how much have you spent? 
Yes 1 
No 0 
If Yes, specify amount 
_______________________________(Rand) 
SECTION 3: AFFORDABILITY 
READ OUT: I am now going to ask you some questions about the financial difficulties you might face in seeking health care for 
your HIV/AIDS. 
3.1 





How much money did you borrow? _____________________________(Rand) 
3.3 




How much time did you spend at the clinic last time you came to 
collect your ARV treatment? ___________ hrs _____________ minutes 
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3.5 
How much time did you spend at the clinic last time you came to 
see the doctor/nurse for your ARVS? 
 
 
___________ hrs _____________ minutes 
3.6 
What would you have 
been doing if you 
weren’t at the clinic 
today?  
 
Circle “Yes” or “No” on 
every row. 
Activity Yes No 
Working for pay 1 0 
Doing unpaid community work or volunteer work 1 0 
Doing household chores such as cleaning, cooking, shopping for food, 
maintenance and repairs, working in the garden, gathering wood, gathering 
water, housework etc.  
1 0 
Taking care of children 1 0 
Leisure activities (sport, watching TV, listening to music, reading, visiting 
friends and family, going to movies etc) 
1 0 
Attending school or other educational institution 1 0 
Nothing 1 0 
I don’t know 99 
Other 97 
If other, specify 
3.7 
In coming to receive 
treatment today, how 
much did you pay for: 
 
Read out each item. If 
no money spent, code 
as “0” for each item 
Category Rand 
Transport (one way)  
Clinic/hospital fees  
Medicines   
Someone to take over your tasks while you are here including childcare  
Accommodation if you need to stay the night nearby  
Food during visit  
Phoning or sms’ing  
Other, specify:  
3.8 
Did you find it easy or difficult to incur these expenses? Refer to expenses in 3.7 
Easy 1 
Difficult 2 
Neither easy nor difficult 3 
Don’t know 99 
3.9 
If respondent is working for pay 










Who has been helping you financially, i.e. 
with cash, buying food, providing transport 
etc, with your HIV/AIDS?  
 
Circle “Yes” or “No” on every row. 
Person Yes No 
Husband/wife 1 0 
Father/mother 1 0 
Boyfriend/girlfriend 1 0 
Other relatives 1 0 
Friends 1 0 
Nobody 1 0 
Employer (over and above normal wages) 1 0 
Don’t know 99 
Other 97 
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SECTION 4: AVAILABILITY  
4.1 















Are the opening hours of this clinic convenient for you?  
Yes 1 
No 0 
Don’t know 99 
4.4 
How did you get here today? 
 
Circle “Yes” or “No” on every row. 
Transport mode Yes No 
By foot 1 0 
Bicycle 1 0 
Minibus taxi  1 0 
Bus / Train 1 0 
Own private car  1 0 
Other private car (can be meter taxi, hired car, 
catching a lift) 
1 0 
Ambulance / hospital transport 1 0 
Other 1 0 
If other, specify 
 
4.5 
How long did it take you to get here? (one way only) time 




___________ hrs _____________ minutes 
4.6 


















Since you learnt about your HIV status, has anyone from the health service ever visited you at 








If YES write result 
 
 
___________________________ CD4 count result 
READ OUT Please tell me if you think the following two statements are true/correct or false/incorrect: 
4.13 
It is acceptable to stop ARVs after gaining weight 
True / correct 1 
False / incorrect 2 
Don’t know 99 
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ARVs cure HIV/AIDS False / incorrect 2 
Don’t know 99 
SECTION 5: ACCEPTABILITY  
5.1 





Who have you told about your HIV status? indicate relationship 

















READ OUT For the following three questions, please tell me whether you agree or disagree with the statements I make. 
5.3 
 “I have all the support from my partner that I need to cope with my illness”? 
Agree 1 
Disagree 0 
Don’t know 99 
Not applicable 98 
   
5.4 
“I have all the support that I need from my family” 
Agree 1 
Disagree 0 
Don’t know 99 
Not applicable 98 
5.5 
“I have all the support that I need from my friends” 
Agree 1 
Disagree 0 
Don’t know 99 
Not applicable 98 
5.6 
Do you feel that people in the community judge you negatively for attending this 
facility for your ARV treatment? 
Yes 1 
No 0 
Don’t know 99 
5.7 
For your ARV treatment what would you prefer: 
 
a) To see a nurse in a nearby clinic or  
b) To travel further to see a doctor 
Nurse 1 
Doctor 2 
Indifferent  3 
Don’t know 99 
5.8 




READ OUT: Can you tell me whether you agree or disagree with these statements when thinking about your general 
experience in this clinic? 
5.9 
The queues to see a doctor or nurse are too long at this facility  
Agree 1 
Disagree 0 
Both agree and disagree 2 
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5.10 




Both agree and disagree 2 
Don’t know / not sure 99 
5.11 
It is a problem that the health workers DO NOT speak my language. 
Agree 1 
Disagree 0 
Both agree and disagree 2 
Don’t know / not sure 99 
5.12 
I find it easy to tell the health workers when I have missed taking my tablets 
Agree 1 
Disagree 0 
Both agree and disagree 2 
Don’t know / not sure 99 
Not applicable 98 
5.13 
The health workers are too busy to listen to my problems  
Agree 1 
Disagree 0 
Both agree and disagree 2 
Don’t know / not sure 99 
5.14 
Patient information is kept confidential in this clinic 
Agree 1 
Disagree 0 
Both agree and disagree 2 
Don’t know / not sure 99 
5.15 
Some staff DO NOT treat patients with sufficient respect  
Agree 1 
Disagree 0 
Both agree and disagree 2 
Don’t know / not sure 99 
5.16 
The health workers I see respect me 
Agree 1 
Disagree 0 
Both agree and disagree 2 
Don’t know / not sure 99 
5.17 
The facilities (including waiting area and toilets) are dirty  
Agree 1 
Disagree 0 
Both agree and disagree 2 
Don’t know / not sure 99 
5.18 
How satisfied were you with the service today? 
Very satisfied/ Satisfied 1 
Neither satisfied nor dissatisfied 2 
Dissatisfied/ Very dissatisfied 3 
Don’t know 99 
5.19 
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5.21 






Why did you not use ARV 
services? 











How do you think the service in 
this clinic could be improved?  
 
Circle “Yes” or “No” on every 
row. 
Improvement Yes No 
Shorter queues 1 0 
More health workers 1 0 
Cleaner facilities 1 0 
Better patient facilities (toilets, waiting room area etc) 1 0 
Don’t know 99 
Other 97 
If other, specify 
SECTION 6: DWELLING CHARACTERISTICS,  HOUSEHOLD INCOME, EXPENDITURE AND HOUSEHOLD ASSETS  
READ OUT Finally, we want to ask you some questions about the characteristics of the house where you live and type of 
facilities available within your household 
6.1 
Where do you live? 
 
 
______________________________________________village or community 
 
 
_________________________________________________area or township 
6.2 
Which best 
describes the type of 









House or brick structure on a separate stand or yard or on farm 1 
Traditional dwelling/hut/structure made of traditional materials  2 
Flat  3 
Town/cluster/semi-detached house (simplex, duplex or triplex) 4 
Unit in retirement village 5 
Dwelling/house/flat/room in backyard 6 
Informal dwelling/shack IN the backyard of a formal house 7 
Informal dwelling/shack NOT in backyard e.g. in an informal/squatter settlement or on farm 8 
Room/flatlet not in backyard but on a shared property e.g granny flat 9 
Caravan/tent 10 
Worker’s hostel 11 
Other 97 
If other, specify 
6.3 




Circle one only 
 
 
Bricks & plaster/finished 1 
Bare brick/cement block 2 




Mixture of mud and cement 7 
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Mud 9 
Other 97 
If other, specify 
6.4 
What is the main material of your house’s roof? 
Clarify answer 
Circle one only 
Tiles 1 






If other, specify 
6.5 
How many rooms, including kitchens, does your house have?  Interviewer, prove 
and exclude bathrooms, sheds, garages, stables, etc. from the total unless people 
are living in them. ________________No. rooms 
6.6 
What is the main source of drinking water for members 
of your household? 
Clarify answer 
Circle one only 
Piped (tap) water in dwelling 1 
Piped (tap) water on site or in yard 2 
Borehole on site 3 
Rain water tank on site 4 
Neighbour’s tap 5 
Public/communal tap (either free or paid) 6 
Water carrier/tanker 7 
Borehole off site/communal 8 
Flowing water/stream/river 9 




If other, specify 
6.7 
What type of toilet does your household use? 
Clarify answer 
Circle one only 
Flush toilet (connected to sewage) 1 
Flush toilet (with septic tank) 2 
Chemical toilet 3 
Pit latrine with ventilation pipe 4 
Pit latrine without ventilation pipe 5 
Bucket toilet 6 
No facility/bush/field 7 
Other 97 
If other, specify 
6.8 
What is the main source of energy for cooking in your 
household? 
Clarify answer 
Electricity from mains 1 
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Circle one only Wood 5 
Coal 6 
Animal dung 7 
Solar energy 8 
Other 97 
If other, specify 
 
6.9 
Does your household have any of the following items in good 
working order?  
 
Read out each item and circle “Yes” or “No” on every row. 
 
 
 Yes No 
Telkom / landline phone 1 0 
Cell phone 1 0 
Radio 1 0 
Television 1 0 
Video recorder/DVD player 1 0 
Electric stove with oven 1 0 
Bicycle 1 0 
Personal computer at home 1 0 
Internet facilities at home 1 0 
Fridge 1 0 
Car/truck/bakkie 1 0 
Primus cooker, Sikeni 1 0 
Electric hot plate 1 0 
Gas cooker 1 0 
Electric kettle 1 0 
Sewing machine 1 0 
Block maker 1 0 
Motorcycle or scooter 1 0 
Kombi, lorry or tractor 1 0 
Bed 1 0 
Table and chairs 1 0 
Sofa or sofa set 1 0 
Kitchen sink 1 0 
Car battery for electricity 1 0 
Wheelbarrow 1 0 
Hoe, spade or garden fork 1 0 
Bed nets 1 0 
Cattle 1 0 
Other livestock (chickens etc) 1 0 
6.10 
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6.12 
IF YES  
 





Don’t know 99 
6.13 
IF YES  
 






Don’t know 99 
6.14 
IF YES  
 






Don’t know 99 
6.15 
IF YES  
 
Does the HH own any other farm animals? IF YES What 
are they 
 
How many [other] does the household own? 
 







Don’t know 99 
6.16 
In general how much does your household usually 
spend in a month? 
 
If the respondent does not give you a precise estimate 
ask him/her 
 
In which of the following ranges, would you say your 
household EXPENDITURE generally falls?   
 





R0 – R399 1 
R400 – R799 2 
R800 – R1 199 3 
R1 200 - R1 799 4 
R1 800 - R2 499 5 
R2 500 - R4 999 6 
R5 000 - R9 999 7 
R10 000 or more 8 
Don’t know 99 
Refuse 97 
6.17 
Do you have anything 
else that you would like to 
tell us about your 
experience of seeking or 



















        hour                         min 
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CONSENT TO PARTICIPATE IN THE INTERVIEW  
 
 
Facility: [enter name of facility]_____________________________________ 
 
 
I have been informed about the project Researching equity in access to health care, and I understand that it is up to me whether 
or not to be interviewed.   
 
I understand that there will be no consequences of any kind through my responding to this questionnaire; in particular, there will 
be no impact on the care that I receive in this hospital. 
 
I understand that I can ask the person interviewing me to stop the interview at any time.  
 
I understand that the information that I give will be treated in the strictest confidence and that my name will not be used when 
the interviews are analysed. 
 
 
Yes, I give my permission for the interview      
 
 
__________________________________  _________________ 
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___________________________________  ___________________ 
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0.4 







        hour                         min 
0.5 







Instructions for interviewers: 
 
 
This research is part of a multi-center study and the questionnaire has therefore been adapted to suit the different sites. In your 




Questions or parts of questions that do not always need to be read out and instructions are 
 in highlighted text. 
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SECTION 1: SOCIOECONOMIC AND DEMOGRAPHIC BACKGROUND QUESTIONS ABOUT THE RESPONDENT, HIS/HER 
HOUSEHOLD AND HOUSEHOLD HEAD 
READ OUT: 
I am going to start by asking you a few questions about you and your household. When I talk about your household, I am 
including all the people who live in your house and who share the same food with you. 













If other, specify 
1.3 
What was your age at your last birthday? 





Who is the head of your household? By this, I mean, who is the person
who usually makes the important decisions in the household. Indicate








Code position in HH of respondent. If unclear, ask: 
What is your position in the household, in relation to the 
household head such as …read out a few relevant options. 
Head/acting head 1 
Husband/wife/partner 2 
Son/daughter/stepchild/adopted child 3 
Brother/sister/step brother/step sister 4 
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Circle one only 
Grandparent/great grandparent 6 
Grandchild/great grandchild 7 
Other relative (e.g. in laws or aunt/uncle) 8 
Non-related persons (tenant, boarder, lodger) 9 
Don’t know 99 
Other 97 
If other, specify 
 
1.7 
What was the age of your HHH i.e. husband / father / 














What is your current marital status? 
Circle one only 
Married 1 
Living with partner 2 
Widow/widower 3 
Divorced or separated 4 
Never married (single) 5 
Other 97 
If other, specify 
1.10 
What is YOUR highest level of 
education? 
Circle one only 
 
If the person is NOT the HHH ask 
 
What is the highest level of education 
of your HHH i.e. husband / father / 
mother etc. 
Type of education You Your HHH 
No schooling  0 0 
Highest grade passed in school  (1-12)  
 
  
Completed diploma/certificate 13 13 
Completed degree 14 14 
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1.11 
Are you currently employed working or earning money? 
 
If the person is NOT the HHH ask 
 
Is your HHH i.e. husband / father / mother etc. currently employed? 
Type of employment You Your HHH 
Yes, full-time 1 1 
Yes, part-time 2 2 
No 3 3 
Don’t know 99 99 
1.12 
If respondent employed ask: 
Are you self-employed or do you work for someone else? 
 
If HHH employed, ask 
Is your HHH i.e. husband / father / mother etc. self-employed or does 
HE/SHE work for someone else? 
Type of employment  You Your HHH 
Self-employed 1 1 
Employee 2 2 
Don’t know 99 99 
1.13 
If respondent not employed ask: 
 
What are the reasons that you are not employed?  
 




Reason Yes No 
Studying 1 0 
Looking for work 1 0 
Retired or pensioner 1 0 
Sick or injured 1 0 
Pregnant or caring for own children 1 0 
Caring for other children 1 0 
Caring for sick/injured 1 0 
Retrenched 1 0 
Nothing 1 0 
Don’t know 99 
Other 97 
If other, specify 
1.14 
Including yourself, how many adults (18 years or older) live in your household? When I talk 
about your household, I am including all the people who live in your house and who share the 





No. Adults 18 or older 
1.15  
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How many children (younger than 18 years) live in your household?  
___________________ 
No. Children under 18 
1.16 
Does anyone in your household 
receive a government grant OR 
income from the government such 
as…….read out each option and 
circle yes or no on every row.  
 
IF YES ask: 
How many of each type of grant is 




Type of grant Yes No If yes, number 
received 
Unemployment insurance (UIF) 1 0  
Worker’s compensation 1 0  
State old age pension 1 0  
Disability grant 1 0  
Child support grant 1 0  
Care dependency grant 1 0  
Foster care grant 1 0  
Grant in aid 1 0  
Social relief 1 0  
Other 1 0  
Don’t know 99  
1.17 
If someone in the household receives a disability grant, ask 




If YES ask: 










If NO ask: 




Where were you born? READ OUT I know this is a sensitive 
question to ask at this stage, but we are asking because we want to 
see if health services treat South Africans differently to those who 
are not from South Africa.  
South Africa 1 
Other 97 
If other, specify 
 
 



























If respondent born in South Africa, ask: 
 
Which province were you born in? 
Use current province borders  
Western Cape 1 
Eastern Cape 2 
Northern Cape 3 
Free State 4 
KwaZulu-Natal 5 








If respondent not born in South Africa, ask: 








SECTION 2: UTILISATION OF TB AND OTHER HEALTH SERVICES AND INDIRECT COSTS OF THE DISEASE  
READ OUT: In this section we are asking you some questions about what health care you have used for your TB.  
2.1 








                    MM                    YYYY 
2.3 
Where were you diagnosed with TB?  
 
_____________________________________________ 





Have you been offered an HIV test (during this current treatment episode) 
Yes 1 
No 0 
Don’t know 99 
2.5 
How often do you collect your TB treatment here at the clinic? 
 
 









Who checks that you have taken your 
TB treatment each day? i.e. what form 
of DOTS does the patient receive? 
 
The TB DOTS sister or counsellor in the clinic (clinic DOTS) 1 
A community worker (community DOTS) 2 
Someone at my place of work (workplace DOTS) 3 
No-one 4 
Other 97 
If other, specify 
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During this current treatment episode, have you received TB treatment from a clinic other than this 
one?   
No 0 
2.8 




If NO ask: 
 










READ OUT: Some people find it quite hard to stick to their TB treatment and might not always be able to make their 
appointments at the clinic. We are now going to ask you about whether you have had any of these sorts of problems and what 
the reasons might be.   
2.10 








Did you miss taking any TB tablets 3 DAYS AGO? 








Have you missed any of the 
following since you started TB 
treatment for this current episode 
Type of visit Yes No 
 
N/A  If YES, how many? 
Daily DOTS visit 1 0 98  
Nurse/doctor clinic visit 1 0 98  
TB treatment collection 1 0 98  
2.15 
For the last appointment missed, what 
was your reason(s)? 
 
Do not read the list aloud; probe respondent to 
give you up to three reasons 
 
Circle up to three yes options and circle all 
others no 
Reason Yes No 
Lack of money 1 0 
Lack of time 1 0 
I felt better 1 0 
I could not take time off from work 1 0 
No transport 1 0 
Too ill to travel 1 0 
Other responsibilities 1 0 
The treatment is not effective / does not make me feel better 1 0 
The queues in the facility are too long 1 0 
The staff are rude or uncaring 1 0 
I have had bad experiences with staff in the past 1 0 
Don’t know 99 
Other 97 
Other 1 (specify) 
 
 




Apart from visits to this clinic 
for your TB, have you used this 

























P a g e  | 135 
clinic or any other health 
service in the last four weeks? 
Specify in relation to the 
calendar date 
Read out each option one at a 
time. IF YES ask: 
How many visits (or inpatient 
days) did you have? 
Then ask: 
How much did you have to pay 
the provider for each? 
Circle “Yes” or “No” on every 
row. 
Chemist/pharmacy 1 0 
This clinic (not for TB) 1 0 
A different public clinic 1 0 
A private doctor 1 0 
A traditional healer 1 0 
A public hospital emergency/ outpatient 
department 
1 0 
Inpatient stay in a public hospital 1 0 
A private hospital emergency/ outpatient 
department
1 0 
Inpatient stay in a private hospital 1 0 
ARV (HIV) clinic 1 0 
Leave blank 
Antenatal clinic [women only] 1 0 
Other 1 0 
If other, specify 
2.17 
Have you spent any other money on health care in the past month 
(e.g. traditional medicines, spaza shops, special food, etc). If YES, 
how much have you spent? 
Yes 1 
No 0 
If Yes, specify amount
_______________________________(Rand) 
SECTION 3: AFFORDABILITY 
READ OUT: I am now going to ask you some questions about the financial difficulties you might face in seeking health care for 
your TB. 
3.1 





How much money did you borrow? _____________________________(Rand) 
3.3 




How much time did you spend at the clinic last time you came for 
DOTS 
___________ hrs _____________ minutes 
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3.5 
How much time did you spend at the clinic last time you came to 
see the doctor/nurse for your TB? 
 
 
___________ hrs _____________ minutes 
3.6 
What would you have 
been doing if you 
weren’t at the clinic 
today?  
 
Circle “Yes” or “No” on 
every row. 
Activity Yes No 
Working for pay 1 0 
Doing unpaid community work or volunteer work 1 0 
Doing household chores such as cleaning, cooking, shopping for food, 
maintenance and repairs, working in the garden, gathering wood, gathering 
water, housework etc.  
1 0 
Taking care of children 1 0 
Leisure activities (sport, watching TV, listening to music, reading, visiting friends 
and family, going to movies etc) 
1 0 
Attending school or other educational institution 1 0 
Nothing 1 0 
I don’t know 99 
Other 97 
If other, specify 
3.7 
In coming to receive 
treatment today, how 
much did you pay for: 
 
Read out each item. If 
no money spent, code 
as “0” for each item 
Category Rand 
Transport (one way)  
Clinic fees  
Medicines   
Someone to take over your tasks while you are here including childcare  
Accommodation if you need to stay the night nearby  
Food during visit  
Phoning or sms’ing  
Other, specify:  
3.8 
Did you find it easy or difficult to incur these expenses? Refer to expenses in 3.7 
Easy 1 
Difficult 2 
Neither easy nor difficult 3 
Don’t know 99 
3.9 
If respondent is working 
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3.11 
Who has been helping you financially, i.e. 
with cash, buying food, providing transport 
etc, with your TB?  
 
Circle “Yes” or “No” on every row. 
Person Yes No 
Husband/wife 1 0 
Father/mother 1 0 
Boyfriend/girlfriend 1 0 
Other relatives 1 0 
Friends 1 0 
Nobody 1 0 
Employer (over and above normal wages) 1 0 
Don’t know 99 
Other 97 




SECTION 4: AVAILABILITY  
4.1 




If NO ask: 










Are the opening hours of this clinic convenient for you?  
Yes 1 
No 0 
Don’t know 99 
4.4 
How did you get here today? 
 
Circle “Yes” or “No” on every row. 
Transport mode Yes No 
By foot 1 0 
Bicycle 1 0 
Minibus taxi  1 0 
Bus / Train 1 0 
Own private car  1 0 
Other private car (can be meter taxi, hired car, 
catching a lift) 
1 0 
Ambulance / hospital transport 1 0 
Other 1 0 
If other, specify 
 
4.5 
How long did it take you to get here? (one way only) time 




___________ hrs _____________ minutes 
SECTION 5: ACCEPTABILITY  
5.1 





Who have you told about your TB? Indicate relationship e.g. sister, 





































READ OUT: For the following three questions, please tell me whether you agree or disagree with the statements I make. 
5.3 
“I have all the support from my partner that I need to cope with my illness”? 
Agree 1 
Disagree 0 
Don’t know 99 
Not applicable 98 
5.4 
“I have all the support that I need from my family” 
Agree 1 
Disagree 0 
Don’t know 99 
Not applicable 98 
5.5 
“I have all the support that I need from my friends” 
Agree 1 
Disagree 0 
Don’t know 99 
Not applicable 98 
5.6 
Do you feel that people in the community judge you negatively for attending this 
facility for your TB treatment? 
Yes 1 
No 0 
Don’t know 99 
5.7 
In general, when you need to seek healthcare, what do you prefer: 
 
c) To see a nurse in a nearby clinic or  
d) To travel further to see a doctor 
Nurse 1 
Doctor 2 
Indifferent  3 
Don’t know 99 
5.8 




READ OUT: Can you tell me whether you agree or disagree with these statements when thinking about your general experience 
in this clinic? 
5.9 
The queues to see a doctor or nurse are too long at this facility  
Agree 1 
Disagree 0 
Both agree and disagree 2 
Don’t know / not sure 99 
5.10 




Both agree and disagree 2 
Don’t know / not sure 99 
5.11 
It is a problem that the health workers DO NOT speak my language. 
Agree 1 
Disagree 0 
Both agree and disagree 2 
Don’t know / not sure 99 
5.12 















P a g e  | 139 
 
Both agree and disagree 2 
Don’t know / not sure 99 
Not applicable 98 
5.13 
The health workers are too busy to listen to my problems  
Agree 1 
Disagree 0 
Both agree and disagree 2 
Don’t know / not sure 99 
5.14 
Patient information is kept confidential in this clinic 
Agree 1 
Disagree 0 
Both agree and disagree 2 
Don’t know / not sure 99 
5.15 
Some staff DO NOT treat patients with sufficient respect  
Agree 1 
Disagree 0 
Both agree and disagree 2 
Don’t know / not sure 99 
5.16 
The health workers I see respect me 
Agree 1 
Disagree 0 
Both agree and disagree 2 
Don’t know / not sure 99 
5.17 
The facilities (including waiting area and toilets) are dirty  
Agree 1 
Disagree 0 
Both agree and disagree 2 
Don’t know / not sure 99 
5.18 
How satisfied were you with the service today? 
Very satisfied/ Satisfied 1 
Neither satisfied nor dissatisfied 2 
Dissatisfied/ Very dissatisfied 3 
Don’t know 99 
5.19 




IF YES  
















Why did you not use TB services? 












How do you think the service in this 
clinic could be improved?  
Improvement Yes No 
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Circle “Yes” or “No” on every row. 
More health workers 1 0 
Cleaner facilities 1 0 
Better patient facilities (toilets, waiting room area etc) 1 0 
Don’t know 99 
Other 97 
If other, specify 
 
 
SECTION 6: DWELLING CHARACTERISTICS, HOUSEHOLD INCOME, EXPENDITURE AND HOUSEHOLD ASSETS  
READ OUT: Finally, we want to ask you some questions about the characteristics of the house where you live and type of 
facilities available within your household 
6.1 
Where do you live? 
 
 
______________________________________________village or community 
 
 




describes the type of 









House or brick structure on a separate stand or yard or on farm 1 
Traditional dwelling/hut/structure made of traditional materials  2 
Flat  3 
Town/cluster/semi-detached house (simplex, duplex or triplex) 4 
Unit in retirement village 5 
Dwelling/house/flat/room in backyard 6 
Informal dwelling/shack IN the backyard of a formal house 7 
Informal dwelling/shack NOT in backyard e.g. in an informal/squatter settlement or on farm 8 
Room/flatlet not in backyard but on a shared property e.g granny flat 9 
Caravan/tent 10 
Worker’s hostel 11 
Other 97 
If other, specify 
6.3 




Circle one only 
 
 
Bricks & plaster/finished 1 
Bare brick/cement block 2 




Mixture of mud and cement 7 
Wattle and daub 8 
Mud 9 
Other 97 
If other, specify 
 
6.4 




Tiles  1 
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Circle one only Plastic 5 
Cardboard 6 
Other 97 
If other, specify 
6.5 
How many rooms, including kitchens, does your house have?  Interviewer, prove 
and exclude bathrooms, sheds, garages, stables, etc. from the total unless people 
are living in them. ________________No. rooms 
6.6 
What is the main source of drinking water for members 
of your household? 
Clarify answer 
Circle one only 
Piped (tap) water in dwelling 1 
Piped (tap) water on site or in yard 2 
Borehole on site 3 
Rain water tank on site 4 
Neighbour’s tap 5 
Public/communal tap (either free or paid) 6 
Water carrier/tanker 7 
Borehole off site/communal 8 
Flowing water/stream/river 9 




If other, specify 
6.7 
What type of toilet does your household use? 
Clarify answer 
Circle one only 
Flush toilet (connected to sewage) 1 
Flush toilet (with septic tank) 2 
Chemical toilet 3 
Pit latrine with ventilation pipe 4 
Pit latrine without ventilation pipe 5 
Bucket toilet 6 
No facility/bush/field 7 
Other 97 
If other, specify 
6.8 
What is the main source of energy for cooking in your 
household? 
Clarify answer 
Circle one only 
Electricity from mains 1 





Animal dung 7 
Solar energy 8 
Other 97 
If other, specify 
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Does your household have any of the following items in good 
working order?  
 
Read out each item and circle “Yes” or “No” on every row. 
 
 
Telkom / landline phone 1 0 
Cell phone 1 0 
Radio 1 0 
Television 1 0 
Video recorder/DVD player 1 0 
Electric stove with oven 1 0 
Bicycle 1 0 
Personal computer at home 1 0 
Internet facilities at home 1 0 
Fridge 1 0 
Car/truck/bakkie 1 0 
Primus cooker, Sikeni 1 0 
Electric hot plate 1 0 
Gas cooker 1 0 
Electric kettle 1 0 
Sewing machine 1 0 
Block maker 1 0 
Motorcycle or scooter 1 0 
Kombi, lorry or tractor 1 0 
Bed 1 0 
Table and chairs 1 0 
Sofa or sofa set 1 0 
Kitchen sink 1 0 
Car battery for electricity 1 0 
Wheelbarrow 1 0 
Hoe, spade or garden fork 1 0 
Bed nets 1 0 
Cattle 1 0 
Other livestock (chickens etc) 1 0 
6.10 











Don’t know 99 
6.12 
IF YES  
 





Don’t know 99 
6.13 
IF YES  
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6.14 
IF YES 
How many pigs does the household own? 
__________________________________(No. pigs) 
None 0 
Don’t know 99 
6.15 
IF YES 
Does the HH own any other farm animals? IF YES What 
are they 
How many [other] does the household own? 
If other, specify 
________________________________(No. other) 
None 0 
Don’t know 99 
6.16 
In general how much does your household usually spend 
in a month? 
If the respondent does not give you a precise estimate 
ask him/her 
In which of the following ranges, would you say your 
household EXPENDITURE generally falls?  
Circle one only 
________________________________Rand 
R0 – R399 1 
R400 – R799 2 
R800 – R1 199 3 
R1 200 - R1 799 4 
R1 800 - R2 499 5 
R2 500 - R4 999 6 
R5 000 - R9 999 7 
R10 000 or more 8 
Don’t know 99 
Refuse 97 
6.17 
Do you have anything 
else that you would like to 
tell us about your 
experience of seeking or 











Note the end time of the 
interview 
_____________:________________ 
        hour   min 
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Appendix 2: Ethics Approval Letter 
UNIVERSITY OF CAPE T OWN , 
07 November 2007 
REC REF: 460/ 2006 
A/ ProfD McIntyre 
Health Economics Unit 
School of Public Health 
Dear A/ Prof McIntyre 
Health Sciences Faculty 
Research Ethics Committee 
Room E52-24 Groote Schuue Hospital Old Main Building 
Observatory 7925 
T e lepho ne I021]4() (i 6338 • Facs imile 102 11 4Q6 6411 
e-m ail: prcaw:lrd@Cuflc.uCt .. ac.z;l 
PROJECT TITLE: RESEARCHING EQUITY IN ACCESS TO HEALTH CARE (REACH) 
Thank you for your letter to the Research Ethics Committee dated 26,h October 2007. 
It is a pleasure to inform you that the E thics Committee has granted ethical approval to use the set of data 
gathering tools and information sheets and informed consent forms described in appendices 1-18. 
Please could you address the following two concerns: 
• Will patient-participants receive any compensation for taking part'in the in-depth interviews (semi-
structured and narratives)? These are long and may be burdensome for some patients. 
• Do you intend to take any action should you observe harmful staff-patient interaction? You indicate 
that all observations will be strictly confidential which might pose an ethical dilemma should 'patient-
abuse' be observed by researchers. 
Please would you notify Dr Tracey Naledi in the Western Cape Department of Health that you are 
undertaking this study. You indicate that you already have provincial permission to do this research, so it may 
be a redundant exercise (I'll email you her latest requirements). 
Please note that the ongoing ethical conduct of the study remains the responsibility of the principal 
investigator. 
Please quote the REC. REF in all your correspondence. 
Yours sincerely 
PROF M BLOCKMAN 
CHAIRPERSON. HSF H U MAN E THICS 
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Appendix 3: Journal Instructions for authors 
Instructions for BMC Health Services Research authors 
Preparing main manuscript text 
File formats  
 
The following word processor file formats are acceptable for the main manuscript document: 
 Microsoft Word (version 2 and above) 
 Rich text format (RTF) 
 Portable document format (PDF) 
 TeX/LaTeX (use BioMed Central's TeX template) 
 DeVice Independent format (DVI) 
 Publicon Document (NB) 
Users of other word processing packages should save or convert their files to RTF before uploading. 
Many free tools are available which ease this process. 
TeX/LaTeX users: We recommend using BioMed Central's TeX template and BibTeX stylefile. If you 
use this standard format, you can submit your manuscript in TeX format (after you submit your TEX file, 
you will be prompted to submit your BBL file). If you have used another template for your manuscript, or 
if you do not wish to use BibTeX, then please submit your manuscript as a DVI file. We do not 
recommend converting to RTF. 
Note that figures must be submitted as separate image files, not as part of the submitted DOC/ 
PDF/TEX/DVI file. 
Article types  
 






















Please read the descriptions of each of the article types, choose which is appropriate for your article and 
structure it accordingly. If in doubt, your manuscript should be classified as a Research article, the 
structure for which is described below. 
 
Manuscript sections for Research articles  
 










List of abbreviations used (if any) 
Competing interests 
Authors' contributions 
Authors' information (if any) 
Acknowledgements and Funding 
References 
Figure legends (if any) 
Tables and captions (if any) 
Description of additional data files (if any) 
You can download a template (compatible with Mac and Windows Word 97/98/2000/2003/2007) for your 
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The Accession Numbers of any nucleic acid sequences, protein sequences or atomic coordinates cited in 
the manuscript should be provided, in square brackets and include the corresponding database name; for 
example, [EMBL:AB026295, EMBL:AC137000, DDBJ:AE000812, GenBank:U49845, PDB:1BFM, 
Swiss-Prot:Q96KQ7, PIR:S66116]. 
 
The databases for which we can provide direct links are: EMBL Nucleotide Sequence Database (EMBL), 
DNA Data Bank of Japan (DDBJ ), GenBank at the NCBI (GenBank), Protein Data Bank (PDB), Protein 
Information Resource (PIR) and the Swiss-Prot Protein Database (Swiss-Prot). 
 
Title page  
This should list the title of the article. The title should include the study design, for example: 
A versus B in the treatment of C: a randomized controlled trial 
X is a risk factor for Y: a case control study 
The full names, institutional addresses, and e-mail addresses for all authors must be included on the title 
page. The corresponding author should also be indicated. 
 
Abstract  
The abstract of the manuscript should not exceed 350 words and must be structured into separate sections: 
Background, the context and purpose of the study; Methods, how the study was performed and statistical 
tests used; Results, the main findings; Conclusions, brief summary and potential implications. Please 
minimize the use of abbreviations and do not cite references in the abstract; Trial registration, if your 
research article reports the results of a controlled health care intervention, please list your trial registry, 
along with the unique identifying number, e.g. Trial registration: Current Controlled Trials 
ISRCTN73824458. Please note that there should be no space between the letters and numbers of your 
trial registration number. We recommend manuscripts that report randomized controlled trials follow the 
CONSORT extension for abstracts. 
 
Background  
The background section should be written from the standpoint of researchers without specialist 
knowledge in that area and must clearly state - and, if helpful, illustrate - the background to the research 
and its aims. Reports of clinical research should, where appropriate, include a summary of a search of the 
literature to indicate why this study was necessary and what it aimed to contribute to the field. The section 
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Methods  
This should include the design of the study, the setting, the type of participants or materials involved, a 
clear description of all interventions and comparisons, and the type of analysis used, including a power 
calculation if appropriate. 
 
Results and Discussion  
The Results and Discussion may be combined into a single section or presented separately. Results of 
statistical analysis should include, where appropriate, relative and absolute risks or risk reductions, and 




This should state clearly the main conclusions of the research and give a clear explanation of their 
importance and relevance. Summary illustrations may be included. 
 
List of abbreviations  
If abbreviations are used in the text, either they should be defined in the text where first used, or a list of 
abbreviations can be provided, which should precede the competing interests and authors' contributions. 
 
Competing interests  
A competing interest exists when your interpretation of data or presentation of information may be 
influenced by your personal or financial relationship with other people or organizations. Authors should 
disclose any financial competing interests but also any non-financial competing interests that may cause 
them embarrassment were they to become public after the publication of the manuscript. 
Authors are required to complete a declaration of competing interests. All competing interests that are 
declared will be listed at the end of published articles. Where an author gives no competing interests, the 
listing will read 'The author(s) declare that they have no competing interests'. 
When completing your declaration, please consider the following questions: 
 
Financial competing interests 
In the past five years have you received reimbursements, fees, funding, or salary from an organization 
that may in any way gain or lose financially from the publication of this manuscript, either now or in the 
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Do you hold any stocks or shares in an organization that may in any way gain or lose financially from the 
publication of this manuscript, either now or in the future? If so, please specify. 
Do you hold or are you currently applying for any patents relating to the content of the manuscript? Have 
you received reimbursements, fees, funding, or salary from an organization that holds or has applied for 
patents relating to the content of the manuscript? If so, please specify. 
Do you have any other financial competing interests? If so, please specify. 
Non-financial competing interests 
Are there any non-financial competing interests (political, personal, religious, ideological, academic, 
intellectual, commercial or any other) to declare in relation to this manuscript? If so, please specify. 
If you are unsure as to whether you or one of your co-authors has a competing interest, please discuss it 
with the editorial office. 
 
Authors' contributions  
In order to give appropriate credit to each author of a paper, the individual contributions of authors to the 
manuscript should be specified in this section. 
An "author" is generally considered to be someone who has made substantive intellectual contributions to 
a published study. To qualify as an author one should 1) have made substantial contributions to 
conception and design, or acquisition of data, or analysis and interpretation of data; 2) have been involved 
in drafting the manuscript or revising it critically for important intellectual content; and 3) have given 
final approval of the version to be published. Each author should have participated sufficiently in the 
work to take public responsibility for appropriate portions of the content. Acquisition of funding, 
collection of data, or general supervision of the research group, alone, does not justify authorship. 
 
We suggest the following kind of format (please use initials to refer to each author's contribution): AB 
carried out the molecular genetic studies, participated in the sequence alignment and drafted the 
manuscript. JY carried out the immunoassays. MT participated in the sequence alignment. ES participated 
in the design of the study and performed the statistical analysis. FG conceived of the study, and 
participated in its design and coordination and helped to draft the manuscript. All authors read and 
approved the final manuscript. 
 
All contributors who do not meet the criteria for authorship should be listed in an acknowledgements 
section. Examples of those who might be acknowledged include a person who provided purely technical 
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Authors' information  
You may choose to use this section to include any relevant information about the author(s) that may aid 
the reader’s interpretation of the article, and understand the standpoint of the author(s). This may include 
details about the authors' qualifications, current positions they hold at institutions or societies, or any 
other relevant background information. Please refer to authors using their initials. Note this section should 
not be used to describe any competing interests. 
 
Acknowledgements and Funding  
Please acknowledge anyone who contributed towards the study by making substantial contributions to 
conception, design, acquisition of data, or analysis and interpretation of data, or who was involved in 
drafting the manuscript or revising it critically for important intellectual content, but who does not meet 
the criteria for authorship. Please also include their source(s) of funding. Please also acknowledge anyone 
who contributed materials essential for the study. 
 
The role of a medical writer must be included in the acknowledgements section, including their source(s) 
of funding. 
Authors should obtain permission to acknowledge from all those mentioned in the Acknowledgements. 
Please list the source(s) of funding for the study, for each author, and for the manuscript preparation in 
the acknowledgements section. Authors must describe the role of the funding body, if any, in study 
design; in the collection, analysis, and interpretation of data; in the writing of the manuscript; and in the 
decision to submit the manuscript for publica ion. 
 
References  
All references must be numbered consecutively, in square brackets, in the order in which they are cited in 
the text, followed by any in tables or legends. Reference citations should not appear in titles or headings. 
Each reference must have an individual reference number. Please avoid excessive referencing. If 
automatic numbering systems are used, the reference numbers must be finalized and the bibliography 
must be fully formatted before submission. 
 
Only articles and abstracts that have been published or are in press, or are available through public e-
print/preprint servers, may be cited; unpublished abstracts, unpublished data and personal 
communications should not be included in the reference list, but may be included in the text and referred 
to as "unpublished data", "unpublished observations", or "personal communications" giving the names of 
the involved researchers. Notes/footnotes are not allowed. Obtaining permission to quote personal 
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abbreviations follow Index Medicus/MEDLINE. Citations in the reference list should contain all named 
authors, regardless of how many there are. 
Examples of the BMC Health Services Research reference style are shown below. Please take care to 




Web links and URLs should be included in the reference list. They should be provided in full, including 
both the title of the site and the URL, in the following format: The Mouse Tumor Biology Database 
[http://tumor.informatics.jax.org/mtbwi/index.do]. If an author or group of authors can clearly be 
associated with a web link, such as for weblogs, then they should be included in the reference. 
 
BMC Health Services Research reference style 
Style files are available for use with popular bibliographic management software: 
BibTeX 




Article within a journal  
1. Koonin EV, Altschul SF, Bork P: BRCA1 protein products: functional motifs. Nat Genet 1996, 13:266-
267. 
 
Article within a journal supplement  
2. Orengo CA, Bray JE, Hubbard T, LoConte L, Sillitoe I: Analysis and assessment of ab initio three-
dimensional prediction, secondary structure, and contacts prediction. Proteins 1999, 43(Suppl 3):149-170. 
 
In press article  
3. Kharitonov SA, Barnes PJ: Clinical aspects of exhaled nitric oxide. Eur Respir J, in press. 
 
 
Published abstract  
4. Zvaifler NJ, Burger JA, Marinova-Mutafchieva L, Taylor P, Maini RN: Mesenchymal cells, stromal 
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Article within conference proceedings  
5. Jones X: Zeolites and synthetic mechanisms. In Proceedings of the First National Conference on 
Porous Sieves: 27-30 June 1996; Baltimore. Edited by Smith Y. Stoneham: Butterworth-Heinemann; 
1996:16-27. 
 
Book chapter, or article within a book  
6. Schnepf E: From prey via endosymbiont to plastids: comparative studies in dinoflagellates. In Origins 
of Plastids. Volume 2. 2nd edition. Edited by Lewin RA. New York: Chapman and Hall; 1993:53-76. 
 
Whole issue of journal  
7. Ponder B, Johnston S, Chodosh L (Eds): Innovative oncology. In Breast Cancer Res 1998, 10:1-72. 
Whole conference proceedings  
8. Smith Y (Ed): Proceedings of the First National Conference on Porous Sieves: 27-30 June 1996; 
Baltimore. Stoneham: Butterworth-Heinemann; 1996. 
Complete book  
9. Margulis L: Origin of Eukaryotic Cells. New Haven: Yale University Press; 1970. 
Monograph or book in a series  
10. Hunninghake GW, Gadek JE: The alveolar macrophage. In Cultured Human Cells and Tissues. Edited 
by Harris TJR. New York: Academic Press; 1995:54-56. [Stoner G (Series Editor): Methods and 
Perspectives in Cell Biology, vol 1.] 
 
Book with institutional author  
6. Advisory Committee on Genetic Modification: Annual Report. London; 1999. 
 
PhD thesis  
7. Kohavi R: Wrappers for performance enhancement and oblivious decision graphs. PhD thesis. 
Stanford University, Computer Science Department; 1995. 
 
Link / URL  
13. The Mouse Tumor Biology Database [http://tumor.informatics.jax.org/mtbwi/index.do] 
 
Link / URL with author(s)  
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Microsoft Word template  
Although we can accept manuscripts prepared as Microsoft Word, RTF or PDF files, we have designed a 
Microsoft Word template that can be used to generate a standard style and format for your article. It can 
be used if you have not yet started to write your paper, or if it is already written and needs to be put into 
BMC Health Services Research style. 
Download the template (Mac and Windows compatible Word 1998/2000) from our site, and save it to 
your hard drive. Double click the template to open it. 
 
How to use the BMC Health Services Research template  
The template consists of a standard set of headings that make up a BMC Health Services Research 
Research article manuscript, along with dummy fragments of body text. Follow these steps to create your 
manuscript in the standard format: 
 
Replace the dummy text for Title, Author details, Institutional affiliations, and the other sections of the 
manuscript with your own text (either by entering the text directly or by cutting and pasting from your 
own manuscript document). 
If there are sections which you do not need, delete them (but check the rest of the Instructions for Authors 
to see which sections are compulsory). 
If you need an additional copy of a heading (e.g. for additional figure legends) just copy and paste. 
For the references, you may either manually enter the references using the reference style given, or use 
bibliographic software to insert them automatically. We provide style files for EndNote, Reference 
Manager and Zotero. 
For extra convenience, you can use the template as one of your standard Word templates. To do this, put a 
copy of the template file in Word's 'Templates' folder, normally C:\Program Files\Microsoft 
Office\Templates on a PC. The next time you create a new document in Word using the File menu, the 
template will appear as one of the available choices for a new document. 
 
 
Preparing illustrations and figures 
Figures should be provided as separate files. Each figure should comprise only a single file. There is no 
charge for the use of color. 
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Formats  
The following file formats can be accepted: 
EPS (preferred format for diagrams) 
PDF (also especially suitable for diagrams) 
PNG (preferred format for photos or images) 
Microsoft Word (figures must be a single page) 







Figure legends  
The legends should be included in the main manuscript text file rather than being a part of the figure file. 
For each figure, the following information should be provided: Figure number (in sequence, using Arabic 
numerals - i.e. Figure 1, 2, 3 etc); short title of figure (maximum 15 words); detailed legend, up to 300 
words. 
Please note that it is the responsibility of the author(s) to obtain permission from the copyright holder to 
reproduce figures or tables that have previously been published elsewhere. 
 
Preparing a personal cover page 
If you wish to do so, you may submit an image which, in the event of publication, will be used to create a 
cover page for the PDF version of your article. The cover page will also display the journal logo, article 
title and citation details. The image may either be a figure from your manuscript or another relevant 
image. You must have permission from the copyright holder to reproduce the image. Images that do not 
meet our requirements will not be used. 
 
Images must be 300dpi and 155mm square (1831 x 1831 pixels for a raster image). 
Allowable formats - EPS, PDF (for line drawings), PNG, TIFF (for photographs and screen dumps), 
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Preparing tables 
Each table should be numbered in sequence using Arabic numerals (i.e. Table 1, 2, 3 etc.). Tables should 
also have a title that summarizes the whole table, maximum 15 words. Detailed legends may then follow, 
but should be concise. 
Smaller tables considered to be integral to the manuscript can be pasted into the document text file. These 
will be typeset and displayed in the final published form of the article. Such tables should be formatted 
using the 'Table object' in a word processing program to ensure that columns of data are kept aligned 
when the file is sent electronically for review; this will not always be the case if columns are generated by 
simply using tabs to separate text. Commas should not be used to indicate numerical values. Color and 
shading should not be used. 
Larger datasets can be uploaded separately as additional files. Additional files will not be displayed in the 
final, published form of the article, but a link will be provided to the files as supplied by the author. 
 
Tabular data provided as additional files can be uploaded as an Excel spreadsheet (.xls) or comma 
separated values (.csv). As with all files, please use the standard file extensions. 
 
Preparing additional files 
Although BMC Health Services Research does not restrict the length and quantity of data in a paper, there 
may still be occasions where an author wishes to provide data sets, tables, movie files, or other 
information as additional information. These files can be uploaded using the 'Additional Material files' 
button in the manuscript submission process. 
The maximum file size for additional files is 20 MB each, and files will be virus-scanned on submission. 
Any additional files will be linked into the final published article in the form supplied by the author, but 
will not be displayed within the paper. They will be made available in exactly the same form as originally 
provided. 
If additional material is provided, please list the following information in a separate section of the 
manuscript text, at the end of the document text file: 
 
File name 
File format (including name and a URL of an appropriate viewer if format is unusual) 
Title of data 
Description of data 
Additional datafiles should be referenced explicitly by file name within the body of the article, e.g. 'See 
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Formats and uploading  
Ideally, file formats for additional files should not be platform-specific, and should be viewable using free 
or widely available tools. The following are examples of suitable formats. 
Additional documentation 
PDF (Adobe Acrobat) 
Animations 





XLS (Excel spreadsheet) 
CSV (Comma separated values) 
As with figure files, files should be given the standard file extensions. This is especially important for 
Macintosh users, since the Mac OS does not enforce the use of standard extensions. Please also make sure 
that each additional file is a single table, figure or movie (please do not upload linked worksheets or PDF 
files larger than one sheet). 
 
Mini-websites  
Small self-contained websites can be submitted as additional files, in such a way that they will be 
browsable from within the full text HTML version of the article. In order to do this, please follow these 
instructions: 
Create a folder containing a starting file called index.html (or index.htm) in the root 
Put all files necessary for viewing the mini-website within the folder, or sub-folders 
Ensure that all links are relative (ie "images/picture.jpg" rather than "/images/picture.jpg" or 
"http://yourdomain.net/images/picture.jpg" or "C:\Documents and Settings\username\My 
Documents\mini-website\images\picture.jpg") and no link is longer than 255 characters 
Access the index.html file and browse around the mini-website, to ensure that the most commonly used 
browsers (Internet Explorer and Firefox) are able to view all parts of the mini-website without problems, 
it is ideal to check this on a different machine 
 
Compress the folder into a ZIP, check the file size is under 20 MB, ensure that index.html is in the root of 
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Style and language 
General  
Currently, BMC Health Services Research can only accept manuscripts written in English. Spelling 
should be US English or British English, but not a mixture. 
Gene names should be in italic, but protein products should be in plain type. 
There is no explicit limit on the length of articles submitted, but authors are encouraged to be concise. 
There is no restriction on the number of figures, tables or additional files that can be included with each 
article online. Figures and tables should be sequentially referenced. Authors should include all relevant 
supporting data with each article. 
BMC Health Services Research will not edit submitted manuscripts for style or language; reviewers may 
advise rejection of a manuscript if it is compromised by grammatical errors. Authors are advised to write 
clearly and simply, and to have their article checked by colleagues before submission. In-house 
copyediting will be minimal. Non-native speakers of English may choose to make use of a copyediting 
service. 
 
Help and advice on scientific writing  
The abstract is one of the most important parts of a manuscript. For guidance, please visit our page on 
"Writing titles and abstracts for scientific articles"  
Tim Albert has produced for BioMed Central a list of tips for writing a scientific manuscript. 




Abbreviations should be used as sparingly as possible. They can be defined when first used or a list of 
abbreviations can be provided preceding the acknowledgements and references. 
 
Typography  
Please use double line spacing. 
Type the text unjustified, without hyphenating words at line breaks. 
Use hard returns only to end headings and paragraphs, not to rearrange lines. 
Capitalize only the first word, and proper nouns, in the title. 
All pages should be numbered. 
Use the BMC Health Services Research reference format. 













P a g e  | 158 
Greek and other special characters may be included. If you are unable to reproduce a particular special 
character, please type out the name of the symbol in full.  
Please ensure that all special characters used are embedded in the text, otherwise they will be lost during 
conversion to PDF. 
Genes, mutations, genotypes, and alleles should be indicated in italics, and authors are required to use 
approved gene symbols, names, and formatting. Protein products should be in plain type. 
Units  
SI Units should be used throughout (liter and molar are permitted, however). 
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